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QUILL ON SCALPEL
This section provides a medium through which Canadian surgeons can declare themselves, briefly 
and informally, on the day-to-day affairs of surgery.
Advances in Total Colonic Aganglionosis
As defined in Louw’s paper in this 
issue (page 397) total colonic agangli­
onosis is that type of Hirschsprung’s 
disease in which ganglion cells are 
absent throughout the colon and a 
greater or lesser part of the small in­
testine. The condition accounted for 
approximately 8% of the 217 cases of 
Hirschsprung’s disease reported in his 
article.
This disease, affecting as it does an 
extremely long segment of the in­
testine, presents a most difficult thera­
peutic problem. In seeking its elucida­
tion Professor Louw has carefully 
analysed the data from his 17 patients 
collected over a 21-year period.
The pitfalls in the interpretation of 
roentgenographic findings are em­
phasized and the radiologic features 
specific to total colonic aganglionosis 
are indicated. These include the “egg 
on end” appearance of the inverted 
lateral roentgenogram which should 
raise one’s suspicion of the diagnosis.
Rectal manometry appears to be an 
unreliable diagnostic procedure in pa­
tients with total colonic aganglionosis 
since it was characteristic of the dis­
ease in only one of five patients.
Suction rectal biopsy as described 
by Noblett1 has proved highly satis­
factory in those cases in which its per­
formance is possible. Attention is given 
to the importance of increased cholin­
esterase activity in confirming the com­
plete absence of ganglion cells and an 
increased number of large peripheral 
nerves.
The histochemical demonstration of
increased acetylcholinesterase in the 
myenteric plexus is well known in 
Hirschsprung’s disease, but now Profes­
sor Louw points out that the biochem­
ically determined concentrations of 
serum pseudocholinesterase and ery­
throcyte acetylcholinesterase vary with 
the length of the aganglionic segment. 
They are higher in the long segment 
disease and lower in the short segment 
disease. This observation has provided 
us with additional information concern­
ing Hirschsprung’s disease and for the 
first time has shown that the disease 
has systemic effects that require fur­
ther study.
Louw makes clear that the successful 
management of total colonic agangli­
onosis depends on early recognition of 
the disorder, prompt decompression of 
the obstructed bowel by ileostomy or 
even jejunostomy, control of critical 
fluid losses occasioned by the short- 
bowel syndrome, an appropriate defini­
tive surgical operation and, finally, in 
the postoperative period, management 
of fluid losses and perianal excoriation 
and a regimen leading to satisfactory 
weight gain and growth.
The author’s choice of the best defi­
nitive operation seems to have been 
based upon experience gained from 
this small series of different procedures 
which resulted in 8 survivors among 
17 patients. One survivor had a classic 
Swenson abdominoanal pull-through 
operation, another had a Duhamel ile- 
orectal end-to-side anastomosis and a 
third survivor had a typical Soave en­
dorectal pull-through procedure.2 In all 
three patients the treatment was com­
plicated by recurrent enterocolitis and 
severe perianal excoriation.
Since 1974 five survivors were sub­
jected to the Lester Martin operation.3 
This is essentially an extension of the 
operation proposed by Duhamel for 
total colonic aganglionosis, in which 
an end-to-side anastomosis is created 
between the ganglionic small intestine 
and the aganglionic rectum in the re­
trorectal space leaving the aganglionic 
colon in situ. In its performance one 
removes all the aganglionic colon ex­
cept the descending colon and effects 
a long side-to-side anastomosis between 
the descending colon and a correspond­
ing length of small bowel. This creates 
a larger reservoir and absorptive sur­
face.
It appears that if only half the cir­
cumference of the bowel (180°) is 
supplied with ganglia, this is suf­
ficient to propel semiliquid bowel con­
tents distally. The Lester Martin opera­
tion sometimes results in alternating 
constipation and diarrhea in the early 
postoperative phase, but perianal exco­
riation was much reduced in Professor 
Louw’s series.
Loperamide hydrochloride, a non­
narcotic antidiarrrheal drug, seems to 
be a useful adjunct in postoperative 
management.
Our understanding of this difficult 
variation of Hirschsprung’s disease has 
certainly been advanced by the in­
formation contained in this detailed 
analysis of carefully collected data. 
However, all the factors concerned 
in this fascinating variety of congenital 
intestinal aganglionosis have not yet
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been discovered. To confuse the issue, 
pathologists now refer to “hypoganglio- 
nosis” as an entity and pharmocologists 
allude to a nonadrenergic inhibitory 
system in the innervation of the in­
testine, the absence of which gives rise 
to the signs and symptoms of Hirsch­
sprung’s disease!
It is hoped that some day, some­
where, someone will put all this to­
gether and that, for his current con­
tribution, Professor J. H. Louw will be 
included in the list of those who have 
made the final solution possible.
H arvey E. Beardmore, m d, frcs[c], 
FACS
Department of pediatric general surgery, 
The Montreal Children’s Hospital, 
Montreal, PQ
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Compression Treatment for Burn Scars
The effectiveness of prolonged com­
pression treatment of keloids and hy­
pertrophic scars has been well estab­
lished. Larson and associates1 and 
others2-4 have reported fully the meth­
ods used and results obtained from 
this form of treatment. Complications 
and failures of treatment with pro­
longed compression3 have been due to 
reluctance of patients to wear the com­
pression apparatus, breakdown of the 
skin and, presumably, failure of the 
technique. In spite of these failures, 
about 50% of patients are spared ex­
tensive release and reconstructive pro­
cedures, while others require only minor 
surgery or none at all.
A compression treatment section was 
established several years ago in the re­
gional burn unit of the Hamilton Gen­
eral Hospital. Personnel from this sec­
tion were sent to Texas to learn the 
technique that had proved most suc­
cessful. Anyone who has used com­
pression treatment knows that poor 
technique and makeshift compression 
garments will lead to as many compli­
cations as good results. It took several 
months to iron out the wrinkles in our 
section, but compression treatment has 
proved worth while and our results now 
approximate those reported elsewhere.
In this issue of the Journal (page
450) Garcia-Velasco and colleagues de­
scribe in detail compression treatment 
of hypertrophic burn scars in children 
and the use of a custom-made silicone 
mask that is a valuable aid in the 
treatment of patients with facial scar­
ring. Probably more important is that 
these authors have attempted to throw 
additional light on the pathophysiol­
ogy of scarring and to show the ef­
fects of compression bandaging on it. 
They demonstrate realignment of col­
lagen bundles from the whorled ar­
rangement present before treatment to 
the linear grouping after treatment. A 
decrease in chondroitin sulfate values 
and decreased vascularity in the post­
treatment group of patients is shown. 
Prolonged compression appears to in­
crease scar maturation in some patients, 
and to force maturation in others in 
whom it had been arrested. There can 
be no doubt that microscopically, clin­
ically and even biologically, the char­
acteristics of a mature scar have been 
almost, or possibly completely, attained.
Erie Peacock in the preface to “Sur­
gery and Biology of Wound Repair”5 
alluded to the fact that the gap between 
laboratory and bedside needed to be 
bridged to bring the two closer together. 
This can, in part, be accomplished by 
the publication of papers such as that
of Garcia-Velasco and colleagues. So 
much has yet to be done in the in­
vestigation of scarring that I hope this 
paper will encourage others to con­
tribute to Canadian journals and there­
by close that gap.
Barry L. C lark, m d , frcs[c]
Chief of plastic surgery,
St. Joseph’s Hospital,
Hamilton, Ont.
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Introducing
our versatile new suture.
SURGILENE
polypropylene monofilament suture.
® Registered Trademark
•  It is stronger
•  Has longer flex life
•  Has less elasticity
•  Minimizes tissue drag... no sawing
•  Handles well
•  Has minimal tissue reaction, minimal scarring
•  Won't adhere to tissue
•  Maintains in vivo tensile strength
•  Comes in unique DIRECT DISPENSING packages
Ask your scrub nurse for "SURGILENE"
-you'll be glad you did.
SURGILENE®
Blue-Monofilament polypropylene 
Sterile, NONABSORBABLE 
Surgical Sutures, U.S.P.
The best in
nonabsorbable polypropylene 
monofilament sutures
CORRESPONDENCE
Annular Pancreas
To the coeditors: Contrary to the com­
ments made by Dr. O.G. Thurston in 
his editorial entitled “Annular Pan­
creas” (Can J Surg 21: 193, 1978), I 
submit that the classification I set forth 
in my paper (page 241) in the same 
issue does indeed affect the type of sur­
gical treatment offered to the patient.
I make the point that bypass proce­
dures are indicated only in the extra­
mural type of annular pancreas; in the 
intramural type, surgical treatment is 
directed towards the treatment of the 
duodenal ulcer. I think this is made 
clear in the final paragraph of my paper 
and I draw this to the attention of the 
readers of the Journal.
D.W.B. Johnston, md, frcs[c], facs
Director of surgical studies,
Westminster Hospital,
London, Ont.
To the coeditors: In my editorial I 
stated that some form of bypass proce­
dure is indicated in both the extramural 
and intramural types of annular pan­
creas as described by Dr. Johnston. In 
his letter and article Dr. Johnston cor­
rectly points out that in the intramural 
type of annular pancreas the surgical 
treatment is directed towards treatment 
of the duodenal ulcer. I submit that 
this is true providing the annular pan­
creas is bypassed by the surgical proce­
dure on the ulcer, such as the gastro- 
jejunal anastomosis performed on the 
patient in his case 3. Would Dr. John­
ston recommend a vagotomy and an­
trectomy with a Billroth I anastomosis 
for the treatment of such a patient? If 
so, the role of the annular pancreas in 
the pathogenesis of such a duodenal 
ulcer is in doubt.
Olin G. Thurston, md, frcs[c]
Professor,
Department of surgery,
University of Alberta,
Edmonton, Alta.
Standards of Acceptance for 
Surgical Procedures
To the coeditors: In theory, reviewers 
of scientific papers enforce standards 
for acceptance based on the aim of all 
scientists—to report a true result. For 
therapeutic trials a true result depends 
on appropriate design (i.e., the results
should reveal real effects of treatment 
by measures that minimize bias in se­
lecting patients and administering ther­
apy). Acceptance of the results for 
publication implies merit, and without 
publication it is very difficult to estab­
lish a new treatment in practice. Thus, 
medical journals become the filter 
through which appropriately studied 
modalities can go on to application but 
through which inappropriately studied 
modalities should not be able to pass. 
While this has been increasingly true 
for studies on medicinal agents it has 
not been the case for those on new sur­
gical procedures and new applications of 
established procedures. Most reviewers, 
abstract referees for scientific meetings 
and hospital research committees main­
tain high standards for the design of 
medical therapeutic trials. Yet they do 
not impose equal standards upon the 
design of surgical trials. However, this 
is not because such reliable trials can­
not be devised.
It has been shown that prospective, 
controlled trials of surgical therapy, in­
cluding random allocation of patients, 
are feasible, although perhaps they are 
more complicated to perform than com­
parably designed trials of nonsurgical 
therapy. But relatively few have been 
done and these have followed rather than 
preceded the widespread introduction of 
new operations. Yet to establish as early 
as possible that a treatment is truly ef­
fective and exactly for whom it is in­
dicated, the same principles must apply 
to all therapies. Unless this is recog­
nized, uncertainty will continue to 
provoke protracted arguments over ap­
propriate operations for common di­
seases such as peptic ulcer, breast car­
cinoma and coronary artery obstruc­
tion. The years consumed and the heat 
generated by disputants whose skill and 
intellect are undoubted testify to the 
persistent problem of getting valid 
evidence—to the detriment of our pa­
tients. We believe this problem results 
from the absence of appropriate stand­
ards for proof of the effectiveness of 
new surgical treatments and new appli­
cations of existing surgical treatments.
There is no scientific or humanistic 
reason why standards for acceptance 
should not be the same for all types of 
treatment. Indeed, science and ethics 
demand our best efforts to apply such 
equal standards. Moreover, there is 
every reason for their application to 
the very first clinical trial of any mode
of treatment. It is true that operative 
mortality will be reduced with experi­
ence, but the proof of current benefit 
to patients is necessarily derived from 
current experience. Our point is related 
to the quality of such proof.
We believe that the publication “fil­
ter” is the place to maintain equally high 
standards for all treatments. We request 
that the coeditors and reviewers of the 
Canadian Journal of Surgery consider 
an explicit policy of equal standards for 
trials of all modes of therapy.
David H. Spodick, md, d sc 
University of Massachusetts
Wilbert Aronow, md 
University of California
Bernard Barber, ph d 
Columbia University
H enry Blackburn, md 
University of Minnesota
David Boyd, md 
Lahey Clinic, Boston
C. Richard Conti, md 
University of Florida
James P. LoGerfo, md 
University of Washington
Bernard Lown, md 
Harvard University
VlRENDRA S. M aTHUR, MD 
Baylor University
Henry D. McIntosh, md 
Watson Clinic, Lakeland, FL
Thomas A. Preston, md 
US Public Health Service,
Seattle, WA
Arthur Selzer, md 
University of California
T imothy Takaro, md 
Veterans Administration,
Asheville, NC
Recurrent Spontaneous 
Pneumothorax Concurrent 
with Menses
To the coeditors: Recurrent spontaneous 
pneumothorax concurrent with menses 
is becoming increasingly recognized. I 
have recently treated a patient with this 
condition and in reviewing the litera­
ture I found 32 documented cases. 
Much controversy surrounds the cause 
and treatment of this condition. I re­
port my experience for the benefit of 
readers of the Journal.
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A 38-year-old woman, para 2, gravida 2, 
was menstruating regularly. She had no 
history of dysmenorrhea. About 4 hours 
before vaginal bleeding started, she would 
experience a pleuritic type pain on the right 
side of the chest with a dry hacking cough 
and moderate shortness of breath. The 
first time she had these symptoms a chest 
roentgenogram was done that showed 
about 20% pneumothorax; unfortunately 
the roentgenogram was interpreted as nor­
mal. She had 24 such episodes at regular 
monthly intervals before again seeking 
medical assessment. At this time she was 
suffering from severe shortness of breath 
and was found to have a 50% pneumo­
thorax. This was treated with tube thora­
costomy. No evidence of endometriosis 
was obtained by history or physical exam­
ination. Laparoscopy was not done because 
there were no notable physical findings.
During the next menstrual cycle, there 
was again a right-sided pneumothorax. This 
time a thoracotomy was performed. Dia­
phragmatic defects, diaphragmatic fenes­
tration, subpleural endometrioma and en- 
dometrioma involving the diaphragm were 
sought. Only apical bullae were found. 
When the pleural cavity was filled with 
saline, the leak was seen to be coming from
these apical bullae. The pneumothorax was 
treated by excising the apical bullae and 
oversewing the defect with chromic cat­
gut. Gauze abrasion of both pleurae was 
performed. The patient has had no recur­
rence of pneumothorax and she continues 
to menstruate regularly.
Because Rogers, Saperstein and 
Rosenfeld1 advocated that a diagnosis 
of endometriosis could be confirmed by 
laparoscopy and satisfactory treatment 
achieved by suppression of ovulation, 
the opinion of a gynecologist was 
sought. Since there was no suggestion 
of pelvic endometriosis, he believed that 
laparoscopy was unwarranted. From my 
experience I would take exception to 
the treatment advocated by Rogers, 
Saperstein and Rosenfeld although 
some might regard it as a less traumatic 
approach than thoracotomy.
No satisfactory explanation has yet 
been made as to why the pneumothorax 
almost always occurs on the right side. 
The condition can sometimes be attri­
buted to congenital diaphragmatic de­
fects, either single or “fenestrated” .
There are a few reports of cases as­
sociated with a subpleural endometrio­
ma but no evidence of endometriosis 
was found in the tissue removed at oper­
ation in my patient, nor was there any 
diaphragmatic defect.
Although recurrent spontaneous 
pneumothorax concurrent with menses 
remains a relatively rare condition, 
more than 30 cases have been reported. 
The case presented here seems to be the 
most typical presentation; no abnormal­
ities other than the usual apical bullae 
were found. Because of the paucity of 
documented cases, however, I believe 
that this particular case report may be 
useful as the condition becomes better 
recognized and the search for its cause 
continues.
A drian A . M in o r , b sc, m d , fr cs[c]
The Peterborough Clinic,
Peterborough, Ont.
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SESAP II Question
Items 465-468
(A) Congenital aganglionic megacolon (Hirschsprung’s disease)
(B) Psychogenic constipation
(C) Both
(D) Neither
465. Malnutrition and anemia
466. Rarely diagnosed in infancy
467. Roentgenogram of the colon with barium is usually diagnostic
468. Rectal ampulla loaded with feces
For each of the item numbers above select the appropriate lettered word or phrase. Your answer should be
A if the item is associated with (A) only,
B if the item is associated with (B) only,
C if the item is associated with both (A) and (B),
D if the item is associated with neither (A) nor (B)
For the critique of Items 465-468 see page 453 of this issue.
(Reproduced by permission of the American College of Surgeons from SESAP II Syllabus: Surgical Education and 
Self-assessment Program No. 2. For enrolment in the Surgical Education and Self-assessment Program  No. 2 please 
apply to the American College of Surgeons, 55 East Erie St., Chicago, IL  60611.)
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To control upper 
gastrointestinal bleeding 
due to stress ulcer, 
hemorrhagic gastritis, stress 
gastritis, bleeding gastric 
erosions, duodenal and 
gastric ulcers...
New
Tagamet
(cimelidine) injection
The 'Tagamet'effecl
The precise mechanism by which 'Tagamet' controls upper g.i. bleeding is not 
understood, although several theories exist, of which these seem the most likely.
Significantly Inhibits Gastric Acid Secretion,
raising the pH of the stomach to inactivate pepsinogen (thereby decreasing pepsin which is 
known to digest protein in an acidic environment) and possibly promoting clot formation.
■  May Decrease Gastric Mucosal Blood Flow
due to inhibition of acid secretion, allowing the body's hemostatic mechanism 
to control bleeding.
■  May Prevent Further Damage to the Mucosa
by acid through blockade of histamine H2 receptors, thereby encouraging 
healing of the mucosal injury.
65 patients in whom other non- 
surgical measures had failed, or 
for whom surgical intervention 
was considered impossible or 
unduly hazardous, were 
evaluated; the results are 
reported in the adjacent table.1
C o m p lete
S u cce ss
P a rtia l
S u cce ss
C o m p lete  
&  P a rtia l 
S u cce ss
F a ilu re
Heavy 65% 15% 80% 20%
Moderate 52% 22% 74% 26%
Subacute/recurrent 45% 25% 70% 30%
1. Data on file, SK&F Medical Department
The H2 Receptor Antagonist-A major clinical 
advance for uncontrolled g.i. bleeding
SMITH KLINE S-FRENCH CANADA LTD.
Montreal, Quebec H4M 2L6
Tagamet®
(cimetidine SK&F)
Tablets
Injection
Prescribing Information
(Product Monograph available to practitioners on request)
ACTION
Cimetidine competitively inhibits the action of histamine 
at the histamine Ho receptor, and thus represents a new 
class of pharmacological agents, the histamine 
H2 -receptor antagonists.
Cimetidine is not an anticholinergic agent. Studies have 
shown that cimetidine inhibits both daytime and nocturnal 
basal gastric acid secretion. Cimetidine also inhibits 
gastric acid secretion stimulated by food, histamine, 
pentagastrin, caffeine and insulin. Its ability to inhibit 
gastric acid secretion via this unique mechanism of action 
permits a new approach to the treatment of acid-related 
gastrointestinal disorders.
Cimetidine is absorbed rapidly after oral administration. 
The plasma half-life is approximately two hours. The 
principal route of excretion is the urine.
The degree and duration of inhibition of basal and 
stimulated gastric acid secretion are dose-related; the 
data suggest that 80%  or higher inhibition throughout a 
2 4  hour period can be achieved by a dosage regimen of 
3 0 0  mg four times daily given with meals and at bedtime. 
Cimetidine 3 0 0  mg reduced total pepsin output as a result 
of the decrease in volume of gastric juice. The drug had no 
effect on the rate of gastric emptying or lower esophageal 
sphincter (LES) pressure.
INDICATIONS AND CLINICAL USE
Tagamet® (cimetidine) is primary therapy for conditions 
where the inhibition of gastric acid secretion is likely to be 
beneficial, such as:
□  Duodenal ulcer
□  Non-malignant gastric ulcer
□  Gastroesophageal reflux disease
□  Management of upper gastrointestinal hemorrhage
□  Pathological hypersecretion associated with Zollinger- 
Ellison Syndrome, systemic mastocytosis and multiple 
endocrine adenomas.
CONTRAINDICATIONS
There are no known contraindications to the use of 
'Tagam et' (cimetidine).
PRECAUTIONS
Use in Pregnancy: Nursing Mothers:
There has been no experience, to date, with use of 
'Tagam et' (cimetidine) in pregnant patients. Reproduction 
studies performed in rats, mice and rabbits have revealed 
no evidence of impaired fertility or harm to the fetus due to 
'Tagam et'. Studies have demonstrated that 'Tagamet' 
crosses the placental barrier. It is also secreted in the milk 
of animals. 'Tagamet' should be used in pregnant or 
lactating patients or women of child-bearing potential only 
when, in the judgement of the physician, the anticipated 
benefits outweigh the potential risks.
Use in Children
C linical experience in children is limited. Therefore, 
’Tagam et' (cimetidine) therapy cannot be recommended 
for children unless, in the judgement of the physician, 
anticipated benefits outweigh the potential risks. In very 
limited experience, 20-40 mg kg per day has been 
administered in divided doses by mouth or intravenously. 
Use in Im paired Renal Function
Because 'Tagam et' (cimetidine) is excreted by the kidney, 
a reduced dosage should normally be administered to 
patients with impaired renal function. (See DOSAGE AND 
ADMINISTRATION)
Drug Interactions
Studies in animals revealed no pharmacological inter­
action between 'Tagamet' and commonly used drugs. No 
significant interactions have been observed in man.
ADVERSE REACTIONS
Mild and transient diarrhea, muscular pain, dizziness and 
rash have been reported in a small number of patients 
during treatment with 'Tagamet' (cimetidine). There have 
been reports that a few patients have developed mild 
nonprogressive gynecomastia during prolonged treatment. 
No evidence of induced endocrine dysfunction was found, 
and the condition remained unchanged with continuing 
'Tagam et' treatment. Some increases in plasma creatinine 
and serum transaminase have been reported.
OVERDOSAGE
In cases reported to date, involving oral ingestion of up to 
10 grams of 'Tagamet' (cimetidine), no untoward effects 
have been noted, and recovery has been uneventful. 
Treatment
The usual measures to remove unabsorbed material from 
the gastrointestinal tract, clinical monitoring and 
supportive therapy should be employed. Studies in animals 
indicate that assisted respiration may be of value and that 
any tachycardia may be controlled by administration of a 
B-blocker.
D OSAGE AND ADMINISTRATION
ADULTS:
(Experience with 'Tagamet' in children is limited and it has 
not been evaluated in clinical studies—see PRECAUTIONS) 
In c lin ical studies ’Tagamet' (cimetidine) has been used in 
divided doses of up to 240 0  mg/day.
DUODENAL ULCER. NON-MALIGNANT 
GASTRIC ULCER. AND GASTRO­
ESOPHAGEAL REFLUX DISEASE
The recommended adult oral dosage for duodenal ulcer, 
non malignant gastric ulcer and gastroesophageal reflux 
disease is 300 mg four times a  day, with m eals and at 
bedtime.
While healing with 'Tagamet' often occurs during the first 
week or two, treatment should be continued for at least 
four weeks unless healing has been demonstrated by 
endoscopic examination.
Some patients may require concomitant antacids until 
symptoms disappear.
MANAGEMENT OF UPPER 
GASTROINTESTINAL HEMORRHAGE
In patients with upper gastrointestinal bleeding of 
sufficient magnitude as to require blood transfusions, 
'Tagam et' should be administered parenterally, 
preferably by intravenous injection or intermittent 
infusion or, if necessary, by constant intravenous infusion 
until 4 8  hours after active bleeding has stopped. At this 
time an oral dosage regimen may be instituted and should 
be continued for at least 7 -10 days.
Recommended dosage for oral administration:
3 0 0  mg every 6  hours.
Recommended dosage for intramuscular injection 
administration:
3 0 0  mg every 6  hours. Inject the entire contents of a 2  ml 
ampul.
Recommended dosage for intravenous injection 
administration:
3 0 0  mg every 6  hours. Dilute ’Tagamet' in Sodium 
Chloride Injection (0.9% ) (or other compatible i.v. 
solution) to a total volume of 2 0  ml and inject over 1-2 
minutes.
Recommended dosage for intermittent intravenous 
infusion administration:
3 0 0  mg every 6  hours. Dilute 'Tagamet' 3 0 0  mg in 1 0 0  ml 
of Dextrose Injection (5%) (or other compatible i.v. 
solution) and infuse over 15-20 minutes.
In some patients it may be necessary to increase dosage. 
When this is necessary, the increases should be made by 
more frequent administration of a 3 0 0  mg dose, but total 
daily dosage should not exceed 2 4 0 0  mg.
Recommended dosage for constant intravenous 
infusion administration:
2 mg/kg/hour. Dilute ’Tagamet' for injection in a 
compatible i.v. solution, such as Sodium Chloride Injection 
(0.9% ) or Dextrose Injection (5% or 10%). In some patients 
it may be necessary to increase dosage. Dosage should 
usually not exceed 4  mg/kg/hour.
DOSAGE ADJUSTMENT FOR PATIENTS WITH 
IMPAIRED RENAL FUNCTION
Patients with severely impaired renal function have been 
treated with ’Tagamet’. However, such usage has been 
very limited. On the basis of this experience the 
recommended dosage is 3 0 0  mg every 12 hours orally or 
by intravenous or intramuscular injection. Should the 
patient's condition require, the frequency of dosing may be 
increased to every 8  hours or even further with caution. In 
severe renal failure accumulation may occur and the 
lowest frequency of dosing compatible with an adequate 
patient response should be used. Hemodialysis removes 
circulating cimetidine, therefore, the timing of dosage 
should be adjusted to the dialysis schedule
PATHOLOGICAL HYPERSECRETORY 
CONDITIONS
(e.g., Zollinger-Ellison Syndrome)
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Glimpses of Surgical History:
W for Witchcraft, Earliest 
Basis of Medicine
David A. E. Sheph ard
WITCHCRAFT is a Jekyll-and- 
Hyde facet o f man’s attempts to cure 
disease. Witches have been regarded 
as being of two types—those who, 
positively, worked various wonders 
and those who, negatively, used 
drugs, poisons and other adverse 
agents. Perhaps because witchcraft 
has negative connotations—it is the 
negative aspect of magic, which is 
based on “marvellous physical pheno­
mena" and “some occult controlling 
principle of nature” (and who does 
not pay heed to magic of this type?) 
—its interest is perennial. In medi­
cine we can note the great influence 
o f witchcraft. The witch-doctor (or 
medicine man or magician—they 
were one) constituted the earliest 
professional class in society; the 
witch-doctor originally was not a 
witch but one whose job was to 
expel evil from a patient’s body; 
and the first type of surgical opera­
tion developed from man’s attempts 
to drive out of the body “demons" 
that were causing suffering in his 
unfortunate fellows.
The earliest concept of disease 
causation was a dual one: either 
morbid material or influences were 
projected into the body, or the soul 
was abstracted from the body. Early 
medicine men tried to counter par­
ticularly the effects o f evil spirits 
within the body. So they used suc­
tion, cupping, vapour baths, incanta­
tions—or they performed surgical 
trephining. Witch doctors were thus 
the earliest surgeons.
Medicine was once influenced by 
all o f man’s beliefs, o f which witch­
craft was the earliest. Ancient medi­
cine was thus based on witchcraft. 
Such a belief system may seem to 
be the antithesis o f our conviction 
of the value of modern surgery, yet 
in facilitating healing today’s sur­
geons must still help their patients 
deploy natural resources; surgeons, 
one could say, must help their pa­
tients rely on the “controlling prin­
ciple of nature” that defines “magic”. 
Even if one rejects any relation to 
surgery of ineffable forces such as 
“magic” or “witchcraft”, one can 
at least see how far surgery has 
developed out o f the witch-doctor's 
technique of trephining. As for the 
wiser surgeon, he or she is likely 
to remain aware of the value of 
such forces, whatever words are used 
to define them.
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Pheochromocytoma in the Modern Context
N o rm an  C. D elar u e , m d , frcs[c],* John D . M o r r o w , m d , FRCP[c],f 
Jam es H. K er r , m d , f r c p [c ]$ and Ronald  F. Co l a p in t o , m d , f r c p [c]§
The hypertensive patient faces an 
uncertain future. Therefore a search 
for those cases in which the condition 
is potentially curable is eminently 
worth while and has become 
increasingly productive because of the 
specific diagnostic aids now available 
and because of the present safety of 
surgical intervention.
Detection and localization of a 
pheochromocytoma allows a planned 
surgical approach. Correction of hypo­
volemia preoperatively ensures a safe 
course postoperatively. The use of 
blocking agents pre- and peroperatively 
prevents the hazardous hypertensive 
crises and arrhythmias that were a 
part of early surgical experience. 
Monitoring of central venous and arterial 
pressures as well as the electrocar­
diographic tracing during the operation 
permits prophylactic therapy when 
necessary.
On the basis of a series of 31 
patients the authors compare many 
aspects of the current management 
with earlier experience of pheochromo­
cytoma in the same institution. The 
incidence of extra-adrenal lesions
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(3.8%), multicentric tumours (3.8%) 
and malignant change (11.5%) was 
lower in this group of patients than 
that usually reported. Abdominal 
exploration remains the approach of 
choice in most cases.
Treatment of the solitary 
pheochromocytoma has become 
straightforward. However, management 
of the familial syndromes and the 
malignant form of the disease still 
requires careful scrutiny.
Le patient hypertendu fait face a un 
destin incertain. La recherche des cas 
ou I'hypertension est potentiellement 
guerissable est done eminemment 
valable et est devenue de plus en plus 
productive a cause de les aides 
diagnostiques et specifiques maintenant 
disponible et a cause de la securite 
actuelle des interventions chirurgicales.
La detection et la localisation d’un 
pheochromocytome permet de planifier 
I'abord chirurgical. La correction de 
I'hypovolemie avant I’operation assure 
une evolution postoperatoire sure. 
L'emploi d’agents bloquants, avant et 
pendant la periode operatoire, previent 
les crises hypertensives dangereuses 
et les arythmies qui faisaient partie 
des premieres experiences chirurgicales. 
La surveillance des pressions veineuse 
centrale et arterielle, ainsi que du 
trace electrocardiographique pendant 
I'operation permet un traitement 
prophylactique quand cela est 
necessaire.
S'appuyant sur une serie de 31 
patients, les auteurs comparent plusieurs 
aspects du traitement actuel du 
pheochromocytome avec I'experience 
anterieure enregistree dans le meme 
hopital. L'incidence des lesions extra-
surrenales (3.8%), des tumeurs 
polynodulaires (3.8%) et des transfor­
mations malignes (11.5%) a ete plus 
basse pour ce groupe de patients que 
celle qui est habituellement signalee. 
L'exploration adominale demeure la 
voie d’abord de choix dans la plupart 
des cas.
Le traitement du pheochromocytome 
solitaire est devenu simple et direct. 
Toutefois, le traitement du syndrome 
familial et de la forme maligne de la 
maladie exige toujours un examen 
minutieux.
The pheochromocytoma syndrome is 
clearly defined, resembling as it does 
the alarm phase (Fig. 1) of the stress 
(or homeostatic) reaction as well as 
presenting other characteristic features, 
namely, hypertensive crises, sweating, 
palpitation and diabetes. These symp­
toms were noted in the 22 hypertensive 
patients described in this series (Table
I).
Previous reports13 have detailed the 
familial relationships of the tumour, its 
association with many other endocrine 
conditions that are now commonly 
recognized4 and the problems en­
countered in managing the pheochro­
mocytoma that is first recognized dur­
ing pregnancy.5 In 1963 the value of 
peroperative monitoring of blood pres­
sure and cardiac action was emphasized,1 
although central venous pressure re­
cordings were not commonly used at 
that time. The importance of recogniz­
ing and correcting hypovolemia pre­
operatively was also noted— particularly 
in patients with constriction o f peri­
pheral vessels. Some of these patients 
were suffering from an Addisonian
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depletion of sodium (and blood volume) 
as a result of either depression of 
ACTH due to cortisol produced by the 
tumour or a diminished response of the 
adrenal cortex to ACTH brought about 
by high concentrations of epinephrine. 
When the tumour was excised and the 
excess of norepinephrine thereby with­
drawn, vessel walls lacking in sodium 
content could not respond to the sharp 
reduction in circulating catecholamines, 
hence there was vasodilatation and 
peripheral pooling. In these circum­
stances essential treatment included the 
administration of blood, sodium-con­
taining fluid and steroids. Vasocon­
strictors were relatively ineffective un­
til blood volume and vessel reactivity 
had been restored to normal. More­
over, in an attempt to prevent the oc­
currence of potentially hazardous peaks
HOMEOSTASIS
I ALARM PHASE
S T R E S S
♦
E P I N E P H R I N E
♦
PUP ILLA RY D I L A T A T I O N  
B R O N C H I A L  R E L A X A T I O N  
S W E A T I N G  
C A R D I A C  EFFECTS
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•  C o n t ra c t i l i t y
•  I r r i tab i l i t y  
G L Y C O G E N O L Y S I S  
V A S C U L A R  RE DIS TR IBUTION
( H O M E O S T A S I S  I I )
FIG. 1— Physiologic response to epi­
nephrine.
of systolic hypertension and of refrac­
tory arrhythmias during manipulation 
of the tumour at operation, the use 
preoperatively of an a-blocking agent 
(phenoxybenzamine hydrochloride) was 
investigated. Initial experience encour­
aged further study of the potential 
value of this technique. Consequently, 
the preoperative management of pa­
tients suspected of harbouring a pheo- 
chromocytoma (i.e., a potentially cur­
able disease) became increasingly so­
phisticated, with respect to both diag­
nostic considerations and the use of 
a -  and /3-blocking agents to minimize 
intra- and postoperative complications.6
Patients
Our series comprised 31 patients 
with a diagnosis of pheochromocyto- 
ma—5 seen in the period 1950 to 1960, 
15 in the period 1961 to 1970 and 6 
between 1971 and 1975. The data from 
five patients were excluded from the 
study—in three instances because the 
patient was lost to follow-up too soon 
after resection of the lesion to permit 
adequate review, in one because the 
lesion was discovered at autopsy and 
in one because no tumour was found at
Table 1—Symptoms in 22 Hypertensive 
Patients
Symptom No. of patients
Headache 22
Sweating 16
Palpitations 10
Heat intolerance 10
Nausea and vomiting 9
Diabetes 9
Anorexia, weight loss 8
Fatigue 7
Blurring of vision 6
Postural hypotension 5
Flushing 3
Irritab ility 3
Constipation 3
Trembling 2
Blanching 2
Epistaxis 1
operation. In the last instance the pa­
tient’s preoperative vanillylmandelic acid 
(VMA) value (11.1 mg/d [56 /zmol/d]) 
and the cathecholamine values (urinary 
norepinephrine 322 /zg/d [1903 nmol/d] 
and epinephrine 203 /zg/d [1108
nmol/d]) had supported the clinical 
diagnosis in the presence of hyperten­
sion. These values began to fall within 
2 months of operation (VMA 8.6 mg/d 
[43 /zmol/d], norepinephrine 57 /zg/d 
[337 nmol/d], epinephrine 24 /zg/d
[131 nmol/d]) and 2 years later were 
normal (norepinephrine 42 /zg/d 
[248 nmol/d], epinephrine 10 /zg/d
[54.6 nmol/d]). The plasma catechol­
amine concentrations of venous blood 
samples were also normal and localiza­
tion of a possible lesion was therefore 
impossible. Five years after operation 
the patient was still normotensive. The 
values in this patient may represent a 
false-positive biochemical profile, but 
this does not explain fully the accom­
panying change from a hypertensive to 
a normotensive state.
Data from the remaining 26 patients 
form the basis of our report. There 
were 16 women and 10 men with an 
age range from 19 to 69 years (aver­
age, 43 years). Twenty-two were hyper­
tensive; 17 of them had typical par­
oxysmal episodes. The duration of hy­
pertension varied from 1 month to 20 
years (average, 51 months).
Only one extra-adrenal lesion was 
encountered (Table II) and this was 
located in the para-aortic organ of 
Zuckerkandl.7'8 The tumour was malig-
Table I I— Location of Lesions in 26 Patients  
with Pheochromocytoma
Location No. of patients
Adrenal
Right 17
Left 7
Bilateral 1
Extra-adrenal
Para-aortic 1
FIG: 2,~ Bila*eral multip,e pheochromocytomas. (a) Variegated appearance of right-sided lesion, (b) Lesions in right and 
left adrenal glands, (c) Multiple lesions in left adrenal gland.
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nant and subsequently metastasized. 
The one patient with bilateral adrenal 
tumours (Fig. 2) was only 23 years of 
age and had a remarkable family his­
tory of pheochromocytoma. The father 
was found to have bilateral adrenal tu­
mours at autopsy and a brother, three 
first cousins and an aunt had adrenal 
tumours.
In 3 of the 26 patients the lesion 
was detected during the investigation 
of hypertension that developed during 
pregnancy. One had a miscarriage pre- 
operatively. In the second patient the 
tumour was resected at 16 weeks’ gesta­
tion, but an abortion occurred 1 month 
after resection. The patient is alive and 
well 14 years later. The third patient 
who underwent cesarean section at 37 
weeks’ gestation had resection of the 
pheochromocytoma on the same occa­
sion. At the time of writing both the 
patient and the child are well 11 years 
after the operation.
Refinements in Diagnostic Technique
Detection of Pheochromocytoma
The fact that catecholamines and 
their metabolites are excreted in the 
urine has permitted chemical demon­
stration of the presence of a catechola­
mine-secreting tumour (Fig. 3). How­
ever, since only 2% to 4% of nore­
pinephrine and epinephrine is excreted 
directly, attention has been directed at 
detecting the common metabolite VMA, 
a larger proportion (40%) of which is 
excreted. Although there were no 
recognized false-negative reports in this 
series, others9 have reported that the 
frequency of false-negative results may 
be as high as 25% to 30%. Conse­
quently the reports that metanephrine 
and normetanephrine measurements 
were more accurate were evaluated 
since larger amounts of these metabolic 
by-products are excreted in the urine. 
A sharp reduction (to 0% to 4%) in
false-negative reports has been obtained 
so that this problem has been practical­
ly eliminated.9 In eight patients in whom 
a comparison was made, the average 
preoperative concentrations of urinary 
catecholamines (epinephrine 107 /rg/d 
[584 nmol/d], range 26 to 263 [142 to 
1435], and norepinephrine 1275 ftg/d 
[7536 nmol/d], range 265 to 3718 
[1566 to 21 977]) were considerably 
lower than those recorded for the meta­
bolites (metanephrine 679 /u.g/d [3700 
nmol/d], range 231 to 2071 [1260 to 
11 300] and normetanephrine 4631 
fjtg/d [27 300 nmol/d], range 1857 
to 11 912 [11 000 to 70 300]).
Not only do the higher concentra­
tions make detection easier and there­
fore more accurate, but also the wide 
fluctuations ensure earlier detection of 
residual or recurrent disease— a matter 
of importance when the disease is 
malignant in nature.
There were no false-negative results 
in the 25 patients in whom estimations 
were made preoperatively. Values de­
creased to normal in the immediate 
postoperative period in 14 of 16 pa­
tients who had postoperative testing. 
Two patients in whom postoperative 
concentrations were elevated were 
tested several years later and were 
found to have metastatic disease. In 
one woman the VMA values returned 
to normal postoperatively but she re­
mained hypertensive and catecholamine 
values were actually higher than during 
the preoperative period. This patient 
also had bilateral renal artery stenosis 
(Fig. 4) and died 8 months after oper­
ation of a massive cerebrovascular 
hemorrhage complicating the persist­
ing hypertension (300/160 mm Hg). 
There was no evidence of residual 
pheochromocytoma at autopsy.
Localization of Pheochromocytoma
In view of the reported occurrence
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FIG. 3—Metabolism of catecholamines and urinary metabolites.
Fig. 4a Fig- 4b Fig. 4c
FIG. 4— Localization of pheochromocytoma. (a) Intravenous pyelogram showing depression of right kidney by suprarenal 
tumour, (b) Adrenal arteriogram showing right suprarenal tumour “blush”, (c) Renal arteriogram showing bilateral renal artery 
stenosis.
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Table III—Roentgenographic Localization of Pheochromocytoma
Method Normal "Positive” Not done
Intravenous pyelography (n =  18) 12 6 8
Arteriography (n =  15) 2 13 11
of multiple lesions and lesions in extra- 
adrenal locations, attempts to localize 
the tumour preoperatively are worth 
while in order to plan the appropriate 
surgical approach, particularly if the 
concentrations of norepinephrine are 
much higher than those of epinephrine. 
In this event an extra-adrenal location 
is likely, since methylation of nore­
pinephrine to epinephrine occurs pri­
marily in the adrenal gland itself.
Certain risks are associated with ar­
terial and venous catheterization. Hy­
pertensive crises may occur following 
arterial injection of the radiopaque 
dye, although in our experience these 
are readily controlled by the adminis­
tration of phentolamine (2.5 to 5.0 mg 
intravenously). During venography in­
tramedullary hemorrhage may result 
from manipulation of the catheter and 
there is the danger of adrenocortical 
atrophy due to pressure necrosis asso­
ciated with the development of a medul­
lary hematoma. For this reason we 
prefer arteriography and have been 
encouraged by having obtained “posi­
tive” findings in 13 of 15 patients 
(Table III). In only two cases were the 
lesions not demonstrated.
Pheochromocytomas are generally 
vascular and easily demonstrated.10’11 
Usually an aortic “flush” will suggest 
the presence of the tumour and is par­
ticularly valuable in signalling the 
presence of extra-adrenal lesions, spe­
cifically the para-aortic paragangliomas 
which are characteristically supplied by 
a myriad of vessels arising directly from 
the aorta.
Measurement of plasma catechola­
mine values in blood samples taken 
from different levels of the inferior 
vena cava is useful primarily in the 
search for possible sites of recurrent 
or metastatic disease. In one case of a 
malignant lesion in this series the 
source of repeated elevated catechola­
mine concentrations was discovered in 
the right iliac fossa through the in­
creased values found in blood samples 
from this point.
Intravenous pyelography is also war­
ranted because approximately one third 
of the patients will have the character­
istic depression of the ipsilateral kid­
ney (Fig. 4a).
Although abdominal exploration (as 
in 19 of our 26 patients) remains the 
approach of choice because of the fre­
quency of bilaterality and the possibil­
ity of extra-adrenal location of pheo­
chromocytomas, arteriographic localiza­
tion of large adrenal lesions (Fig. 5) 
has permitted utilization of a posterior 
approach (provided that good visualiza­
tion of the normal opposite adrenal 
has been obtained), thereby ensuring a 
smoother postoperative course. In three 
patients the unilateral posterior ap­
proach was used; all have done well 
and are without evidence of residual 
tumour. Thoracoabdominal extensions 
of the incision (in four patients) are 
occasionally advisable when dealing 
with very large tumours.
FIG. 5—Adrenal arteriogram shows left 
suprarenal tumour. In this patient right 
adrenal was normal; aortic “flush” showed 
no extra-adrenal lesion. Operation was by 
unilateral posterior approach.
Table IV—Use of Preoperative “Blockade”
Type of blocking agent No. of patients
None 9
a 8
aandp 9*
*a-methyl paratyrosine was used in 1 patient.
Refinements in Technical 
Management
Preoperative Blocking of Catecho­
lamines
The use preoperatively of both a- 
and /3-blocking agents (Table IV) not 
only ensures a fully expanded vascular 
system but also minimizes large 
fluctuations in blood pressure intraop- 
eratively and the risk of intractable 
cardiac arrhythmias. The effectiveness 
of this prophylactic therapy increases 
with the duration of treatment. Occa­
sionally stabilization has been achieved 
only after several weeks and operation 
should preferably be deferred until this 
objective has been realized. The 
smoother peroperative course (Fig. 6) 
that results from the use preoperatively 
of a- and //-blocking agents can be 
compared with the experience in the 
cases treated earlier in this series, when 
either no prophylactic measures were 
used (Fig. 7) or an a-blocking agent 
was used over the short term only (Fig. 
8). In the more favourable situation re­
sulting from use of a- and /3-blocking 
agents the technical problems are great­
ly simplified for the surgeon.
The regimen that has been most ef­
fective is; phenoxybenzamine hydro­
chloride, 10 mg tid or qid with staged
GLAND REMOVED
200 mm Hg
100 mm Hg
UNBLOCKED PATIENTS
°- and p- BLOCKED PATIENTS
MG. 6 Comparison of fluctuations of blood pressure during surgical excision of 
pheochromocytoma in patients receiving «- and ^-blocking agents and in those in whom 
such agents were not used.
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increases to 40 mg qid if required, and 
propranolol, 10 to 20 mg tid or qid 
with staged increases up to 100 mg 
qid if necessary.
For one patient in whom this regi­
men produced incomplete stabilization, 
a-methyl paratyrosine was added be­
ginning with 250 mg qid and increas­
ing to 500 mg qid. Although stabiliza­
tion at a normotensive state ensued we 
are not certain whether this additional 
treatment was helpful or not because 
a number of agents were being used.
Peroperative Care
During the operative procedure the 
major responsibility devolves upon the 
anesthetist.12 For example, anesthetic 
agents that stimulate catecholamine or 
histamine release are to be avoided.
FIG. 7— Peroperative fluctuations of 
blood pressure in patient receiving no 
blocking agent.
3 0 0  r
Halothane, although it is a potent 
a-blocking agent that facilitates blood 
pressure control, unfortunately stimu­
lates production of epinephrine and 
therefore increases the risk of arrhyth­
mias. Opiates and d-tubocurare cause 
histamine release and anectine, which 
induces fasciculation, is also to be 
avoided.
Monitoring of blood pressure (by 
arterial line) permits its regulation by 
continuous infusion of phentolamine (1 
to 2 mg/mL) and avoids the spectacu­
lar fall in blood pressure that follows 
intravenous administration of a bolus 
of phentolamine (2.5 to 5.0 mg) for 
control of a hypertensive crisis.
The use of a central venous pressure 
line will provide information on fluid 
replacement requirements. Blood trans­
fusion is indicated when a low central 
venous pressure is associated with a low 
blood pressure, whereas if the central 
venous pressure is normal or elevated 
when the blood pressure is low, vaso­
pressors are required. Over-replacement 
of fluid before vasomotor tone recovers 
and possible production of edema are 
thereby prevented.
Continuous electrocardiographic mon­
itoring is advisable because of the fre­
quency of sinus tachycardias. These 
can be effectively corrected by pro­
pranolol (0.5 to 1.0 mg intravenously) 
if treatment is instituted promptly. With 
the use of this precautionary step only 
two frank arrhythmias were detected in 
the entire series.
From the surgical standpoint, more
efficient management by the anesthetist 
permits easier technical mobilization of 
the tumour, particularly when it is 
large, thereby shortening the operative 
procedure and lowering the frequency 
of technical complications.
Results
Benign Disease
In this group of 26 patients, 23 of 
the tumours were clinically benign (Ta­
ble V). The single postoperative death 
occurred early in our experience; the 
patient had unrecognized hypovolemia 
and a benign lesion that was associated 
with prolonged peripheral vasoconstric­
tion preoperatively. Cerebral edema de­
veloped with tentorial herniation and 
cerebellar coning as the result of post­
operative vasodilatation and loss of 
fluid through anoxic capillaries. This 
death could have been prevented by 
preoperative correction of the dimin­
ished blood volume and the restoration 
of a fully expanded vascular reservoir.
Sixteen of the patients with benign 
tumours were normotensive postoper- 
atively. In the 15 patients who have 
been kept under surveillance the aver­
age duration of observation now ex­
ceeds 7 years. One patient was lost to 
follow-up while still well. Two others 
remained normotensive to death, which 
resulted in one case from a cardiac 
arrest 7 years later (there had been 
demonstrable evidence of cardiac is­
chemia preoperatively) and in the other 
case from metastatic thyroid cancer 
after 13 years. This last patient was 
seen before we realized the significance 
of medullary carcinoma of the thyroid 
so that calcitonin studies were omitted.
Curative therapy was therefore 
achieved in 18 of the 23 patients with 
benign tumours. At the time of writing, 
one additional patient remains normo­
tensive while taking medication (methyl- 
dopa, 250 mg/d) after 16 years. In this 
patient therapeutic control was impos­
sible preoperatively. Moreover, a pre- 
operative malignant retinopathy has not 
progressed.
The other three patients with benign 
tumours remained hypertensive follow­
ing excision of the tumour. Reference 
has already been made to the patient 
with bilateral renal artery stenosis who
Tab le  V— Incidence of M alignancy
Type of tumour No. of patients
Benign 22
M alignant
H istologic (clin ica lly
benign) 1
C lin ica l course 3 (11.5% )
Total 26
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FIG. 8— Peroperative fluctuations of blood pressure in patient receiving short-term 
(24-hour) a-blocking agent only.
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died 8 months postoperatively of a 
massive cerebrovascular accident when 
blood pressure readings were as high 
as 300/ 160 mm Hg, although the VMA 
values were normal. One other patient 
has moderate hypertension (130/100 
to 140/ 110 mm Hg) but has been com­
pletely asymptomatic for 14 years with­
out treatment. The third patient also 
has significant hypertension (188/105 
mm Hg); he has required only diuretic 
therapy during 5 years of follow-up 
and the VMA (3.5 to 4.8 mg/d [17.7 
to 24.2 yxmol/d]), epinephrine (8.5 
/zg/d [46.4 nmol/d]) and norepine­
phrine (32.6 to 170 /Ltg/d [192.7 to 
1005 nmol/d]) values have remained 
normal with the exception of one 
isolated norepinephrine recording.
M alignant Disease
Although pathology reports suggested 
that four of the lesions were malignant 
according to their histologic features, 
only 3 of the 26 patients fulfilled the 
necessary clinical criteria of malignant 
change by demonstrating metastases in 
the follow-up period. The fourth pa­
tient has remained normotensive and 
well for over 10 years.
Of the three patients with clinically 
malignant disease (Table V) one died 
of metastases to the central nervous 
system after 1 year, having been hyper­
tensive in the interim. The other two 
warrant more detailed reporting be­
cause they survived for long periods 
following resection of the primary le­
sion, despite the need for treatment 
of symptomatic metastatic disease.
Case 1 (Fig. 9).-—This 54-year-old 
woman was first seen in May 1968 be­
cause of a 4-month history of hyperten­
sion; her blood pressure was 240/140 mm 
Hg. A  pheochromocytoma was excised 
and for 3 Vi years she remained normo­
tensive. In January 1972 her blood pressure 
was 190/110 mm Hg and the VMA ex­
cretion value was 24 m g/d (121 u.mol/d). 
Phenoxybenzamine hydrochloride, 10 mg 
qid, was prescribed and her symptoms 
were relieved. The location of recurrent 
disease could not be discovered.
A month later roentgenography demon­
strated a metastasis in the right ilium and 
diabetes was diagnosed for the first time. 
Radiotherapy (5000 rad over 5 weeks) was 
administered.
In September 1975 a progressively en­
larging mass was evident in the right 
lower abdominal quadrant and the pa­
tient complained of constipation. It was 
thought that metastases were present in 
the fourth lumbar vertebra and in the 
liver. Her blood pressure was 220/125 
mm Hg and the VMA excretion value 
was 69.5 mg/d (351 u.mol/d). Venous 
sampling showed high catecholamine con­
centrations at the right iliac fossa. By 
January 1976 the dose of phenoxybenza­
mine hydrochloride was increased to 30 
mg qid and of insulin to 50 units each 
morning. In May of that year congestive
heart failure with dyspnea developed; her 
blood pressure was 200/100 mm Hg and 
the VMA excretion value 134 m g/d (677 
u.mol/d). By August the edema of the feet 
and ankles had increased. A venogram at 
this time showed occlusion of the right 
common iliac vein and the distal 4 to 5 
cm of the inferior vena cava. Aorto­
graphy failed to demonstrate other meta­
static foci. The iliac mass was shown to 
receive its main blood supply from the 
right internal iliac artery. The vessel was 
catheterized and pledgets of Gelfoam 
were injected; a coiled wire vessel oc­
cluder was introduced and placed 4 cm 
from the origin of the artery, producing 
complete occlusion. Subsequently the 
urinary norepinephrine value fell from 
3096 p.g/d (18 300 nmol/d) to 1840 
p.g/d (10 876 nmol/d).
5000 i-
EXCISION FEB. SEPT. OCT
PHEOCHROMOCYTOMA
FIG. 9—Comparison of urinary excre­
tion values of catecholamines and cate­
cholamine metabolites in primary and 
metastatic malignant adrenal disease. 
---------- =  norepinephrine, - - - - — epi­
nephrine, -------------  =  normetanephrine
(1968 to February 1972 o n ly ) ,--------  =
metanephrine (1968 to February 1972 
only). Content of norepinephrine was 
44.6 Mg/g of tissue in primary tumour 
and of epinephrine was 139.7 Mg/g.
FIG. 10—Sequential change in urinary 
secretion values of catecholamines and 
catecholamine metabolites in primary and 
metastatic malignant extra-adrenal para­
aortic pheochromocytoma (normal upper 
limits: epinephrine 15 to 30 Mg/d [82 to 
164 nmol/d], norepinephrine 50 to 90 Mg/d 
[296 to 532 nmol/d]. ---------- —  norepi­
nephrine, - - - - — epinephrine,---------- —
normethanephrine (1970-71 only), - - - - 
=  metanephrine (1970-71 only). Primary 
tumour (1966) content of norepinephrine 
was 3.9 Mg/g and of epinephrine was 
0.002 Mg/g. In extradural metastasis (1970) 
content was 380 n_g/g of norepinephrine 
and 35 y.g/g of epinephrine.
The patient died on Sept. 30, 1976. 
Autopsy revealed retroperitoneal exten­
sion of the tumour, involvement of para­
aortic lymph nodes, pulmonary metastases, 
a single hepatic nodule and metastases in 
the lumbar spine. There was a small 
focus of recurrent tumour above the left 
kidney.
Case 2 (Fig. 10).—A 19-year-old pa­
tient who first came under our care in 
December 1966 had had paroxysmal hy­
pertension (blood pressure range, 130/90 
to 200/100 mm Hg) for 4 months. The 
VMA value was 32 m g/d (162 (xmol/d). 
Arteriography demonstrated a para-aortic 
lesion, which was excised. The patient re­
mained normotensive for 3 years follow­
ing the operation but in February 1970 
had recurrence of headaches, sweating and 
fatigue; blood pressure was 160/105 mm 
Hg and the VMA excretion value 82 mg/d 
(414 y.mol/d). Parethesias to the level of 
the nipple line were present. Roentgeno­
graphy disclosed evidence of osseous meta­
stases at the T-l to T-3 levels and a 
laminectomy was performed for residual 
extradural tumour: radiotherapy was ad­
ministered postoperatively. Afterwards the 
blood pressure decreased to 138/85 mm 
Hg and the VMA value to 11.7 mg/d 
(59 (j.mol/d).
In September 1972 further radiotherapy 
was necessary because of metastases in 
the spinous process of C-3 and in the 
shaft of the left femur. The patient re­
mained free of symptoms and the blood 
pressure was stationary at 140/90 mm Hg 
until January 1977 when it was found to 
be 150/105 mm Hg. A further rise to 
170/120 mm Hg was discovered in Aug­
ust of the same year when the patient 
again noticed numbness of the left an­
terior chest wall and complained of pain 
on coughing. A myelogram showed total 
obstruction at the T-8 level and therefore 
irradiation to a total dose of 4000 rad 
was administered. This partially relieved 
the spinal block as demonstrated by a later 
myelogram and reduced the paresthesias.
The possibility of the disease being 
malignant should not therefore affect 
surgical treatment of the primary le­
sion regardless of its location, since 
its removal is compatible with lengthy 
survival, and worthwhile palliation for 
prolonged periods can still be achieved 
when metastatic disease has declared 
its presence. Local radiotherapy is in­
dicated for bony and soft tissue recur­
rences, and, although not used in this 
group of patients, chemotherapy with 
vincristine and cyclophosphamide has 
been reported to produce temporary 
improvement in some cases.13
Multiple Endocrine Neoplasia
The presence of a possible genetic 
or familial background for their disease 
in some patients with pheochromocyto­
ma was discussed in our original pub­
lications on the subject.1-3 In the in­
tervening 15 years we have encountered 
several additional cases that reflect this 
predisposition, although no patient has
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exhibited all the attributes of specific 
multiple endocrine neoplasia (MEN) 
syndromes. A review of this group of 
26 patients has discovered the follow­
ing associations:
Family History
1. Hypertension in five patients.
2. Diabetes in two patients.
3. Pheochromocytoma in six other 
family members (in one of whom it 
was bilateral) of one patient.
4. Multiple brain tumours in four 
other family members of one patient.
Personal History
In patients with the MEN syndromes 
in which the adrenal medulla may be 
involved the primary association is with 
medullary carcinoma of the thyroid 
(type 2 syndrome). Pheochromocytoma 
is frequently bilateral in this syndrome14 
and is found most often when there is 
a familial occurrence of medullary 
thyroid cancer.15 Calcitonin estimations 
can now be employed to detect thyroid 
lesions of this type and in occult cases 
in which the presence of the lesion is 
suspected, glucagon or calcium infu­
sions may be used to stimulate calci­
tonin production. Recently the penta- 
gastrin stimulation test has been found 
to be more reliable than calcium infu­
sion in demonstrating occult lesions.15
The relationship of pheochromocyto­
ma to parathyroid hyperplasia or ade­
nomas may be secondary or compen­
satory in nature, representing reactive 
stimulation of the parathyroid in an at­
tempt to maintain normal calcium con­
centrations in response to the calcium­
lowering effect of calcitonin.
Any of the three components (adre­
nal medulla, thyroid, parathyroid) of 
the MEN syndromes may give rise to 
the presenting symptoms in individual 
patients. Furthermore, each pathologic 
entity may begin as a hyperplastic reac­
tion before tumours develop and the 
hyperplastic reaction itself may be 
capable of producing both symptoms 
and signs.16 Fortunately it is now pos­
sible to demonstrate the lesion at the 
stage of hyperplasia in each instance. 
An excess production of epinephrine 
affecting the epinephrine/norepine­
phrine ratio may reflect the presence 
of adrenal medullary hyperplasia. In­
creased serum calcitonin values follow­
ing pentagastrin stimulation will identi­
fy thyroid hyperplasia, and if infusion 
of calcium does not suppress the para­
thormone concentration, this constitutes 
substantial evidence of parathyroid hy­
perplasia.
There appears to be a consensus, in 
view of the capacity of medullary car­
cinoma of the thyroid to metastasize in 
the occult stage, that total thyroidec­
tomy is warranted if increased calci­
tonin production is demonstrated. On
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the other hand, the parathyroid hyper­
plasias do not usually present a 
significant clinical problem and there­
fore only frank adenomas require sur­
gical excision.
Although some16'17 have advised 
bilateral adrenalectomy for adrenal 
medullary hyperplasia, the ultimate 
biologic behaviour of this condition 
cannot be clearly predicted. Admittedly, 
pheochromocytoma and adrenal medul­
lary hyperplasia, if present, are bila­
teral in cases of MEN and if a frank 
tumour exists bilateral resection is 
probably warranted. However, unless a 
tumour can be identified or disabling 
symptoms are already present, a con­
servative therapeutic approach would 
seem advisable, since the risk of death 
from hypertensive complications or 
malignant disease can be avoided by 
annual screening for developing dis­
ease and increasing complaints.
The chronicity of the various disease 
processes and the lengthy induction 
period that precedes the development 
of symptomatic disease can be illus­
trated by the experience acquired in 
the present series of cases. The follow­
ing histories were obtained from in­
dividual patients in the group:
1. Parathyroid adenoma 6 years prior 
to resection of pheochromocytoma at 
25 years of age in 1948. At last fol­
low-up, 14 years after treatment of the 
adrenal lesion, the patient was well and 
completely asymptomatic.
2. Medullary thyroid cancer resected 
by subtotal thyroidectomy 7 years be­
fore excision of a pheochromocyto­
ma in 1961 at 35 years of age. The 
patient died of metastatic carcinoma of 
the thyroid 13 years after treatment 
of the adrenal lesion. He was normo- 
tensive at that time.
3. Thyroidectomy at 13 years of age. 
A solitary pheochromocytoma was re­
sected 36 years later in 1962. The pa­
tient was well and normotensive 14 
years after adrenal surgery. No descrip­
tion of the histologic features of the 
thyroid lesion was available but it 
would be reasonable to infer that it 
was a medullary carcinoma since it 
occurred so early in life.
4. Resection of single pheochromocy­
toma at 29 years of age. The initial 
thyroid scan showed the presence of 
a cold nodule. There were cafe-au-lait 
spots, a history of neurofibromas and 
a family history of hypertension. The 
patient remained normotensive 1 year 
after resection (1976). At that time re­
peat thyroid scan was normal as were 
serum calcium and calcitonin values.
5. Myxedema noted at 57 years of 
age at the time of resection of an 
adrenal tumour (1961). At last follow­
up 4 years later the patient was re­
ported to be completely well and nor­
motensive.
6. Adrenal cyst removed 8 years 
before excision of an adrenal tumour 
at age 49 years (1970). The patient was 
normotensive and well 2 years after 
the second operation. The pathologic 
features of the adrenal cyst were not 
recorded.18
Conclusions
The investigative techniques avail­
able at present will identify and in 
most cases accurately localize pheo- 
chromocytomas if they are present in 
patients with hypertension. The search 
is eminently worth while since curative 
therapy may be accomplished in the 
majority of patients. Approximately 
four out of five patients with benign 
tumours will remain normotensive post- 
operatively. With careful attention to 
prophylactic measures serious hyper­
tensive crises and arrhythmias can be 
controlled during the operative mani­
pulation and there should be no sig­
nificant operative mortality.
Effective screening techniques are 
now available for patients with a 
family history of hypertension and 
should be more fully utilized, particu­
larly in young people and when several 
family members have been hypertensive.
In addition, recognition of MEN 
syndromes makes screening for asso­
ciated disease in the thyroid (and para­
thyroid) a practical and valuable aid 
for the early recognition of hyperplastic 
precursors and occult neoplastic le­
sions.
The situation is not hopeless even 
when the disease is malignant. Cellular 
pleomorphism makes it unwise to ac­
cept the diagnosis of a malignant lesion 
on histologic grounds alone. Annual 
screening of urine samples may detect 
increasing concentrations of catechola­
mine metabolites (metanephrine and 
normetanephrine) as the first indicators 
of recurrent (metastatic) disease. Long­
term relief of hypertensive and meta­
bolic symptoms can be provided with 
phenoxybenzamine hydrochloride or 
propranolol, or both. Radiotherapy (or 
surgical excision when warranted) may 
relieve disabling complaints of localized 
disease. The place of systemic chemo­
therapy remains to be established. Use 
of these various therapeutic measures 
is compatible with long-term survival 
and worthwhile palliation in some pa­
tients.
Recent evidence that adrenal medul­
lary hyperplasia may not only be a 
precursor of solitary or multiple pheo- 
chromocytomas, but may itself be 
capable of producing substantial com­
plaints, indicates the advisability of 
screening for its presence in patients 
in whom it is suspected or in whom 
there is evidence of symptomatic mul­
tiple endocrine neoplasia.
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BOOK REVIEWS
It is evident that great advances 
•have been made in the recognition 
and management of adrenal medul­
lary syndromes in the past 15 years. 
Full utilization of these techniques will 
obviate many of the problems asso­
ciated with such disease that plagued 
both the physician and the patient in 
the past.
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CONGENITAL ADRENAL HYPER­
PLASIA. Edited by Peter A. Lee, Leslie 
P. Plotnick, A. Avinoam Kowarski and 
others. 532 pp. Illust. University Park 
Press, Baltimore, 1977. $37.50. ISBN 
0-8391-0974-1.
This book is the product of a symposium 
entitled “The Treatment of Congenital 
Adrenal Hyperplasia: A Quarter of a 
Century Later”, which was held at the 
Johns Hopkins Hospital in October 1975. 
It presents contributions from over 50 
international investigators and is divided 
into seven general areas: historical aspects; 
pathophysiology; hormone measurement 
in diagnosis and management; long range 
follow-up; surgical correction and sexual 
maturation; psychological, intellectual and 
educational aspects; and detection of the 
heterozygous state and prenatal diagnosis.
Each section is well presented and in­
cludes current references to the experience 
of several large groups dealing with con­
genital adrenal hyperplasia (CAH). Bon- 
giovanni deals briefly with the nature of 
the enzymatic defects in the biosynthesis 
of cortisol, whereas the mechanism of 
action of ACTH is described at length. 
I would have preferred that the emphasis 
be reversed. A welcome feature is the 
chapter by Josso on the mullerian in­
hibitory factor (anti-miillerian hormone). 
However, the section on the androgen in­
sensitivity syndromes is out of place in a 
text dealing with CAH and androgen 
excess.
The recent advances in hormone meas­
urement that led to improvement in diag­
nosis and management are well presented; 
the usefulness of the determination of to­
tal blood cortisol (TBC) and 17-hydroxy- 
progesterone (17-OHP) by radioimmuno­
assay is pointed out. The sections dealing 
with long-range follow-up at sexual ma­
turity provide important information on 
the long-term prognosis for fertility, preg­
nancy and normal spermatogenesis in 
adults who have received cortisone therapy 
for over 25 years. However, these sections 
suffer because the experience of several 
different clinics is reported. Often the 
results are comparable but occasionally the 
presentation of conflicting data leaves no 
clear direction for the management of 
particular patients.
Surgical correction is dealt with rather 
briefly, but interesting information is pro­
vided on the follow-up of 84 patients who 
had undergone primary surgical interven­
tion, 25 (30%) of whom required a second 
operation.
The editors include a discussion of the 
pathophysiology of salt loss and the im­
plications with regard to normal growth 
and development and hormone replacement. 
The psychosocial aspects of management 
are well presented and there is an excel­
lent discussion on patient education by 
Rosenbloom. The manual on CAH for 
parents and patients will prove practical 
and useful.
In the final section of the book the
editors deal more with the future than 
with the present or past. They review the 
current state of the art as it applies to 
prenatal diagnosis and detection of the 
heterozygous state. Little progress has 
been made in the use of modern assay 
methods to detect the fetus with 
CAH. Unfortunately, these methods can 
only be used late in gestation, by which 
time the virilization in females has al­
ready been established. Antenatal diag­
nosis might, however, lead to improved 
therapy in the newborn and neonatal death 
could be prevented. Owing to the rela­
tively high gene frequency the detection 
of the heterozygous state is important for 
genetic counselling. Current research is 
involved with attempts to determine the 
heterozygote by utilizing the determination 
of TBC and 17-OHP before and after 
ACTH stimulation. To date, these meth­
ods have not been entirely successful.
The text is too complex for medical 
students. However, it will be of value 
to residents and practitioners in the vari­
ous related specialties, including endocrin­
ology, gynecology, reproductive physiology 
and genitourinary surgery.
H arvey G uyda
Department of endocrinology,
The Montreal Children’s Hospital, 
Montreal, PQ
SCIENTIFIC FOUNDATIONS OF 
UROLOGY. Vol. 1. Renal Disorders, 
Infections and Calculi. Edited by David 
Innes Williams and Geoffrey D. 
Chisholm. 374 pp. Illust. William 
Heinemann Medical Books Ltd., Lon­
don; Year Book Medical Publishers Inc., 
Chicago, 1976. $27.25. ISBN 0-8151- 
4821-6.
SCIENTIFIC FOUNDATIONS OF 
UROLOGY. Vol. II. Urogenital Tract, 
Oncology and the Urological Arma­
mentarium. Edited by David Innes Wil­
liams and Geoffrey D. Chisholm. 474 
pp. Illust. William Heinemann Medical 
Books Ltd., London; Year Book Med­
ical Publishers Inc., Chicago, 1976. 
$29.35. ISBN 0-8151-4822-4.
The scientific method has greatly improved 
the efficacy of the treatment of urologic 
disease. The material presented in these 
two volumes forms the framework of cur­
rent scientific urology within which the 
clinician must work. The scope of scienti­
fic urology is expanding rapidly and the 
authors, for lack of space, have had to 
omit a great deal of material. For example 
embryology, although it is vital to the 
understanding of genital anomalies, had 
to be sacrificed.
The first volume includes discussions of 
the anatomy and physiology of the kidney 
of renal failure, renal hypertension, renal 
transplantation, urinary tract infection, 
urolithiasis, tissue response and tissue 
replacement and genetics. This volume will 
continued on page 419
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CAPS PAPERS
Total Colonic Aganglionosis
J.H. Louw, CH M, FRCS, FACS*
This study is based on 17 neonates 
suffering from total colonic 
aganglionosis. The male:female ratio 
was 2:3 and there was a significant 
familial occurrence. The ages on 
admission varied between 1 and 90 
days. The clinical presentation was 
extremely variable.
Early diagnosis depends on clinical 
awareness of the condition in neonates 
who have intestinal obstruction or 
diarrhea, or both. The most important 
radiologic indication was retention of 
barium for 24 hours. Results of 
manometric studies were misleading. 
Suction biopsy of the rectum provided 
the only sure method of diagnosis, 
although determination of cholinesterase 
activity in the biopsy specimen and in 
the patient's serum was of some value.
Two patients died before operation 
and two died from total colonic and 
small intestinal aganglionosis. Eight 
patients survived both the initial 
ileostomy and subsequent pull-through 
operation. Of the various procedures 
utilized, the Lester Martin operation 
has proved to be the most satisfactory.
Cette communication se ref ere a 17 
patients souffrant d'aganglionose totale 
du colon. Le rapport des patients males 
et femelles etait de 2:3 et une incidence 
familiale significative a ete decelee.
Les ages lors de I’hospitalisation 
variaient entre 1 et 90 jours. Le tableau
From the Red Cross War Memorial 
Children’s Hospital, Cape Town,
South Africa
Fred G. McLeod Lecture presented at the 
10th annual meeting of the Canadian 
Association of Paediatric Surgeons, 
Vancouver, BC, Jan. 25, 1978
*Professor and head, department of 
surgery, University of Cape Town 
medical school
Reprint requests to: Dr. J.H. Louw, 
Department of surgery, University of 
Cape Town Medical School,
Observatory 7925, South Africa
clinique a la consultation etait 
extremement variable.
Le diagnostic precoce depend d'une 
connaissance clinique de cette maiadie 
chez les nouveaux-nes ayant une 
obstruction intestinale, une diarrhee, 
ou les deux a la fois. L’indice radiolo- 
gique le plus important a ete la 
retention du barium pendant 24 heures. 
Les resultats des etudes manometriques 
ont ete trompeurs. La biopsie par 
aspiration du rectum a offert la seule 
methode sure de diagnostic, bien que 
la determination de I’activite cholines- 
terasique dans I'echantillon de biopsie 
et dans le serum du patient ait ete 
d’une certaine aide.
Deux patients sont decedes avant 
I'operation et deux sont morts d’une 
aganglionose totale du colon et de 
I'intestin grele. Huit patients ont 
survecu a I'ileostomie initiale et a 
I’anastomose subsequente. De toutes 
les interventions utilisees, I'operation 
de Lester Martin s'est averee la plus 
satisfaisante.
During the 21-year period July 1, 1956 
to June 30, 1977 we treated 217 pa­
tients suffering from Hirschsprung’s 
disease at the Red Cross War Memorial 
Children’s Hospital, Cape Town (i.e., 
approximately 10 patients per year). 
Seventeen (8%) of these patients had 
total colonic aganglionosis and they 
form the basis of this paper.
The incidence of Hirschsprung’s dis­
ease in populations of Western Euro­
pean origin has been calculated at about 
0.02% or 1 in 5000 births.1,2 In Cape 
Town, where we have seen an average 
of 10 patients with this disease per 
year, our mean annual birth rate is 
20 000, that is, the incidence is 0.05% 
or 1 in 2000 births. The overall sex 
ratio of three males to one female is 
somewhat less than the four to one 
ratio reported in other large series,2"5 
but can be accounted for by the fact 
that 21% of our patients had long seg­
ment disease and total colonic agan­
glionosis in which female patients are 
more frequently affected.1"3,6,7
The occurrence of short segment dis­
ease in three quarters of the patients 
(Table I) is similar to that reported by 
Swenson, Sherman and Fisher5 and 
others,6 while the 15% incidence of 
long segment disease is about half-way 
between the extremes of 8% and 26% 
reported by others.2 An incidence of 
8% for total colonic aganglionosis is 
also in keeping with the findings of 
others, who report 2% 3 to 13%8 with 
an average of 6% .6
The male preponderance of four to 
one in the classical short segment dis­
ease (Table I) has now been well 
established. The less evident predo­
minance of males in the other types is 
in keeping with reports from many 
authors,2’3,6’7 with the notable exception 
of Swenson, Sherman and Fisher,5 who 
found no variation with the length of 
the aganglionic bowel in their series of 
501 patients. Our ratio of two males to
Tab le  1— Sex, Fa m ilia l Inc id ence  and A ge on A dm iss ion  o f P a tie n ts  
H irs c h s p ru n g 's  D isease (217 P a tie n ts )
w ith  V a rio u s  T yp es  o f
S hort segm ent Long segm ent T o ta l c o lo n ic
d isease disease a g a n g lio n o s is
No. o f pa tie n ts 171 29 17
M a le : fem ale  ra tio 4:1 2:1 1:1.5
No. o f s ib lin g s 2 1 6
A ge on adm iss ion 
Range 1 d -  13 y r 1 d -  8 y r 1 -  90 d
Mean 114 y r 6 mo 12 d
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three females in total colonic agan- 
glionosis is similar to that reported by 
Prevot and colleagues6 from Nancy.
The familial occurrence of Hirsch­
sprung’s disease has been noted by 
many workers1-’-6-7 and is of consider­
able theoretical and practical interest. 
In our series as a whole there were 
nine cases in which siblings were af­
fected, an incidence of 4.1%, which 
corresponds to the 4% occurrence do­
cumented by geneticists.1-’-7 However, 
only five families were involved because 
two pairs of siblings and one family 
of three are included among our cases. 
On the other hand, there was an addi­
tional case with well-documented evi­
dence of older siblings dying of sus­
pected Hirschsprung’s disease without 
histologic proof, and one pair of 
siblings had a cousin with proven 
aganglionosis.
The length of the aganglionic seg­
ment has an important bearing on the 
familial occurrence, the long and total 
segment cases being at greater risk.1-7 
In our cases the incidence was 1.2% 
for short segment disease, 3.4% for 
long segment disease, and as high as 
35% for total colonic aganglionosis 
(27% on a familial basis). If we com­
bine our cases of long segment disease 
and total colonic aganglionosis the in­
cidence was 15% (11% on a familial 
basis) which corresponds with Pas­
sage 's1 calculation that the risk in long 
segment disease plus total colonic 
aganglionosis is 10%.
We have had only one patient who 
had an affected twin. He suffered from 
long segment disease and she from 
total colonic aganglionosis. In the 
literature there are only a few accounts 
of the disease occurring in twins, either 
dizygous or monozygous.1 Our series 
includes one family in which two fe­
male siblings suffered from total colonic 
aganglionosis and a younger first cou­
sin had short segment disease. Passarge1 
found that 10% to 15% of the propo­
siti in his study had first cousins who 
were affected. There were no affected 
parents in our study. Our first suc­
cessfully treated patient with Hirsch­
sprung’s (short segment) disease is now 
25 years old and married, but she has 
not yet had children. An affected 
parent who had an affected child has 
been described at least four times and 
there are several reports of suspected 
but unproven parental disease.1
We have records of an Australian 
family seen by us for check-up during 
a visit to South Africa early in 1977. 
The mother had short segment disease, 
which was treated in Sydney, and two 
of her children had total colonic 
aganglionosis, also treated there. They 
are now 14 and 11 years of age and 
well, apart from loose stools, especially 
in the younger child, but this symptom
has been controlled with loperamide 
hydrochloride.
A ge on A dm ission
It is not surprising that symptoms 
severe enough to necessitate hospitaliza­
tion correlate with the length of the 
aganglionic segment, that is, the longer 
the segment the earlier the onset of 
symptoms and the greater their urgency 
(Table I). However, it is well known 
that this correlation is not absolute.’ 
Among our cases one third with short 
segment disease presented with urgent 
symptoms on the first or second day of 
life, and in 50% of our neonatal cases 
the disease was of the short segment 
type.9 On the other hand, in 25% of 
those with long segment disease and 
in 15% of those with total colonic 
aganglionosis, the initial symptoms were 
so mild that they were overlooked, or 
first became manifest after weeks or 
even months.9
The lack of a constant relation be­
tween the extent of aganglionosis and 
severity of symptoms is further il­
lustrated by our patients with total 
colonic aganglionosis (Fig. 1). Only two 
infants were admitted on the first day 
—one with only colon involved and the 
other with involvement of colon plus 
5 cm of small bowel. On the other 
hand, in an infant with involvement of 
colon and 20 cm of small bowel ad­
mission was delayed for 13 days, while 
one of those with total colon and small- 
bowel involvement was admitted on the 
10th day. Of special note is the infant 
with involvement of colon plus 5 cm 
of ileum who was admitted on the 30 th 
day; she had been completely asymp­
tomatic for the first 2 weeks of life 
but then diarrhea and vomiting devel­
oped and she was treated at home for 
the next 2 weeks. Of even greater in-
FIG. 1— Extent of aganglionic bowel 
and age (in days) at time of admission. 
Figures in parentheses indicate age (in 
days) on admission elsewhere.
terest is the infant with involvement of 
colon plus 10 cm of ileum who remained 
completely asymptomatic for 3 months 
(I shall refer to him again).
It should be emphasized that in 
babies with total colonic aganglionosis 
the delay in admission was by no means 
always due to lack of symptoms, but 
in many cases resulted from failure 
to suspect the fcondition because of its 
protean clinical manifestations. Indeed, 
in retrospect, 15 of our 17 patients had 
suggestive symptoms during the first 
2 days of life.
Symptoms
The frequency of the various symp­
toms is shown in Table II, from which 
it is evident that distension and vomit­
ing were the most common. Surprising­
ly, four of the infants passed their first 
meconium stool before they were 24 
hours old. In three of them it was re­
lated to the development of enteroco­
litis, but the fourth had no suspicious 
symptoms for 3 months and then pre­
sented with acute peritonitis due to a 
perforated appendix. In this connection 
Swenson, Sherman and Fisher9 have 
reported that 95% of infants with 
Hirschsprung’s disease fail to pass a 
stool within 24 hours.
More important than the frequency 
of occurrence of each individual symp­
tom was the combination of complaints 
(Table III). In seven patients the char­
acteristic triad of constipation or de­
layed passage of the first stool, disten­
sion and bile-stained vomiting was 
present, and in three more diarrhea oc­
curred as well.
Also of importance was the vari­
ability in the onset of the symptoms
Table I I—Symptoms in 17 Patients
Symptom
No. of 
patients
Absolute constipation 10
Delayed passage of first stool 3
Distension 15
Vomiting 14
Diarrhea 6
Other 1
Table I I I—Combinations of Symptoms
Symptoms
No. of 
patients
Constipation +  distension +
vomiting 5
Delayed stool +  distension +  
vomiting 2
Constipation +  distension 2
Delayed stool +  vomiting 1
Constipation - f  distension +  
vomiting +  diarrhea 3
Vomiting +  diarrhea +  distension 3
Other 1
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and the presentation of the disease. At 
one extreme was an infant admitted at 
the age of 1 day with the classical triad 
of symptoms and a barium enema ap­
pearance suggestive of total colonic 
aganglionosis. He collapsed soon after 
admission and died within 12 hours 
before corrective surgery could be car­
ried out. At the other extreme was the 
child who remained asympomatic for 
3 months and then suddenly developed 
an ucute illness with vomiting, restless­
ness, pyrexia and collapse. He was op­
erated on within 24 hours of the onset 
and found to have total colonic agan­
glionosis complicated by acute per­
forated appendicitis and peritonitis. He 
failed to rally postoperatively and died 
3 days later.
Between these extremes was an in­
fant who remained asymptomatic for 
2 weeks and then had diarrhea and 
vomiting with later distension. She was 
admitted to hospital only 2 weeks later. 
Hirschsprung’s disease was suspected 
but the barium enema was misinter­
preted, which led to a further delay of 
6 days. Then repeat roentgenography 
revealed retained barium, but soon 
afterwards she had upper gastrointes­
tinal bleeding and collapsed and died 
within a few hours. At autopsy total 
colonic aganglionosis and a perforated 
duodenal ulcer with peritonitis were 
found.
Finally, there is the variability in the 
severity and course of the disease (Ta­
ble IV). This is well illustrated by the 
remaining 14 patients, in all of whom 
symptoms commenced during the first 
2 days of life.
Surgery in First Week
In only three patients were the 
symptoms severe enough to demand 
immediate admission within the first 2 
days of life. All three were operated 
upon during the first week of life, but 
only one survived. Two were admitted 
on the third day and were also operated 
upon within the first week. One sur­
vived despite an inappropriate opera­
tion but had a very stormy course until 
the proper operation was done at 13 Vi
months. An infant admitted on the 
fourth day also had an inappropriate 
operation; she survived but also had a 
stormy passage until appropriate de­
compression was carried out at 5 
months. Then there was an infant in 
whom an inappropriate operation was 
done elsewhere when she was 5 days 
old. She remained partially obstructed 
until the appropriate operation was 
done on the 26th day. Thus in a group 
of seven with symptoms urgent enough 
to demand admission within 5 days, 
there were four survivors. If we in­
clude in this group the infant, previ­
ously referred to, admitted on the first 
day who died without surgery within 
12 hours, we are left with four sur­
vivors out of eight—a truly serious 
situation.
Surgery in Second Week
In two infants admitted on the fourth 
day, the symptoms were mild enough 
to postpone surgery until the second 
week. One succumbed from total colon­
ic and total small intestinal aganglio­
nosis, while the other survived. The 
same applies to two infants admitted at 
the ages of 10 days and 13 days re­
spectively. The mortality in this group 
was also 50% but was due entirely to 
total colonic and total small intestinal 
aganglionosis.
Surgery in Third Week
In one infant admitted on the fifth 
day the symptoms were so mild that 
surgery was deferred until the third 
week, and he survived. The same holds 
for another infant admitted on the 12th 
day. Thus the survival rate was 100%.
Later Initial Surgery
An infant admitted at 5 days of age 
was in complete remission after 2 
weeks’ hospitalization and remained 
asymptomatic until the age of 414 
months, when she was operated upon. 
She survived this operation as well as 
a later definitive procedure, but died 
at home at the age of 314 years. In ad­
dition, there were the two patients ad­
mitted much later and already referred
to. They were aged 30 days and 90 
days respectively; both died.
These various cases serve to illus­
trate the crux of total colonic agangli­
onosis, namely, that while it is usually 
a highly lethal disease unless promptly 
treated, it occasionally does tend to 
remain asymptomatic, or to remit, and 
patients with the disease may withstand 
incorrect surgical procedures for pro­
longed periods.6-10 These idiosyncrasies 
no doubt account for the apparent late 
onset or prolonged survival of some 
untreated or incorrectly treated cases 
reported in the literature.11 There are 
many reports of infants with total co­
lonic aganglionosis who first presented 
at up to 12 weeks of age,6,8’12 and occa­
sional reports of first presentation in 
adolescence13’14 and even in adults.15 
However, in all of them there was a 
history of “bowel trouble” during the 
neonatal period. Our patient who re­
mained entirely asymptomatic until the 
age of 3 months is, therefore, unique. 
Indeed, this infant had been under our 
personal observation since birth because 
two older siblings suffered from Hirsch­
sprung’s disease, one with short segment 
disease and the other with total colonic 
aganglionosis. At the age of 214 
months he was seen for a check-up and 
found to be perfectly well. Two weeks 
later acute appendicitis developed, 
which has been recorded as a com­
plication of total colonic agangliono­
sis.16’17 Unfortunately he died despite 
appendectomy and ileostomy.
Diagnosis
Clinical Features
The keynote to early diagnosis is a 
clinical awareness of the possibility of 
total colonic aganglionosis in every in­
fant who presents with signs and symp­
toms of neonatal intestinal obstruction 
or diarrhea, or both. Delay in the pas­
sage of the first meconium stool is 
usually, but not always, present, while 
abdominal distension is a constant sign 
although it may be intermittent at 
first.6 Rectal examination reveals a 
narrow rectal ampulla but rarely pro­
vokes the efflux of liquid stools which 
is so often seen in short segment di­
sease and even in long segment disease.
The presence of certain complica­
tions should also suggest the diagnosis. 
Early perforations are less frequent in 
long segment than in short segment 
disease but do occur; for example, a 
cecal perforation occurred in one of 
our patients at the age of 3 days. 
More frequently, perforations tend to 
occur after inappropriate surgery, espe­
cially if an ostomy is established in a 
zone of aganglionosis and does not 
function. This occurred in three of our 
patients—in one after two laparotomies,
Table IV—Variability in Severity and Course
Timing of operation (no. of patients/survivors)
Age on admission, d 1st week 2nd week 3rd week Later Total
1-2 3/1 — — — 3/1
3 2/1* — — — 2/1
4 1/1* 2 f/ l — — 3/2
5 1/1* — 1/1 1 / lt 3/3
10-13 — 2 f/ l 1/1 — 3/2
Total 7/4 4/2 2/2 1/1 14/9
’ Operation inappropriate; correct operation at 13VJ mo, 5 mo and 26 d (with survival), 
f l  each had total colonic and total small intestinal aganglionosis. 
fComplete remission until 414 mo.
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in another after cecostomy and in the 
third after ileostomy (instead of jeju- 
nostomy).
Another complication is acute appen­
dicitis as occurred in one patient who 
presented at 3 months. It should be 
noted that acute appendicitis com­
plicating total colonic aganglionosis has 
been reported by a number of work­
ers16'17 including Swenson, Sherman and 
Fisher.5 Indeed, it is a good rule to 
suspect total colonic aganglionosis in 
any young infant in whom acute ap­
pendicitis develops.
The family history can provide useful 
information especially when a history of 
Hirschsprung’s disease can be elicited in 
a sibling or close relative. Death of a 
previous child with alimentary symp­
toms of unknown etiology may also be 
significant.
Radiologic Findings
Hirschsprung’s disease should be sus­
pected in all infants with a history of 
intermittent vomiting and diarrhea who 
have multiple fluid levels on the plain 
roentgenogram.18 An inverted lateral ro­
entgenogram that shows a deficiency of 
rectal gas and dilated small bowel, giv­
ing an “egg on end” appearance, should 
increase the suspicion19 (Fig. 2). After a 
barium enema the colon usually appears 
normal in calibre, unlike the microcolon 
of atresias and meconium ileus. In addi­
tion, the following special features 
should be sought:20 reduction in the 
length of the colon, especially at the 
flexures and the loops of sigmoid and 
transverse colon (Fig. 3); an irregular 
contour with areas of abnormal rip­
pling (Fig. 4); free and rapid reflux
FIG. 2—Inverted lateral roentgenogram 
showing lack of gas in rectum and “egg 
on end” appearance. Apex of “egg” points 
to pelvis.
into the terminal ileum (Fig. 4); a tran­
sitional zone into dilated ileum (Fig. 5), 
which may be misinterpreted as an ileal 
intussusception; retention of barium 
throughout the colon for 24 hours18'20 
(Fig. 6) and longer. Unfortunately, false 
transitional zones in the sigmoid (Fig. 7) 
or transverse colon may appear,20 and 
misled us in two of our cases. One of 
these patients had a juvenile polyp at 
the site of apparent transition, and this 
might have caused the confusion.
Operative Findings
When colonic aganglionosis is sus-
FIG. 3— Barium enema showing fore­
shortening of sigmoid and transverse 
colon.
FIG. 4— Barium enema showing ir­
regular colon from enterocolitis, and free 
reflux into dilated ileum.
FIG. 5— Barium enema showing reflux 
into narrowed terminal ileum which dilates 
into transitional zone.
FIG. 6— Barium enema showing reten­
tion of barium in whole colon after 24 
hours.
FIG. 7— Barium enema showing false 
transitional zone in sigmoid colon.
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pected on the basis of clinical and 
radiologic findings, laparotomy is in­
dicated to establish the diagnosis and 
determine the extent of the disease by 
histologic studies of biopsies taken at 
various levels during the operation. At 
laparotomy variable lengths of the small 
bowel are distended and hypertrophied, 
and mechanical obstruction must first 
be excluded. Total colonic aganglionosis 
should be suspected when there is 
marked dilatation of the small intestine 
in association with a ribbon-like fore­
shortened colon. In one of our cases 
the condition was misdiagnosed as 
Ladd’s syndrome, in a second as an in­
ternal hernia, and in yet another as 
meconium ileus. The typical cone of the 
transitional zone can often be detected 
in the ileum, but there may be false 
cones in the transverse or sigmoid 
colon. Two of our patients had false 
cones.
The extent of the disease cannot be 
determined from the macroscopic ap­
pearance alone. In more than half of 
the reported cases and in one third of 
our own the extent was misjudged. 
Frozen sections from multiple biopsies 
are therefore mandatory and a rapid, 
nonspecific cholinesterase stain21 has to 
be used to distinguish immature from 
absent ganglia (Fig. 8). However, his­
tologic abnormalities may be misinter­
preted in frozen sections, especially in 
total colonic aganglionosis, and this was 
unfortunately so in one of our patients.
Manometry
In the neonate who presents with 
acute symptoms preoperative mano­
metry is obviously out of the question. 
Even in older infants with mild symp­
toms the technical difficulty is such that 
the investigation is seldom of value. 
However, it should be performed later
after an ostomy has been established or 
occasionally preoperatively in older in­
fants and children who present late. We 
have used the method described by 
Boston and Scott.22 Normally the in­
ternal sphincter relaxes when rectal 
pressure is increased.23 In classical 
Hirschsprung’s disease there is fail­
ure of relaxation.23 We performed 
rectal manometry in five of our patients 
with total colonic aganglionosis, and in 
only one was a response as in Hirsch­
sprung’s disease obtained (Fig. 9). The 
behaviour of the other four was normal 
(Fig. 10), although the relaxation of 
the internal sphincter was less complete. 
A particularly instructive case was the 
patient who remained asymptomatic un­
til the age of 3 months, when he pre­
sented with acute appendicitis. At the 
age of 2Vi months rectal manometry 
had been done and had produced an 
apparently normal response (Fig. 11). In 
retrospect, a barium enema should have 
been the mode of investigation.
Rectal Biopsy
We have been using the Noblett for­
ceps24 for suction biopsy for some years 
and it has proved to be highly satis­
factory. However, even suction biopsies 
are not possible in the acutely ill neo­
nate, hence we have used this method of 
investigation in only six of those who 
have survived their “ostomies”. The 
tissue was first stained by the Meier- 
Ruge modification25 of Karnovsky’s 
method26 for cholinesterase activity. 
From all six patients positive results 
were obtained indicating increased choli­
nesterase activity (Fig. 12), and on his­
tologic examination all showed complete 
absence of ganglia and an increased
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FIG. 8—Two small-bowel biopsies stained by rapid nonspecific cholinesterase 
method showing normal ganglia on left and large peripheral nerve but no ganglia on 
right (reduced by 37% from X125).
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FIG. 10— Results of rectal manometry 
in case of total colonic aganglionosis 
FIG. 9— Results of rectal manometry in patient with total colonic aganglionosis showing relaxation of internal sphincter
showing relaxation of internal sphincter when rectal pressure is increased— similar to when rectal pressure is increased— similar
response in short and long segment Hirschsprung’s disease. to response in normal subjects.
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FIG. 11— Results of rectal manometry in case of total colonic aganglionosis 
showing apparently normal response.
FIG. 12— Rectal suction biopsy, stained 
by Meier-Ruge modification of Karnov- 
sky’s cholinesterase method, showing large 
nerve fibrils with increased cholinesterase 
activity (reduced by 47% from X63).
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FIG. 13— Rectal suction biopsy showing 
large nerve fibrils and absence of ganglia 
(hematoxylin and eosin, reduced by 44% 
from X45).
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FIG. 14— Quantitative biochemical as­
say of acetylcholinesterase in rectal biopsy 
specimens. T indicates total colonic agan­
glionosis. R =  rate units.
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number of large peripheral nerves (Fig. 
13).
Cholinesterase Activity
It is well known that the local con­
centration of acetylcholinesterase in the 
myenteric plexus is increased in the 
affected segment of gut in Hirsch­
sprung’s disease. This can be demon­
strated histochemically by means of the 
Meier-Ruge stain, or biochemically as 
first shown by Boston and Scott from 
Newcastle-upon-Tyne.27 While a post­
graduate fellow at the Red Cross War 
Memorial Children’s Hospital in 1976, 
Victor Boston extended this work, and 
since then we have continued it still 
further. As far as tissue acetylcholin­
esterase activity is concerned, the pre­
vious findings have been confirmed in 
12 index cases and 10 control cases 
(Fig. 14).
Further elaboration of the work has 
included measurement of the serum 
pseudocholinesterase and erythrocyte 
acetylcholinesterase values in 12 pa­
tients with proven Hirschsprung’s di­
sease and in 10 controls28 (Fig. 15). The 
patients with Hirschsprung’s disease in­
cluded five with total colonic aganglio­
nosis. Three of these had already un­
dergone a Lester Martin procedure but 
were included because in all three there 
remained in situ almost 50% of the 
aganglionic large bowel. As shown in 
Fig. 15, there is a significant difference 
between the index cases and the con­
trols. In the former the mean serum 
pseudocholinesterase value was 11.7 
units and in the controls it was 5.0 
units. The mean erythrocyte acetylcholi­
nesterase value in the two groups was 
1.39 units and 0.73 units, respectively. 
The difference between the means is 
statistically significant, but there is over­
lap between index cases and controls 
with respect to both serum and erythro-
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FIG. 15— Serum measurements in patients with Hirschsprung’s disease and in control 
subjects.
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cyte cholinesterase activity. In general, 
the longer the segment involved by the 
disease, the greater is the serum and 
erythrocyte activity. Of interest was the 
reduction of serum pseudocholinesterase 
activity following a Lester Martin pro­
cedure done in the patient marked with 
a circle in Fig. 15. While this prelimin­
ary study does not clearly separate the 
index and control groups, it has pro­
vided useful additional information on 
Hirschsprung’s disease, and it has also 
demonstrated for the first time that the 
disease has systemic effects that require 
further study. (Since this paper was 
prepared four more cases of Hirsch­
sprung’s disease and five more control 
subjects have been investigated and the 
findings have been similar.)
Management
The successful management of total 
colonic aganglionosis depends on early 
recognition of the disorder, prompt de­
compression of the obstructed bowel 
by ileostomy or jejunostomy depending 
on the extent of the aganglionic bowel, 
control of the critical fluid losses as­
sociated with ileostomy and the short- 
bowel syndrome, appropriate definitive 
surgery, and control of fluid losses, ex­
coriation, etc. thereafter.
The problems associated with early 
recognition have already been outlined, 
and resulted in no operation being car­
ried out in two of our patients (Table 
V). One, only 18 hours old, was mori­
bund with enterocolitis on admission. A
Table V— Details of Two Patients Not Operated Upon
Patient
no. Segment History D ied ,d
7 Colon +  5 cm 
ileum
Admitted day 1 with 
enterocolitis
2
11 Colon +  5 cm 
ileum
1st symptom day 14, 
admitted day 30
36
Table V I— Patients with Inappropriate In itia l Surgery
Patient
no. Segment In itia l surgery
Corrective
operation Outcome
4 Colon small 
intestine
Ladd’s operation, 10 d 
Jejunostomy, 29 d
— Died, 29 d
9 Colon Laparotomy, 2 d 
Laparotomy, 8 d
21 d Died, 22 d
8 Colon +  150 cm 
ileum
Laparotomy, 2 d 16 d Died, 25 d
3 Colon +  small 
intestine
Jejunostomy, 12 d — Died, 22 d
6 Colon + 1 5 0  cm 
ileum
Ileostomy, 3 d 17 d Died, 35 d
10 Colon Cecostomy, 3 d 
Transverse colostomy, 1 mo 
Closure colostomy, 6 mo 
Transverse colostomy, 654 mo
1354 mo Alive and w ell, 
8 yr
13 Colon +  10 cm 
ileum
Transverse colostomy, 4 d 5 mo Alive and w ell, 
3 yr
16 Colon +  150 cm 
ileum
Ileostomy, 5 d 26 d Alive and w ell, 
14 mo
Table V II— D efin itive Surgery -1957-1971
Patient
no. Segment Operation
Age at 
operation Outcome
1 Colon +  50 cm 
ileum
Swenson’s 5 mo Died, 354 yr
2 Colon -f- 20 cm 
ileum
Swenson’s 2 mo Alive and w ell, 
19 yr
5 Colon +  5 cm 
ileum
Duhamel 354 mo Alive and w ell, 
17 yr
6* Colon + 1 5 0  cm 
ileum
Duhamel 17 d Died, 35 d
10* Colon Soave 1354 mo A live and w ell, 
8 yr
'Inappropriate in itial surgery.
barium enema suggested total colonic 
aganglionosis, but the infant died with­
in 24 hours before surgery was possible. 
Another, whose symptoms commenced 
at the age of 14 days, was admitted 
when she was 30 days old. Agangliono­
sis was suspected but the barium enema 
was misinterpreted and she died 6 days 
later without having been operated on.
More important are eight patients in 
whom the condition was not properly 
recognized at operation, with the result 
that inappropriate operations were per­
formed (Table VI). In three infants the 
diagnosis was completely missed. One 
had a Ladd’s procedure performed, one 
was thought to have an internal 
hernia and, at a later operation, adhe­
sions, and the third was operated upon 
elsewhere. The first patient succumbed 
to total colonic and small intestinal 
aganglionosis and could not have been 
saved. The other two died despite later 
appropriate surgery. In five patients 
the extent of the disease was misjudged 
and the ostomy made through agan­
glionic bowel. One succumbed to total 
colonic and small-bowel aganglionosis 
and could not have been saved, one 
died despite corrective surgery 2 weeks 
later, and three survived but had very 
stormy courses until appropriate surgery 
was carried out 13 Vi months, 5 months 
and 26 days later. Fluid losses contri­
buted greatly to the deaths of the three 
patients who had later corrective proce­
dures.
With regard to fluid and electrolyte 
losses, it should be mentioned that in 
the early days (1957 to 1961) we were 
forced to perform the definitive proce­
dure fairly soon because of problems 
with the ileostomies. Thus, in our first 
four patients the pull-throughs were 
done 2 weeks, 6 weeks, 3 months and 
2 weeks after the ileostomies and con­
sequently all were subjected to defi­
nitive surgery at an early age (Table 
VII). These infants had extremely 
stormy postoperative courses because of 
diarrhea and excoriation. One died 2Vi 
weeks after a Duhamel operation, and 
another 3 years after a Swenson’s oper­
ation. The other two required repeated, 
lengthy periods of hospitalization dur­
ing the first 3 years of their lives, but 
are now well at 19 years and 17 years 
of age.
Since that time we have managed to 
cope with the fluid losses by means of 
hyperalimentation, and definitive sur­
gery has been postponed for 7 to 17 
months. However, a patient who had a 
Soave pull-through procedure at 13 Vi 
months had to be hospitalized for most 
of the succeeding 2 years. He is now 8 
years old and somewhat retarded.
Since 1974 we have adopted the Les­
ter Martin procedure for total colonic 
aganglionosis29 (Table VIII), and al-
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Table V I I I— Patients Who Underwent a Lester M artin  Procedure
Patient
no. Segment
Age at
operation, mo Outcome
12 Colon +  10 cm 
ileum
15 Alive and w ell, 3 yr
13* Colon +  10 cm 
ileum
16 Alive and w ell, 3 yr
14 Colon +  30 cm 
ileum
13 Alive and w ell, 214 yr
15 Colon 9 Alive and w ell, 19 mo
16* Colon +  150 cm 
ileum
7 Alive and w ell, 13 mo
"Inappropriate in itia l surgery.
Table IX— Summary of Results— Deaths
No. of 
patients
No operation 2
Total colonic and total small intestinal aganglionosis 
Inappropriate in itia l surgery
2
No d e fin itiv e  operation 2
Duhamel procedure 1
Ileostom y 1
Correct in itia l surgery— Swenson’s procedure 1*
Tota l 9
‘ Survived 3% yr.
though there have been early post­
operative problems with alternating 
constipation and diarrhea, these have 
been less severe than those encountered 
after the Swenson’s, Duhamel and 
Soave operations. Anal excoriation in 
particular has been much less, but it is 
still too soon to assess the long-term 
results. As shown in Fig. 16, the small
FIG. 16— Barium enema after Lester 
Martin procedure for total colonic agan- 
glionosis showing gross dilatation of an­
astomosed ileum.
intestine anastomosed to the aganglionic 
left colon becomes considerably dilated 
and acts as a reservoir. This may pose 
problems if too much colon is retained 
or a spastic internal sphincter inter­
feres with emptying.
Summary of Results
Deaths
Nine of our 17 patients died (Table 
IX). Two were not operated upon—one 
because of the moribund condition of 
the infant on admission and the other 
because the diagnosis was missed de­
spite a suspicious barium enema. In two 
with total colonic and total small in­
testinal aganglionosis the deaths were 
unavoidable. In three the extent of the 
aganglionic segment was misjudged and 
the infants died later despite corrective 
surgery. One patient presented at the
Table X— Summary of Results -Survivors
No. of 
patients
Inappropriate in itial surgery
(Soave) 1
(Lester M artin ) 2
Correct in itia l surgery
(Swenson’s) 1
(Duham el) 1
(Lester M artin ) 3
Total 8
age of 3 months with acute appendicitis 
and died of sepsis and fluid loss. Final­
ly, one patient survived for 314 years 
after a Swenson’s operation but had 
repeated attacks of severe enterocolitis.
Survivors
There were eight survivors in all of 
whom the early postoperative period 
posed problems because of fluid losses 
(Table X). Recurrent enterocolitis and 
perianal excoriation occurred in the 
three who had a Soave, Swenson’s, or 
Duhamel procedure, but these compli­
cations improved with time. In recent 
years loperamide hydrochloride30 has 
proved a great help, and the diarrhea 
is less severe in the five children who 
underwent a Lester Martin procedure.
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R eso rt to  laparotom y fo r the staging 
o f H odgk in ’s d isease  has been 
con trove rs ia l because  o f its  questionab le  
advantage over nonsu rg ica l staging 
m ethods. The re cen t concern  over 
sp lenec tom y and subsequen t over­
w he lm ing  in fec tion  has added to th is 
debate.
The author re v iew s experience  w ith 
H odgk in ’s d isease  in 34 pa tien ts whose 
ages ranged from  6 to 18 years. 
Seventeen  pa tien ts underw ent staging 
laparotom y a fte r th e ir  d isease  had 
been staged by  standard  nonoperative 
m ethods; the duration  o f fo llow -up was 
from  2 to 7 yea rs. In 7 of these  17 
pa tien ts the stage o f the ir d isease 
w as changed as a re su lt of the lapa­
rotom y find ings . C om p lica t io n s  have 
been late  sep ticem ia  resu lt in g  in death 
in one patien t and subacute  bowel 
obstruction  not requ iring  reoperation 
in tw o patients.
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In the au thor's op in ion  stag ing 
laparotom y in ch ild ren  w ith  H odgk in ’s 
d isease  is  a va luab le  means o f de c id ing  
on th e ir subsequen t therapy.
Le re cou rs a la laparotom ie pou r la 
c la s s if ic a t io n  du stade c lin ique  de la 
m alad ie  de Hodgkin  a p rete  a co n tro ve rse  
a cause  des avantages d iscu tab le s de 
ce tte  m ethode su r le s  m ethodes non 
ch iru rg ica le s  de c la ss if ica tio n . 
L 'inqu ie tude  re cen te  exprim ee au su je t 
de la  sp lenec tom ie  e t des in fe c t io n s  
in con trd lab le s subsequentes e s t  venue 
s 'a jou te r a ce  debat.
Les au teurs e tud ien t une e xpe rience  
portan t su r la m alad ie  de Hodgkin , 
chez 34 pa tien ts dont I’age va r ia it en tre  
6 e t 18 ans. D ix-sep t patients ont su b it  
une laparo tom ie  destinee  a e ta b lir  
le  stade  de la m alad ie  apres que 
ce lu i-c i eu t e te  de te rm ine  par le s  
m ethodes nonopera to ires hab itue lle s; 
la duree de la periode  de su rve illa n ce  
u lte r ieu re  a ete de 2 a 7 ans. C he z  7 
des 17 pa tien ts le stade de leu r m a lad ie  
a e te  change par su ite  des re su lta ts  
laparo tom ies. Les com p lica tion s 
ob se rvee s ont e te  une sep ticem ie  
ta rd ive  en tra inant la m ort chez un 
pa tien t e t une obstru c tion  in te s t in a le  
sub-aigue qui n ’a pas ne cess ity  
d 'ope ra tion , chez deux patients.
Se lon  I'auteur, la  laparotom ie v isa n t 
a e tab lir  le s tade  c lin ique  chez le s
en fan ts sou ffran t de m alad ie  de  H odgk in  
e s t  un m oyen va lab le  de d e c id e r de 
la condu ite  subsequente  du tra item en t.
The prognosis of Hodgkin’s disease has 
improved greatly over the last 10 to 
15 years as a result of the systematic 
application of modern diagnostic and 
therapeutic advances. One of the more 
controversial diagnostic measures has 
been the use of staging laparotomy. 
Splenectomy has been an integral part 
of this procedure along with liver biop­
sy and multiple intra-abdominal lymph- 
node biopsies. Failure of routine tests 
to detect occult tissue involvement, 
particularly in the abdomen, together 
with negative findings in patients sus­
pected of having Hodgkin’s disease, has 
been a strong argument in favour of 
staging laparotomy. Since this is a diagnostic and not a therapeutic proce­
dure, the morbidity and mortality must 
be kept to a minimum. The reported frequency of complications has varied 
considerably.1-3 The risk of overwhel­ming infection in patients who have undergone splenectomy has been of 
particular interest. There has been dis­
agreement as to whether or not the pediatric patient is at particular risk. 
In this communication we review our 
experience with staging laparotomy in 
the pediatric patient.
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Patients and Methods
During the 11-year period from Jan. 
1, 1965 through Dec. 31, 1975, 34 
patients with Hodgkin’s disease were 
assessed and treated at this institution. 
Of these 18 were boys and 16 were 
girls. The ages of the children ranged 
from 6 to 18 years (median, 14 years) 
(Fig. 1). Seventeen of these patients 
underwent staging laparotomy and 
form the basis of this report. We noted 
the age at diagnosis, the mode of pre­
sentation, the preoperative clinical 
stage of the disease, and the methods 
of diagnosis and the success rate fol­
lowing the various diagnostic proce­
dures. We scrutinized the changes in 
staging subsequent to laparotomy and 
the survival and morbidity associated 
with the surgical procedures. We re­
viewed possible causes of overwhelming 
infection secondary to splenectomy and 
the possible means of preventing such 
infection.
Presentation
Thirty patients had cervical and su­
praclavicular lymphadenopathy as the 
presenting complaint. Two patients had 
inguinal lymphadenopathy and two pa­
tients had evidence of spinal cord com­
pression. Systemic symptoms of weight 
loss, fever and night sweats were 
present in 11 of the children at the 
time of diagnosis.
Clinical Staging
The protocol used in our unit to 
determine preoperatively the clinical 
stage of Hodgkin’s disease includes ob­
taining a detailed history and perform­
ing physical examination with special 
reference to any systemic symptoms. A 
complete hematologic investigation is 
carried out as well as tests of liver func­
tion, serum protein electrophoresis and 
immunography; blood urea nitrogen
FIG. 1— Age distribution of 34 patients 
with Hodgkin’s disease.
and serum creatinine concentrations are 
determined. Chest roentgenography is 
supplemented by whole lung tomo­
graphy if mediastinal or hilar nodes 
are involved. Lower limb lymphangi­
ography is performed by the standard 
technique. A hepatosplenoscan and 
bone scans are obtained routinely. In­
travenous pyelography and skeletal 
surveys are done only for specific in­
dications. Needle biopsy of the bone 
marrow is done. The stage of the dis­
ease was determined according to the 
classification of Carbone and associ­
ates.1 Of the 17 patients who had a 
staging laparotomy 9 were classified as 
stage IA or IIA, 4 as stage IIB, 2 as 
stage IIIA and 2 as stage IIIB after 
completion of their clinical staging. 
Only 14 of the 17 patients had lym­
phangiography but all patients under­
went liver-spleen scans and liver func­
tion tests.
Operative Procedure
Following completion of the clinical 
staging the case is discussed at a con­
ference of the physicians concerned 
and a decision is reached regarding the 
desirability of a staging laparotomy. 
Laparotomy is performed through an 
extended midline incision and involves 
the removal of the spleen and any ob­
vious hilar nodes. A wedge biopsy of 
the liver is performed along with 
needle biopsies of the depths of both 
the right and left lobes. Biopsy is done 
of lymph nodes that appear affected 
or suspicious on lymphangiography and 
of any nodes suspicious on palpation. 
Metallic clips are placed at all sites of 
node biopsies. Roentgenologic facilities 
are available to confirm that suspicious 
nodes have been removed. The iliac, 
portal and mesenteric areas are in­
spected and any suspicious nodes are 
removed. In women of child-bearing 
age an oophoropexy is performed. No 
antibiotics or drains are used.
Results
In 8 of the 17 patients who under­
went a staging laparotomy the stage 
was changed from the preoperative 
one based on the clinical findings. 
In five cases the stage was upgraded, 
in two cases from stage IIA to IIIA, 
in two from IIB to IIIB and in 
one from IIIB to IVB. In three cases 
the stage was downgraded, in one case 
from IVA to IIA, in one from IIIA to 
IA and in one from IIIB to IIB.
Correlation of the stage with the 
preoperative lymphangiograms disclosed 
four cases of false-positive lymphangi­
ograms but no false-negative result. In 
30% of the cases there was false­
negative correlation between the liver- 
spleen scan, results of liver function 
tests and the findings at laparotomy.
There were four instances of unsus­
pected Hodgkin’s disease of the spleen 
and one case of liver involvement.
Survival and Complications
There was immediate survival of all 
patients. Only one late death occurred 
in the 17 patients who underwent stag­
ing laparotomy. This was in a 16-year- 
old boy with stage IIIA disease estab­
lished at laparotomy at which time un­
suspected splenic involvement was 
found. He underwent a full course of 
above-diaphragm irradiation followed 
by a second 4-week course of below- 
diaphragm irradiation. At follow-up 
examination the mediastinal mass had 
increased in size as determined radio- 
logically and the boy complained of 
pruritus. The development of recurrent 
disease was suspected so chemotherapy 
with a combination of nitrogen mustard, 
vincristine, procarbazine and prednisone 
was instituted. Two months later an 
influenza-like illness developed one 
morning and the boy was admitted to 
the local hospital in the early afternoon. 
He died at 5:00 pm on the same day. 
Streptococci were cultured from his 
blood.
Six other patients have died of dis­
seminated disease. Two of these had 
undergone a laparotomy.
In two patients there were three 
episodes of small-bowel obstruction, all 
relieved by conservative treatment with 
nasogastric suction. These patients have 
been well, one for 3 and one for 5 
years. Two patients had unexplained 
fever and were thoroughly investigated 
in hospital; all cultures showed no 
growth of organisms and both patients 
are alive and well at the time of writ­
ing. One boy suffered from vomiting 
for approximately 6 months after his 
staging laparotomy; he was fully in­
vestigated and no cause could be found. 
He has remained well for almost 3 
years. In one patient a stitch granuloma 
drained intermittently but caused no 
major difficulty. One patient who 
initially was treated with chemotherapy 
was well for 5 years. She was then 
suspected of having intra-abdominal 
recurrence so a staging laparotomy was 
carried out and an oophoropexy per­
formed. Afterwards chemotherapy was 
continued. A year later there was an­
other localized abdominal recurrence 
and she was considered a candidate for 
local radiotherapy. At examination it 
was evident that one ovary had be­
come detached from behind the uterus. 
The patient refused to submit to radia­
tion treatment until this ovary had 
been reattached and accordingly this 
was done.
Discussion
If optimal treatment is to be given
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to patients with Hodgkin’s disease, then 
accurate staging is important. Precise 
knowledge of organ involvement is es­
sential in planning the administration 
of radiotherapy or chemotherapy. At 
the same time, overtreatment should be 
avoided to minimize the likelihood of 
excessive irradiation or the side effects 
of chemotherapy. Thus, a major ar­
gument for staging laparotomy is 
the possibility of more accurately 
locating intra-abdominal disease or de­
termining its absence and therefore 
providing more accurate specific treat­
ment, be it irradiation or chemother­
apy. Our experience with 17 children 
who underwent staging laparotomy has 
confirmed the value of this procedure. 
In eight patients the staging was 
changed from the preoperative classi­
fication. In four of the five patients 
in whom the staging was advanced 
more extensive treatment was given. 
Full abdominal irradiation was given 
because of unsuspected splenic involve­
ment in two cases and chemotherapy 
rather than irradiation was given in 
two cases because a stage IIIB classifi­
cation had been made. In one patient 
who was upgraded from stage IIIB to 
stage IVB the treatment regimen was 
not altered but important prognostic 
information was obtained. Of equal im­
portance is the fact that three patients 
were assigned to a lower stage and 
hence required considerably less treat­
ment. Two patients who otherwise 
would have been given chemotherapy 
were found to have above-diaphragm 
disease only and received more localized 
radiotherapy. One patient who would 
have received extensive irradiation to 
the abdomen for stage IIIA disease re­
ceived more limited irradiation to the 
upper abdomen when found to have 
stage IA disease. In only one patient in 
our series did abdominal disease devel­
op in a patient who previously was 
considered free of abdominal disease. 
This 15-year-old boy had recurrent ab­
dominal disease 14 months after a stag­
ing laparotomy and died 2 years later. 
Because some series have reported a 
higher frequency2 we may need a longer 
period of follow-up to exclude com­
pletely the development of abdominal 
disease.
Our series confirms, as have other 
reviews,1'5 that there may be no corre­
lation between lymphangiography, liver 
and spleen scans and liver function 
tests in an appreciable number of cases. 
Twenty-eight percent of our lymphan- 
giograms gave false-positive results 
although we had no false-negative re­
sults. Other series have reported the 
greater likelihood of false-positive than 
of false-negative results. The results of 
liver-spleen scans and liver function 
tests can be quite misleading. Five of
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the 17 patients with Hodgkin’s disease 
involving the spleen or liver had liver 
function tests and scans that gave nor­
mal results. The diagnosis of stage IV 
disease should be based on histologic 
evidence alone and not on serum find­
ings or radioisotope scans, a conclusion 
supported by others.5'6
The strongest opponents of staging 
laparotomy argue that the mortality 
and morbidity of the procedure out­
weigh the useful data obtained for the 
subsequent treatment of these persons. 
In our series we had no operative deaths 
but one patient died of overwhelming 
septicemia 10 months after splenec­
tomy. Our morbidity statistics are com­
parable to those of several other series 
and none of the complications serious­
ly influenced the patient’s future man­
agement or survival. Higher incidences 
of postoperative difficulties have been 
reported2 resulting in abandonment of 
staging laparotomy or limitation of it 
to selected cases.
The risk of overwhelming sepsis in 
patients who have undergone splenec­
tomy is the principal concern at present. 
In 1952 King and Schumaker7 drew at­
tention to the increased susceptibility of 
young infants to serious bacterial in­
fection following splenectomy. Since 
then there has been considerable con­
troversy over whether such a risk does 
exist. At present it seems that splenec­
tomy does increase susceptibility to in­
fection in certain individuals. The fre­
quency of infection varies considerably 
with the indication for the operation. 
It is lowest when the spleen is removed 
because of trauma and tends to be 
highest when the organ is removed for 
congenital hemolytic anemia, thalasse­
mia, portal obstruction, immune defi­
ciency or malignant disease.8,9 Hodgkin’s 
disease certainly falls into the last two 
categories since in many of the patients 
the immune system is depressed or im­
paired because of the primary disease 
and also because of concomitant radio­
therapy or chemotherapy, or both. The 
Children’s Cancer Study Group re­
viewed 200 children under 19 years of 
age with Hodgkin’s disease who under­
went staging laparotomy and splenec­
tomy.10 There were 20 episodes of septi­
cemia and meningitis in 18 children 
and 10 died. Almost all of them had 
fulminating infections resulting in 
death within hours. It is significant that 
78% of these young patients had re­
ceived both chemotherapy and radia­
tion therapy. All of the infections oc­
curred within 3 years of the splenec­
tomy. A number of other authors have 
shown that the chance of infection is 
greatest within the first 2 to 3 years 
after splenectomy although some cases 
have occurred at later intervals.8,10 That 
the very young child is at increased 
risk was shown by King and Schu-
maker’s original paper7 and is supported 
by more recent series.8,11 It appears that 
splenectomy should be avoided in in­
fants under 2 years of age and per­
haps up to 5 years of age. It is inter­
esting that our case of septicemia was 
very similar to those seen in the Chil­
dren’s Cancer Study Group series, the 
boy having died 10 months after opera­
tion and after having received both 
chemotherapy and irradiation.
A number of factors have been im­
plicated in the increased susceptibility 
to overwhelming infection. Splenectomv 
has been shown to decrease the phago­
cytic mass. While the liver and other 
areas of the reticuloendothelial system 
can affect phagocytosis, the efficiency 
of this process is much reduced in the 
absence of the spleen.11"13 It has been 
suggested that a substance found in 
splenic tissue, termed tuftsin, may act 
upon leukocytes to stimulate phagocy­
tosis.14 Weitzman and associates13 
showed that the number of antibodies 
to Hemophilus influenzae was sub­
stantially reduced in patients treated 
for Hodgkin’s disease. Splenectomy and 
radiotherapy when used alone had lit­
tle effect but chemotherapy alone or 
combined with splenectomy depressed 
antibody titres, as did combined treat­
ment of chemotherapy and irradiation. 
They also showed that IgM concentra­
tions were greatly reduced in patients 
who received chemotherapy and that 
this effect was accentuated by splenec­
tomy. IgM appears to facilitate the 
removal of organisms and it is well 
known that normal concentrations are 
not attained until 2 years of age. As 
mentioned above, a general alteration 
in the immunity of the patient either 
from underlying malignant disease or 
the combination of chemotherapy and 
radiotherapy may play a role and ag­
gravate the problems initially induced 
by the splenectomy.
We must consider whether the risk 
of overwhelming infection can be pre­
vented or at least reduced. Physicians’ 
knowledge of this complication must 
be increased. The high-risk group ap­
pears to be patients under 5 years of 
age and particularly those under 2 
years. Fortunately, few such young 
children suffer from Hodgkin’s disease 
and in our series there were no chil­
dren under 2 years of age. The first 
3 to 4 years following splenectomy ap­
pear to be the period of greatest risk 
although sepsis and death have oc­
curred after many years have elapsed. 
Those patients who receive chemo­
therapy, especially if it is combined 
with radiotherapy, appear to be at the 
greatest risk and should be under very 
careful surveillance. Patients or, in the 
case of a child, the family should be 
instructed to seek attention early if an 
infection or high fever develops. Some
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authors have suggested that patients 
should be provided with a supply of 
antibiotics to be taken at the first 
sign of infection until medical atten­
tion can be obtained.15
There is much debate at present on 
whether antibiotics should be pre­
scribed prophylactically. It has been 
advised that patients who have had a 
splenectomy should take penicillin daily 
for 2 to 3 years.8’10 Although pneumo­
coccus has been the organism most 
frequently isolated, H. influenzae, strep­
tococci and occasionally enteric organ­
isms have also been isolated. Not only 
may the prophylactic antibiotic selected 
be the wrong one for the particular 
infection but resistance to the antibiotic 
may develop. The number of strains of 
the various organisms may make com­
plete coverage almost impossible. In­
fections have been confirmed in children 
receiving prophylactic antibiotics.3-16 
Patient compliance is also unreliable; 
there is no assurance that the child will 
remember to take his medication or 
that the parents will give it to him 
regularly. A future possibility may be 
the immunization of these high-risk pa­
tients with bacterial vaccines15 but at 
present these are not generally avail­
able.
Our own policy has been to insist 
that children take phenoxymethyl peni­
cillin, 125 mg twice daily by mouth, 
for 3 years after the staging laparotomy. 
This is particularly necessary in chil­
dren who have received chemotherapy. 
The patient, his parents and his family 
physician are all instructed to seek 
medical attention without delay if signs 
of a respiratory illness or unexplained 
fever appear.
Summary
We have presented our findings in 
34 patients under the age of 18 years 
with the diagnosis of Hodgkin’s disease. 
In 17 the stage of the disease was de­
termined at laparotomy when splenec­
tomy was performed. Morbidity was 
low and the only related death was 
attributable to septicemia 10 months 
after the laparotomy. We have dis­
cussed the role of the spleen in body 
defence mechanisms and the possible 
alterations in these mechanisms induced 
by its removal and augmented by irra­
diation or chemotherapy, or both. Over­
whelming infection is the major com­
plication to be avoided as it carries a 
high mortality in the splenectomized, 
immune-depressed patient.
We believe that staging laparotomy 
is a valuable diagnostic procedure in 
young people with Hodgkin’s disease. 
It reveals occult disease and thus allows 
earlier and more exact treatment. In 
other cases it prevents excessive irradia­
tion to regions shown not to be in­
volved by the disease. As this is a 
diagnostic and not a therapeutic pro­
cedure the mortality and morbidity 
must be kept to a minimum.
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A Critical Look at Delayed Intestinal Motility
in Gastroschisis
S.Z. Rubin, mb, frcs[c], frcs(edin),* D.J. Martin, 
and S.H. Ein, md, frcs[c], faap$
The motility of the gastrointestinal 
tract after the accepted management 
of gastroschisis by using a Silon pouch 
and gradually reducing the herniated 
intestine is compared with the intestinal 
motility after primary reduction and 
closure of the defect.
Since 1970, 46 children with gastro­
schisis have been treated at the 
Hospital for Sick Children, Toronto. 
Twenty-seven were treated with a Silon 
pouch. Eleven died after an average 
postoperative survival of 17 weeks; 
not one had bowel motility that allowed 
oral feeding. Among the 16 survivors 
an average of 10 weeks elapsed 
between operation and the institution 
of full oral feeding.
Seventeen children were treated by 
forceful stretching of the abdominal 
cavity, primary replacement of the 
eviscerated intestines and closure of 
the defect. Two died in the early 
postoperative period of conditions 
unrelated to the gastroschisis or to the 
procedure. The average period between 
operation and full oral intake of food 
was only 4 weeks. In addition, two 
neonates were admitted after primary 
closure was done at the referring 
hospital.
Roentgenograms obtained postoper- 
atively in 24 of the patients showed 
the “ typical" dilated loops with air
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fluid levels in patients treated with a 
Silon pouch.
The authors' findings indicate that 
primary reduction and closure of the 
defect has a distinct advantage over 
use of a Silon pouch in the treatment 
of gastroschisis.
La motilite du tractus gastrointestinal, 
apres recours au traitement courant 
du gastroschisis par I’utilisation de 
la poche Silon et la reduction 
progressive des intestins hernies, a 
ete comparee avec la motilite intestinale 
obtenue apres reduction primaire et 
fermeture de I'anomalie.
Depuis 1970, 46 enfants ayant un 
gastroschisis ont ete traites au 
Hospital for Sick Children de Toronto. 
Vingt-sept ont ete traites a I'aide de 
la poche Silon. Onze sont morts apres 
une survie postoperatoire moyenne de 
17 semaines; aucun n'avait une motilite 
intestinale permettant I'alimentation 
par voie orale. Chez les 16 survivants, 
il s'est ecoule en moyenne 10 semaines 
entre I’operation et I’instauration d'une 
alimentation complete par voie orale.
Dix-sept enfants ont ete traites 
par dilatation forcee de la cavite 
abdominale, restauration primaire des 
intestins evisceres et la fermeture 
de I'anomalie. Deux sont morts dans 
la periode postoperatoire immediate 
dans des circonstances n’ayant aucun 
rapport avec le gastroschisis ou 
■’intervention chirurgicale. La periode 
moyenne s'etant ecoulee entre 
I’operation et I’alimentation complete 
par voie orale n’a ete que de 4 semaines. 
De plus, deux nouveaux-nes ont ete 
hospitalises apres qu'une fermeture 
primaire eut ete realisee a I’hopital 
d’ou ils furent diriges.
Les radiographies obtenues apres 
I’operation chez 24 patients ont montre 
I'anse dilatee “ typique” , avec des 
niveaux d'air et liquide des patients 
traites avec une poche Silon.
Les resultats obtenus par les auteurs 
indiquent que la reduction primaire 
et la fermeture de I’anomalie presentent 
un avantage marque sur I'emploi de 
la poche Silon dans le traitement d'un 
gastroschisis.
MD, FRCP[C]f
Gastroschisis1 is a congenital condition 
in which a baby is born with its un­
covered intestine herniated through an 
anterior abdominal wall defect. The 
increasing incidence of gastroschisis2 
has drawn the attention of pediatric 
surgeons to this condition, which calls 
for immediate operation.
Despite improved treatment and the 
widespread application of total paren­
teral nutrition (TPN), the major prob­
lems of sepsis3'5 and delayed intestinal 
motility3'6,7 still account for a significant 
morbidity and mortality.
The clinical problem of sepsis has 
already been studied.5 In this paper we 
examine the delay in intestinal motility 
associated with gastroschisis.
Patients and Methods
During the period Jan. 1, 1970 to 
Dec. 31, 1977, 46 neonates with gastro­
schisis were treated at the Hospital for 
Sick Children, Toronto. After delivery 
of the baby the exposed intestine was 
covered with petrolatum- or saline- 
soaked gauze and was supported by a 
plastic film or a linen binder fastened 
around the abdomen. A  nasogastric 
tube was passed to which intermittent 
suction was applied. The babies were 
nursed in an incubator in the reversed 
Trendelenberg position. A catheter was 
inserted intravenously for the infusion 
of solutions of glucose. Electrolyte and 
blood-gas abnormalities were corrected.
At operation 27 babies had exposed 
loops of bowel covered with a Silon 
pouch (American Medical and Surgical 
Research Corp., Haverford, PA). The 
other 19 newborns were treated by 
forceful stretching of the abdominal 
wall to allow primary reduction of the 
eviscerated intestine and closure of 
the defect. No special attempt was made 
to close the abdominal wall in layers. 
The thick exudate (“peel”) covering the 
intestine was not removed. Gastro­
stomy, ileostomy or ileotomy to decom­
press the bowel was avoided. The 
nasogastric tube was left in place to 
permit gastrointestinal decompression. 
As soon as the infant’s condition was 
stable TPN was started.
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Intestinal transit was gauged clinical­
ly by the type and amount of naso­
gastric drainage, the degree of ab­
dominal distension, the presence of 
peristalsis and the passage of stools, and 
radiologically by plain abdominal films 
and by roentgenograms obtained after a 
barium meal. Adequate intestinal func­
tion was indicated by tolerance to gas­
trointestinal feeding and ability to dis­
pense with TPN.
Results
According to the initial operation, 
the neonates were assigned to one of 
three categories: those whose defect 
was closed in stages with Silon, those 
who underwent primary closure at our 
institution and those whose primary 
closure was performed at the referring 
hospital.
Eleven of the 27 neonates treated 
by use of a Silon pouch died (Table 
I). The mean birth weight of the 
survivors was 2.29 kg and the mean 
birth weight of the babies who died 
was 2.41 kg. Eighteen proven cases of 
bacterial or monilial sepsis were re­
corded. Sixty-four operative procedures 
were performed on these 27 babies. 
The average age at which complete 
gastrointestinal feeding of the 16 sur­
vivors was possible was 46 days. No 
baby who died was ever weaned from 
TPN and the mean age at death was 
67 days.
Seventeen, infants were treated by 
primary closure at our institution (Ta­
ble I); their mean birth weight was 
2.43 kg. Two died in the early post­
operative period. One infant died on 
the sixth postoperative day of acute 
aspiration and the other on the second 
postoperative day of an intraventricular 
hemorrhage; neither death was directly 
related to the surgical procedure. Each 
infant in this group of 17 required only 
one operation. The mean age at which 
the 15 survivors had adequate intestinal 
function was 32 days.
Two neonates had primary closure 
of the defect performed at the refer­
ring hospital (Table I). Each weighed 
2.4 kg and both survived in spite of 
proven bacterial sepsis. One infant re­
quired four abdominal procedures, in­
cluding drainage of an intraperitoneal 
abscess; adequate intestinal function 
was achieved on the 76th postoperative 
day. The other baby had two operations 
and full gastrointestinal feeding was 
possible by the 128th postoperative day.
Twenty-four of the infants in the 
study had postoperative abdominal 
roentgenography (Table II). The degree 
of intestinal dilatation was noted and 
the patients were classified accordingly. 
There were 13 infants whose films 
demonstrated moderate to severe in­
testinal dilatation of longer than 7 
days’ duration; 11 had been treated 
with Silon while the other 2 had under­
gone primary closure at the referring 
hospital. There were four infants whose 
roentgenograms showed mild intestinal 
dilatation of longer than 7 days’ dura­
tion, but films taken later showed nor­
Table 1— Data of 46 Neonates Treated for Gastroschisis by Use of Silon 
Pouch or Primary Reduction and Closure
Use of
Primary closure
At the Hospital for At referring
Silon pouch Sick Children hospital
Data (n =  27) (n =  17) (n =  2)
Survivors 16 15 2
Deaths 11 2 —
Birth weight, kg 
Survivors 2.29 2.43 2.4
Deaths 2.41 2.00 —
Age at cessation of TPN, d 
Survivors 46 32 102
Deaths 67
Table II -Results  of Roentgenography in 24 Neonates
Dilatation
Degree Duration, d Silon
Primary
closure
Moderate-severe >  7 11 2*
Mild >  7 1 3
Mild-normal <  7 2 5
*Primary closure at referring hospital.
mal bowel-gas patterns and barium 
follow through.
Discussion
Prolonged postoperative ileus is as­
sociated with all methods of correction 
of gastroschisis.3'6'7 Intraoperative at­
tempts to decompress the bowel by 
colotomy, ileotomy or gastrotomy in­
crease the morbidity without beneficially 
affecting the postoperative course.5 The 
“peel” covering, and firmly adherent 
to, the herniated intestine and mesent­
ery may contribute to the prolonged 
ileus. The surgeon should not attempt 
to remove the “peel” at operation 
because of the risk of hemorrhage and 
occasionally of bowel perforation. 
Temporary delay in gastrointestinal 
function is now managed by TPN, 
which is an important factor in re­
ducing mortality.3'6'8
The clinical signs of abnormal bowel 
motility are abdominal distension, lack 
of peristaltic sounds, a large volume of 
nasogastric aspirate and the inability 
to tolerate any enteral feeding. Passage 
of meconium or green, mucus-contain­
ing stool often indicates normal colonic 
function, even though small-bowel 
peristalsis is ineffective.
In 24 infants these clinical signs 
were of sufficient severity or duration 
to warrant abdominal roentgenography. 
The most striking feature was the 
dilatation of the loops of bowel. Fre­
quently most of the bowel was uniform­
ly involved, but at times some loops 
were disproportionately dilated (Fig. 1). 
Air fluid levels were seen and the wide 
separation of the intestinal loops at­
tested to the thickness of their walls 
(Fig. 2). Under any other circum­
stances these appearances would have
FIG. 1— Abdominal roentgenogram 
showing dilated loops in right upper 
quadrant and loops of normal calibre in 
left lower quadrant—example of localized 
dilatation.
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been regarded as evidence of obstruc­
tion, but barium studies demonstrated 
no mechanical obstruction (Fig. 3), 
only inert bowel with poor peristaltic 
activity. Occasionally, ineffective peri­
stalsis producing a to-and-fro move­
ment of the barium was observed. It 
became clear that the amount of ef­
fective peristaltic activity was inversely 
related to the degree of dilatation of 
the loops of bowel (i.e., the most dilated 
loops had the least activity). As the 
condition improved, so the calibre of 
the loops diminished. In many cases, 
the infant was able to tolerate oral 
feedings before the intestinal loops re­
turned to normal size. Even in infants 
with similar roentgenographic appear­
ances initially, there were wide varia­
tions in the speed of recovery of useful 
peristalsis. When the dilatation appeared 
localized, resection of this portion of 
bowel did not result in improved motil­
ity. Although the roentgenograms were 
typical and had prognostic value, they 
did not localize the intestinal disease.
Forty-four neonates were managed 
identically except for the method of 
reduction of the hernia. During the 
initial years of the study staged closure 
with Silon was considered the optimal 
treatment. In the later years primary 
closure became the treatment of choice; 
in only one patient was Silon applied
K ID N E Y  F O U N D A T IO N  
RESEARCH FELLO W SHIPS
A lb e rta , Canada —  1 97 9 -8 0
A p p lican ts  in v ited  fo r tw o  
Postdoctoral M e d ic a l F e llo w ­
ships in N ephro logy or Urology  
to  run co n cu rren tly  fro m  July  
1, 1979, a t U n iv ers ity  o f A lb e r­
ta , Edm onton, and U n ivers ity  
o f C a lg ary  (F acu lty  o f M e d i­
c in e ).
In te rd is c ip lin a ry  tra in in g  in 
basic  research a n d /o r  c lin ica l 
in vestig atio n  a va ilab le . Pro­
gram s provide o p p o rtu n ity  fo r  
fu ll e n ro llm en t in School o f 
G rad u ate  S tu d ies .
S a la ry  concordant w ith  q u a lifi­
catio ns  and p rio r tra in in g  to  
m axim um  $30,000  per annum . 
F e llo w sh ip  is fo r  one y ea r but 
second year ap p lica tio n  a n tic i­
pated .
For application forms contact:
K ID N E Y  F O U N D A T IO N  O F  C A N A D A  
A lb e rta  B ran ch , # 1 4 0 4  
8 3 6 - 5 t h  A v e n u e  S . W . 
C alg ary , A lb e r ta , C an a d a  
T2P 0N 5
Applications not accepted 
after October 31, 1978.
because the surgeon was unable to 
achieve primary closure. There was no 
statistical difference in the mean birth 
weights of the two groups.
In our experience the use of artificial 
material to cover the exposed intestine 
was frequently associated with both local 
and systemic infection. There were, 
however, no intraperitoneal abscesses. 
None of the 11 babies treated by use 
of a Silon pouch who died ever at­
tained intestinal function. In one un­
fortunate infant dilated inert loops of 
small bowel persisted for 1 year before 
he finally died. Although sepsis may 
contribute to delayed intestinal motility, 
application of a Silon pouch is asso­
ciated with such a delay even in the 
absence of infection.
Those neonates who were managed 
by primary closure demonstrated a 
more rapid return of intestinal func­
tion than those who were managed by 
staged closure with Silon. It is con­
ceivable that the earlier restoration of 
the normal intraperitoneal milieu at­
tained by primary closure results in the 
more rapid disappearance of the “peel” 
and an earlier return of normal bowel 
function.
The delayed successful outcome in 
the two infants who had primary
FIG. 2— Abdominal roentgenogram
showing dilated loops and air fluid levels.
FIG. 3—(Same infant as in Fig. 2.) 
Abdominal roentgenogram following in­
gestion of barium showing moderate dilata­
tion of loops with barium in both small 
and large bowel.
closure at the referring hospital may 
be indicative of the importance of im­
mediate preoperative and intraopera­
tive care of the newborn and of the 
exposed intestine in minimizing post­
operative ileus.
Once the abnormal pattern of in­
testinal motility has become established, 
treatment is prolonged, complicated 
and frustrating. In a few cases 
cholinergic agents and metoclopramide 
were used but, although the amplitude 
of contractions was increased, no bene­
ficial effect on propulsion of small- 
bowel content occurred.
Summary and Conclusion
Over a period of 7 years, 46 neonates 
with gastroschisis were studied. Twenty- 
seven were treated by staged closure 
using Silon and 19 by primary closure 
of the defect. A delay in the restoration 
of normal intestinal motility was ob­
served. In such infants serial roent­
genography revealed an abnormal in­
testinal pattern, which was related to 
the degree of disordered intestinal 
motility and was not influenced by 
pharmacologic agents. The delay in 
restoring normal intestinal motility was 
a major cause of morbidity and mortal­
ity. The frequency of delayed intestinal 
motility was increased by staged closure 
using a Silon pouch.
This study indicates that primary 
closure of gastroschisis in a properly 
equipped pediatric surgical and neo­
natal centre will substantially reduce 
the occurrence of delayed intestinal 
motility in gastroschisis.
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Fine Needle Aspiration Biopsy 
in the Management of Palpable Breast Lesions
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B.V. T oth, md, J.C. G agnon, md, H. Savard, md and L.M. Shirley, md
During a 34-month period 2050 fine 
needle aspiration biopsies of solid 
or cystic palpable breast lesions 
were performed.
Of the 1182 patients with solid 
lesions, 384 underwent 405 surgical 
procedures. Carcinoma was the his­
tologic diagnosis of 118 lesions. Of these, 
aspiration cytology had identified 92 
(7 8 % ) as malignant; in 13 (1 1 % ) a 
malignant condition was suspected; 9 
(7 .6 % ) had been falsely assessed as 
benign. Cytology reports were 
accurate in 237 (8 3 % ) of the 287 
histologically confirmed benign lesions. 
There were no false-positive reports.
The 243 patients with cystic lesions 
underwent 572 aspirations for diagnosis 
and as treatment. Four lesions were 
excised and found to be benign.
Needle aspiration biopsy is a most 
valuable tool. It is safe, simple, quick, 
repeatable and easily accepted by 
patients. Its positive predictive value is 
excellent (100% in our series). Cytology 
reports negative for malignant change 
should be disregarded if cancer is 
suspected clinically.
Du 1er janvier 1975 au 31 octobre 1977, 
un total de 2050 ponctions cytologiques 
a I'aiguille fine ont ete faites pour 
des lesions mammaires palpables, 
solides ou kystiques.
Parmi les 1182 patientes porteuses
From the breast clinic and the department 
of pathology, Hopital dtt Saint-Sacrement, 
and the department of social and pre­
ventive medicine, Laval University, 
Quebec, PQ
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de lesions solides, 384 ont eu 405 
biopsies chirurgicales. Le diagnostic de 
cancer a ete porte pour 118 lesions.
De ces lesions, la cytologie en avait 
considere 92 (78% ) comme malignes et 
13 (1 1 % ) comme suspectes; 9 (7 .6 % ) 
avaient faussement ete trouvees beni- 
gnes. L'examen cytologique avait 
correctement identifie 237 (8 3 % ) des 287 
lesions histologiquement benignes. II 
n’y a pas eu d'examen cytologique 
faussement positif.
Les 243 patientes atteintes de kystes 
ont ete soumises a 572 ponctions 
cytologiques pour diagnostic et traite- 
ment. Quatre lesions ont ete excisees 
et trouvees benignes a l'examen 
histologique.
La ponction cytologique a I'aiguille 
fine est un outil de grande valeur.
C'est un examen sans complication, 
simple, rapide, facilement accepte par 
les patientes et qui peut etre repete 
au besoin. Sa valeur predictive positive 
est excellente (100% dans notre serie). 
Des resultats cytologiques negatifs 
doivent etre ignores si la lesion est 
cliniquement suspecte.
Needle biopsy of tumours was first de­
scribed more than half a century ago.1 
Fine needle aspiration of breast lesions 
is a modification of the original tech­
nique. It was initiated in the early 
1930s at the Memorial Hospital for 
Cancer and Allied Diseases in New 
York by Martin and Ellis2,3 and has 
gained wide acceptance in Europe, 
mostly in Sweden4'7 and France,8'10 and 
in some medical centres in the United 
States.11'14 Only one large study has been 
reported from Canada— that of Smith 
and colleagues15 published in 1959.
We have found biopsy by fine nee­
dle aspiration to be a most valuable 
tool in the management of breast le­
sions and report our experience.
Patients and Methods
This study includes all fine needle 
aspiration biopsies performed on pal­
pable breast lesions in women from 
Jan. 1, 1975 to Oct. 31, 1977. During 
this period 2050 such biopsies were 
done on 1331 patients.
Technique o f  Aspiration C ytology
The technique is well known.4,0 We 
use a 20-gauge needle and a 10-mL 
disposable syringe with a special han­
dle which permits single-handed aspira­
tion while the tumour is immobilized 
by the fingers of the other hand. No 
local anesthesia is required.
The smear is spread on four slides. 
Two slides are stained according to the 
Papanicolaou method and two accord­
ing to the Giemsa method.
C ytologic Grading
As suggested by Webb,16 cytologic 
findings are divided into four cate­
gories: malignant, suggestive of malig­
nancy (suspicious), benign, inadequate.
Malignant smears are those in which 
unmistakable malignant cells pre­
dominate.6,18 Suspicious smears contain 
some cells with morphologic anomalies 
suggestive of cancer, but benign cells 
coexist and suspicious clusters are a 
minority.10 Inadequate smears are char­
acterized by the absence of representa­
tive cellular elements,0'10 they are 
acellular or contain only cells from 
fibrofatty tissue. (Details of the cyto­
logic findings from this series of pa­
tients will be published elsewhere.)
A ccuracy o f  Aspiration C ytology
The accuracy of a diagnostic test is 
judged by its ability to detect the 
presence or absence of the disease un­
der study. It is measured by its sen­
sitivity, specificity and predictive val­
ues.
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The sensitivity of aspiration cytology 
indicates the probability that a lesion 
will be labelled as malignant by the test 
given that it is truly malignant (i.e., 
found to be malignant on histologic 
examination).
The specificity is the probability that 
a lesion will be labelled as benign by 
the test given that it is truly benign 
(i.e., found to be benign on histologic 
examination).
The predictive value of a positive 
test is the probability that a lesion is 
truly malignant given that it is so la­
belled by the test. The predictive value 
of a negative test indicates the pro- 
bality that a lesion is truly benign given 
that it is so labelled by the test.
Results
The results of aspiration biopsy on 
each type of lesion (solid or cystic) are 
shown in Table I. Of the 1331 patients, 
1182 had solid lesions and 243 had 
cystic lesions (94 had both solid and 
cystic lesions).
Of the 572 aspirates from cystic le­
sions, 96.5% were assessed as benign
while 2.3% were labelled as suspicious. 
Only four lesions (two cytologically 
suspicious and two benign) required 
surgical excision and were found to be 
benign by their histologic character­
istics.
Of the 1478 aspirates from solid 
lesions, 6.2% were labelled malignant, 
2.8% suspicious and 72.7% benign. 
The proportion of inadequate smears 
was rather high — 18.3%. The 1182 
patients with solid lesions can be as­
signed to one of two groups: those 
who did not have surgery and those 
who did. The 798 patients in the first 
group were and are still being care­
fully followed up. The 384 patients in 
the second group underwent surgery in 
405 instances.
Cytologic and histologic reports for 
these 405 lesions are compared in Ta­
ble II. Breast carcinoma was the his­
tologic diagnosis for 118 lesions in 111 
patients. Seven patients had bilateral 
malignant tumours, synchronous in four 
instances, metachronous in three.
Cytology identified as malignant 92 
of the 118 histologically proven can­
cers. It therefore had a sensitivity of
0.78. It also identified 13 lesions as 
suspicious. Nine lesions (7.6%) were 
assessed as benign. Of the 287 lesions 
diagnosed as benign by histologic meth­
ods (in 273 patients), 237 were so 
classified by aspiration biopsy. The 
specificity of aspiration biopsy was 
therefore 0.83. Aspiration smears were 
inadequate in 3.4% of the 118 his­
tologically malignant lesions and in 
11.8% of the histologically benign le­
sions. In the absence of any false­
positive statements, the positive pre­
dictive value of cytology in our series 
was 1. With nine false-negative state­
ments, its negative predictive value was 
0.96.
Of the 16 cytologically suspicious 
lesions subsequently found to be 
benign at histologic examination, 4 
were fibroadenomas, 11 were cases of 
mammary dysplasia and 1 was an in­
traductal papilloma.
Recorded clinical impressions and 
cytology reports for the 118 histologic­
ally proven breast carcinomas are com­
pared in Table III. Of the 20 cases 
clinically assessed as benign, 10 had 
aspiration smears positive for malig­
nancy. Results of mammography were 
considered suspicious in 4 of these 10 
patients and benign in 5. One patient 
was pregnant and did not have a ro­
entgenogram. These 10 women who 
had a median age of 44.0 years and a 
mean age of 46.1 ± 9.2 years were 
significantly (P =  0.0016) younger than 
the other 101 cancer patients who had 
a median age of 59.2 years and a mean 
age of 58.6 ±  11.8 years.
The age distribution of the 111 con­
firmed cancer patients and of all the 
1220 patients with lesions assessed as 
benign appear in Fig. 1. As expected, 
cancer patients are appreciably older 
(mean age, 57.5 ±  11.8 years) than 
women with benign lesions (mean age, 
38.6 ± 12.6 years).
Discussion
Our results are very similar to those 
reported elsewhere.8,10 Fine needle 
aspiration biopsy is simple, quick, re­
peatable and readily accepted by 
patients. Its excellent positive predictive 
value in malignant cases in our series
F IG . 1— Age distribution of patients 
with malignant disease superimposed on 
that of patients with benign conditions.
Table 1 -Results of 2050 Fine Needle Aspiration Biopsies (1331 Patients)
Type of lesion
Cytology report Solid, no. (and % ) Cystic, no. (and % ) Total, no. (and % )
Benign
Suspicious
Malignant
Inadequate
1074 (72.7) 552 (96.5) 
42 (2.8) 13 (2.3) 
92 (6.2) 0 (0 ) 
270 (18.3) 7 (1.2)
1626 (79.3) 
55 (2.7) 
92 (4.5) 
277 (13.5)
Total 1478 (100.0) 572 (100.0) 2050 (100.0)
Table II -Comparison of Cytology and Histology Reports for 405 Solid Lesions 
of the Breast in 384 Patients
Histology report
Cytology report Malignant, no. (and % ) Benign, no. (and % ) Total, no.
Malignant
Suspicious
Benign
Inadequate
92 (78.0) 0 (0) 92 
13 (11.0) 16 (5.6) 29 
9 (7.6) 237 (82.6) 246 
4 (3.4) 34 (11.8) 38
Total 118 (100.0) 287 (100.0) 405
Table III—Comparison of Clin ical and Cytology Reports for the 118 Breast Cancers Confirmed
by Histology (111 Patients)
C lin ical report
Cytology report Suspicious Benign Total no.
Malignant 82 10 92
Suspicious 8 5 13
Benign 5 4 9
Inadequate 3 1 4
Total 98 20 118
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as well as in other series5,6'10 allows 
a number of patients to be psychologic­
ally prepared for mastectomy and re­
duces the number of those who enter 
the operating room not knowing if they 
will leave it with or without their breast. 
Patients for whom major surgery is 
foreseen are hospitalized whereas the 
others have their surgical biopsy as 
outpatients.
Aspiration cytology appears to be 
particularly useful for detecting cancer 
in younger patients in whom clinical 
assessment may be influenced by age; 
it is also useful in pregnant women. It 
is the most adequate method of assess­
ing recurrent, inflammatory or inoper­
able breast cancers.
The only complication encountered 
occasionally is a hematoma.6 At Stock­
holm’s Radiumhemmet where aspiration 
biopsy has been routinely performed 
for over 20 years, no sign of local 
malignant seeding has ever been ob­
served in that institution’s very large 
series of breast cancers.6 With regard 
to distant dissemination, aspiration 
biopsy seemed to have no effect on the 
15-year survival rates of the carefully 
matched though not randomized pa­
tients with breast cancer studied at 
New York’s Memorial Hospital for 
Cancer and Allied Diseases.17
Although the possibility of false­
negative results must always be kept 
in mind, needle biopsy is also of great 
value in the management of benign le­
sions. When associated with clinical 
findings not indicative of a malignant 
condition, benign smears relieve the 
anxiety of both patient and physician. 
Aspiration cytology allows for a more 
reliable follow-up of such conditions 
as mammary dysplasia.
In the large French and Swedish 
cancer centres, fine needle aspirations 
are performed by the cytologist.6’10 In 
our situation, that of a breast clinic in 
a general hospital, it is the clinician 
who does the aspiration. The syringe 
is then handed over to the cytotechni- 
cian who immediately performs the 
necessary procedures. Experience in 
performing the aspiration reduces the 
proportion of false-negative and inade­
quate results.6'16
Up to the present we have adhered 
to the “established routine of frozen 
section”,15 satisfied to have, and to be 
able to compare, two sources of micro­
scopic diagnosis. Now, however, the 
time may have come to forgo surgical 
biopsy for cytologically malignant le­
sions. Frozen sections remain man­
datory, of course, for cytologically 
negative lesions if cancer is suspected 
on clinical grounds.
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therefore be of interest to the nephrologist 
as well as the urologist. The second vol­
ume will be of interest not only to the 
urologist but to the endocrinologist and 
oncologist as well. The authors deal main­
ly with the neoplastic diseases, but they 
have also included sections on the storage 
and transport of urine, the prostate, the 
genital tract and fertility, the urologic 
armamentarium and anesthetic problems 
with urologic patients.
These books are intended for urologic 
surgeons and will be of special help to 
those in training; they complement, but 
do not compete with, the numerous ex­
cellent textbooks of urology now avail­
able. While the text deals with the clinical, 
diagnostic and operative aspects of the 
topic, the authors have stressed patho­
physiology, the newer aspects of histo- 
pathology and oncology and the scientific 
basis of the technology employed in the 
development of endoscopic instruments.
Although there are 52 contributing au­
thors, the books are amazingly uniform. 
They are well edited and largely free of 
rhetoric. They are highly recommended.
W.E. Collins
Professor of surgery (urology),
Faculty of medicine,
University of Ottawa,
Ottawa, Ont.
SURGERY IN THYROID DISEASE. 
The Place of Total Thyroidectomy. 
Samuel L. Perzik. 273 pp. Illust. Strat­
ton Intercontinental Medical Book Cor­
poration, New York; Longman Canada 
Limited, Don Mills, 1976. $20.75.
ISBN 0-88372-090-6.
versial. It is based on the author’s per­
sonal experience of over 1700 thyroidec­
tomies, more than half of which were to­
tal. The first section deals with the 
indications for surgery. Part II is an atlas 
of thyroid surgery with very compre­
hensive notes and a great deal of prac­
tical detail on operative and postoperative 
management. Part III is made up of 79 
questions and answers; these cover most 
of the controversial points in thyroid 
surgery and help reinforce Perzik’s argu­
ments. In Part IV the author provides a 
comprehensive analysis of his cases. There 
is some unavoidable repetition.
The main thesis is that a total thyroidec­
tomy can be performed as safely as the 
subtotal operation. The results recorded 
here present a strong case in support of 
this position.
The complication rate after a second 
thyroid operation is 10 times greater than 
after the first. Therefore, total removal 
of the thyroid gland in patients with 
nodular goitre, Hashimoto’s thyroiditis 
and Graves’ disease would seem to be a 
reasonable procedure. Retention of a por­
tion of the thyroid gland is not an ef­
fective method of avoiding late onset of 
hypothyroidism. Total removal of the 
gland and immediate institution of thyroid 
replacement therapy might therefore be 
more effective.
Dr. Perzik recommends that the distal 
1 to 2 cm of the recurrent laryngeal nerve 
be identified at the cricotracheoesopha- 
geal junction; this is a point where the 
nerve is angulated during surgery when 
the gland is rotated and traction applied. 
It is precisely at this location that injury 
usually occurs. Parathyroid glands should 
not be sought but their presence should
continued on page 424
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This book is both informative and contro- 
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Expanded Polytetrafluoroethylene Prosthetic Grafts for 
Blood Access in Patients on Dialysis
J.L. Wellington, mb, frcs[c]
The d if f ic u lt ie s  in m ain ta in ing  vascu la r 
a c ce s s  in pa tien ts on long-term  hemo- 
d ia ly s is  are  w e ll recogn ized. The au thor's 
e xpe rience  w ith  bov ine  g ra fts  in su ch  
ca se s  had been that late fa ilu re  from  
se p s is  o r th rom bos is  w as com m on, as 
reported  in the lite ra tu re  by  o the rs. In 
M ay  1976 the expanded po ly te tra flu o ro ­
e thy lene  (PTFE) p ro sthe s is  becam e the 
su b stitu te  o f cho ice  as a v a scu la r graft.
In the  la s t 18 m onths th e se  g ra fts  
have been p laced a s  subcu taneous 
a rte r io venou s f is tu la s  in 22 pa tien ts . 
Three ea rly  fa ilu re s  occu rred  as a re su lt 
o f gra ft th rom bos is  bu t one gra ft w as 
sa lvaged by th rom bectom y us ing  a 
Fogarty  catheter. Two la te  fa ilu re s  
o ccu rred , one after 3 and anothe r a fte r 
6 m onths. A l l  other g ra fts are  fun ctio n ­
ing sa tis fa c to r ily .
Expanded PTFE g ra fts  p rov ide  sa t is ­
fac to ry  vascu la r a c ce ss  fo r m aintenance 
h em od ia ly s is  in se le c ted  pa tien ts and 
th e ir use  m ay prove to be the  p rocedure  
o f cho ice  fo r  hem od ia ly s is  in sm a ll 
ch ild ren .
Les d if f ic u lte s  de m a in ten ir un a cces  
vascu la ire  ch ez  le s pa tien ts ayant 
re cou rs a I 'hem odia lyse a long te rm e 
son t b ien reconnues. L 'e xperience  de 
I’au teur dans ce s  cas, avec des g re ffe s  
de  va is se au x  de boeuf a m ontre  que les 
d e fa illa n ce s  ta rd ive s a ttr ibuab le s a 
I’ in fe c t ion  ou a la th rom bose  son t 
frequen tes , te l que s ig na le  par d 'au tres 
au teu rs dans la  litteratu re . En m ai 1976, 
la p ro these  de  po ly te tra fluoe thy lene  
(PTFE) e t ire e  e s t devenue le  su b stitu t 
de cho ix  pou r la g re ffe  vascu la ire .
A u  cou rs  d e s  18 de rn ie rs  m o is, c e s  
g re ffon s ont e te  p la ce s  com m e f is tu le s  
a r te r io ve in eu se s  sous-cu tanees chez
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22 patients. T ro is e ch e cs  im m ed ia ts son t 
su rvenus a la su ite  d ’une th rom bose  de 
la greffe, m a is un g re ffon  a pu e tre  
recupere  grace  a une th rom bectom ie  
rea lisee  avec un ca the te r de Fogarty. 
Deux echecs ta rd ifs  son t su rvenus, un 
ap res 3 m o is e t I'autre ap res 6 m ois. 
Tous le s au tres g re ffons fonctionnent 
de facon sa tis fa isan te .
Les g re ffons de PTFE e tire e  assu ren t 
un a cces  vascu la ire  sa t is fa isan t pour 
I’hem od ia lyse  d 'en tre tien  chez des 
pa tien ts ch o is is  e t leu r em p lo i peut 
s ’averer i ’ in te rven tion  de cho ix  chez 
le s  jeunes enfants.
In any active hemodialysis unit there 
are a substantial number o f patients who 
pose problems in vascular access. Such 
patients often have already undergone 
multiple vascular procedures and fre­
quently will require a prosthetic graft 
to create a satisfactory arteriovenous 
fistula. The requirements of such a 
graft are that it be inert, resistant to 
clotting, of adequate size to permit 
easy puncture and that it be placed in 
an accessible location.
In May 1975 the Ottawa General 
Hospital and Children’s Hospital of 
Eastern Ontario began a trial of bovine
heterografts in patients on hemodialysis. 
Although the initial results were satis­
factory, the failure rate at the end of 1 
year was so high that the use of bovine 
grafts was discontinued.
Over the past 18 months the ex­
panded polytetrafluoroethylene (PTFE) 
(Teflon) prosthesis has become the sub­
stitute of choice as a vascular graft. 
Our experience with the use of this 
material in patients on hemodialysis is 
reported herein.
Patients and M ethods
Between May 1, 1976 and Nov. 30, 
1977, 25 fistulas were constructed in 
22 patients using expanded PTFE 
grafts. There were 9 male and 13 
female patients whose average age was 
41 years (range, 3 to 67 years). The 
series included four children aged 12 
years and under.
Sixteen grafts were placed as sub­
cutaneous loops in the forearm between 
the brachial artery and an adjacent 
vein (Fig. 1). Seven straight grafts were 
placed in the upper arm between the 
brachial artery and distal axillary vein. 
There was one straight forearm graft 
between the radial artery and basilic
16 1 1
F IG ^ l—Site of placement of polytetrafluoroethylene (PTFE) prosthesis. A
= 2 
=  ar.—  - — ■ —  - . . . . . . . . . . . . .  . 1  i i  y . f i u m  =rery, v =  vein, It =  graft. Figures represent number of grafts placed at each site.
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vein and one thigh loop between the 
superficial femoral artery and saphe­
nous vein. Grafts of 6-mm diameter 
were used in all patients except in a 3- 
year-old child in whom a 4-mm graft 
was used.
Operations were performed under 
local, regional, or general anesthesia, 
with systemic heparinization which was 
reversed by administering protamine 
sulfate after completion of the vascular 
anastomosis.
Anastomoses were performed with 
6-0 Prolene or 7-0 Ethibond sutures. 
They were usually end-to-side between 
bevelled graft and vessel, although the 
occasional venous anastomosis was per­
formed in an end-to-end fashion if the 
diameters of graft and vessel were com­
parable. High flow rates were usually 
achieved immediately as evidenced by 
rapid distension of the graft and strong 
pulsation in the recipient vein beyond 
the venous anastomosis.
Postoperatively the arm was sus­
pended for 48 hours to prevent edema 
of the hand and forearm secondary to 
venous overload. Grafts were not used 
for dialysis until 4 weeks after opera­
tion to allow adequate fixation and in­
growth of fibrous tissue. Observance 
of this rule reduced the risk of post­
dialysis bleeding from the puncture site.
Results
Three fistulas failed within 48 hours 
of operation. One of these was salvaged 
by thrombectomy using a Fogarty ca­
theter. Two late failures occurred, one
FIG. 2— Perianastomotic seroma re­
sembling true or false aneurysm. Angio­
gram was normal and aspiration yielded 
serum.
at 3 and one at 6 months. Two patients 
died in the follow-up period, both from 
cardiac causes unrelated to the opera­
tion; in both the PTFE graft was patent 
at the time of death. Nineteen grafts re­
mained patent although at the time of 
writing not all had been used for 
dialysis.
Complications with PTFE grafts were 
uncommon. In this series there was a 
complication in only six patients. Graft 
infection occurred once in a patient who 
was a chronic carrier of staphylococci. 
The infection was confined to a single 
incision used in creating a subcutaneous 
tunnel and was controlled by compres­
ses to the wound and by antibiotics 
without loss of the graft.
Skin loss with exposure of the un­
derlying graft occurred in two patients. 
In one case the graft was re-covered by 
freshening the skin edges and resuturing 
the wound. In the second the graft was 
transplanted deep to the brachioradialis 
muscle and covered by an advancement 
skin flap.
Two patients had a cystic swelling 
at the anastomotic site (Fig. 2). Arterio­
graphy showed that there was no aneu­
rysm and that the swelling lay outside 
the graft; aspiration identified the swell­
ing as a seroma. In both cases the 
swelling persisted but did not interfere 
with graft function or puncture.
Graft laceration during dialysis led 
to the development of a false aneurysm 
in one patient. This was repaired by 
simple suture without loss of the graft.
In our series, limb ischemia, a “steal 
syndrome”, true aneurysm and conges­
tive heart failure were not encountered.
A comparison of the 1-year cumul­
ative failure rates for bovine and PTFE 
grafts shows that there is little to choose 
between the two at 6 months, but after 
this PTFE is definitely superior (Fig. 3). 
After 6 months there was a progressive 
loss of function in the bovine grafts due 
to delayed sepsis or thrombosis and at 
the end of 1 year, 14 of 22 grafts had 
failed. Conversely there were no new 
failures of PTFE grafts beyond the 6- 
month period. Although the groups are 
not truly comparable in that only 12 
PTFE grafts were available for 1-year 
follow-up, the difference is statistically 
significant (P <  0.05).
m/22)
------BOVINE
-----  PTFE
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FIG. 3— Comparison of 1-year cumul­
ative failure rate for bovine and PTFE  
grafts.
Discussion
The expanded PTFE prosthesis is 
composed of nodules interconnected 
with thin flexible fibrils. The extreme 
porosity of the graft allows rapid and 
thorough tissue ingrowth and formation 
of a smooth pseudointima. Although the 
graft is highly porous, the extremely 
small pore size makes preclotting un­
necessary. The literature contains sev­
eral reports attesting to the value of 
this material as a vascular substitute in 
many clinical settings.1"3 In particular 
the graft appears to tolerate repeated 
puncture for hemodialysis over a long 
period.4-5
Selection of the fistula site is im­
portant. The radial artery is usually too 
small to provide adequate flow through 
the graft. In the single instance in 
which this vessel was used, early throm­
bosis occurred; however, the graft was 
salvaged by thrombectomy and is still 
functioning.
We have favoured graft placement 
as a subcutaneous forearm loop since 
it provides high blood flow, offers ade­
quate length for easy puncture and is 
accessible for patients on home dialysis 
who “needle” their own grafts. Four of 
the patients in our series were on home 
dialysis.
Although our experience with thigh 
loops is limited to one case of a 3-year- 
old child, this type of graft proved 
highly satisfactory. The anastomosis of 
the graft to the superficial femoral ar­
tery provided adequate arterial input 
while an end-to-end anastomosis be­
tween graft and divided saphenous vein 
was technically easy.
Analysis of failures reveals a variety 
of possible causes. Two of three early 
failures were probably due to technical 
errors. In both cases the available ves­
sels were small in size and anastomosis 
was difficult. In addition, both patients 
had a serum concentration of creatinine 
that was lower than the concentration 
in the average patient on dialysis. It 
may be that the qualitative platelet 
defect present in most uremic pa­
tients, which inhibits thrombus forma­
tion, was lacking in these two patients 
thus explaining their comparatively 
more coagulable state. In one patient 
faulty graft puncture led to hypotension 
and formation of a large hematoma, 
both of which may contribute to throm­
bosis.
One graft became thrombosed after 
transplantation, coincident with restora­
tion of normal renal function. In two 
other patients who have successfully 
undergone transplantation the fistulas 
remain patent, which is highly advan­
tageous in the event that the transplant 
is rejected and dialysis becomes neces­
sary.
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Complications other than thrombo­
sis are uncommon. In particular, graft 
sepsis is rare and when it occurs it usual­
ly can be controlled by local therapy 
and antibiotics without loss of the 
prosthesis.
Skin loss with graft exposure can 
usually be managed by freshening the 
wound edges and resuturing, or, in the 
case of larger defects, by transplanting 
the graft deep to an adjacent muscle 
belly and advancing a local skin flap.
Although true aneurysms have oc­
curred with PTFE prostheses when 
these are used as an arterial substitute, 
they are unlikely to develop when the 
graft is placed as an arteriovenous fis­
tula and were not encountered in any 
of our patients. Local perianastomotic 
swellings resembling aneurysms may be 
either seromas or lymphoceles and can 
be differentiated by performing arterio­
graphy and subsequent aspiration. If 
they remain stationary in size and do 
not interfere with puncture of the 
prosthesis, they are probably best left 
alone.
Finally, graft laceration can prob­
ably be avoided if the prosthesis is not 
used for at least 4 weeks after implan­
tation and if appropriate caution is 
shown by the dialysis technician in per­
forming the puncture.
Our results indicate that PTFE grafts 
are superior to bovine grafts for hemo­
dialysis. After 6 months there is a 
progressive failure of bovine grafts 
from sepsis and late thrombosis where­
as, to date, there have been no new 
failures of PTFE grafts beyond the 
6-month follow-up period.
Conclusions
Early results of the use of expanded 
PTFE prostheses for patients on dialy­
sis suggest that these are a useful sub­
stitute in selected patients with prob­
lems related to vascular access.
Although early results of bovine and 
PTFE grafts are similar, PTFE grafts 
appear distinctly superior at 1-year fol­
low-up.
The single most obvious advantage of 
this material is its ability to resist in­
fection. When sepsis does develop it
usually responds to conservative meas­
ures.
More lengthy follow-up is necessary 
to determine accurately the role of 
this material as a vascular substitute in 
patients on dialysis.
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Radionuclide Test for Gastric Bile Reflux
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The authors conducted a study using 
radioactive endogenous bile to detect 
gastric bile reflux in healthy volunteers 
and patients suspected of having bile 
gastritis.
When 7 ixCi of pyridoxylideneglutamate
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or hydroxyiminodiacetic acid labelled 
with technetium-99m is injected intra­
venously it is excreted by hepatocytes, 
and sequential gamma camera images 
visualize the bile ducts and show 
subsequent activity in the gut.
Following such an injection, the 
authors determined the presence of 
isotope-labelled bile in the stomach in 
fasting subjects by assaying count rates 
in serial gastric aspirates obtained by 
means of a nasogastric tube positioned 
in the antrum. The results were related 
to the clinical history and gastroscopic 
findings.
In normal persons only extremely low 
counts were detected, possibly due to
free activity; high counts (in excess 
of 50 000/min) indicated abnormal reflux.
It is suggested that this test is a 
useful adjunct, and is more physiologic 
than endoscopy, in the assessment of 
bile reflux.
Les auteurs ont mene une etude a 
I’aide de bile endogene radioactive, 
afin de deceler un reflux biliaire dans 
I'estomac chez des volontaires normaux 
et chez des patients soupconnes d’avoir 
une gastrite d’origine biliaire.
Ouand 7 ij,Ci de pyridoxylidenegluta­
mate ou d’acide hydroxyiminodiacetique 
marque au technetium-99m est injecte 
par voie intraveineuse, il est excrete
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par les hepatocytes, et des radiographies 
gamma seriees mettent les canaux 
biliaires en evidence et montrent 
I'activite subsequente dans I'intestin.
Apres une telle injection, les auteurs 
ont determine la presence de bile 
marquee dans I'estomac des sujets a 
jeun, par la mesure des comptages 
isotopiques dans les echantillons 
series du contenu gastrique obtenus 
par aspiration au moyen d’une sonde 
nasogastrique placee dans I'antre. Les 
resultats ont ete relies aux antecedents 
cliniques et aux observations de 
gastroscopie.
Chez les personnes normales, 
seulement des comptages tres bas 
ont ete enregistres, possiblement dus 
a I’activite iibre; des comptes eleves 
(de plus de 50 000/min) ont indique 
un reflux anormal.
II est propose que ce test constitue 
une mesure d'appoint utile, et qu’il 
est plus physiologique que I'endoscopie 
dans 1'evaluation du reflux biliaire.
A simple, reproducible and quantitative 
method to measure gastric reflux of bile 
would be a useful adjunct in the diag­
nosis of bile reflux gastritis and esopha­
gitis. Until recently it was thought that 
reflux of bile normally did not occur 
into the stomach because of the sphinc­
ter action of the pylorus.1 Esophago­
gastric endoscopy now makes it pos­
sible to observe the reflux of bile into 
the stomach. When bile is detected in 
the stomach of a patient with symptoms 
of disease in the upper gastrointestinal 
tract associated with hemorrhagic and 
edematous changes in gastric mucosa, 
the diagnosis of bile reflux gastritis is 
often considered. Similarly, in patients 
with symptoms of esophagitis the 
finding of bile in the stomach tends to 
support a diagnosis of alkaline esopha­
gitis. The symptoms of bile reflux gas­
tritis are postprandial pain, bilious 
vomiting and weight loss.2-3 These are 
nonspecific unless supported by more 
objective findings. Changes observed 
at endoscopy are only relatively ob­
jective because the examination is done 
during sedation and the presence of 
the endoscopic instrument in the 
stomach is unphysiologic.
This preliminary report describes a 
new method of measuring bile reflux 
into the stomach using a gamma-emit­
ting radionuclide specific to bile ex­
cretion.
Method
In the fasting patient a radiopaque 
nasogastric tube is positioned with its 
tip in the antrum; this is confirmed by 
fluoroscopy. The tube is taped to the 
patient’s nose and cheek to prevent dis­
placement.
Following an intravenous injection of
7 f i d  of pyridoxylideneglutamate 
(PYG) or hydroxyiminodiacetic acid 
(Hida) labelled with technetium-99m 
("‘"Tc), sequential gamma camera ima­
ges confirm the concentration of the 
radiopharmaceutical within the intra- 
hepatic and common bile ducts, the gall­
bladder (when present) and the small 
bowel. The images confirm that the 
radiopharmaceutical is clearing from 
the liver and entering the duodenum.
The total gastric content is aspirated 
sequentially every 15 minutes, and after 
its volume is recorded it is stored in 
plastic cups. If the volume of aspirate 
is insufficient the stomach is irrigated 
with 50 mL of water.
Aspiration is continued for at least 
2 hours and at least three samples are 
obtained after presence of radioactivity 
in the duodenum is confirmed by scan­
ning. A fatty meal is given to stimulate 
excretion if there is delayed emptying 
of the gallbladder.
Radiation counts of the aspirates, 
diluted with saline to a standard 20-mL 
volume where necessary, are made in 
duplicate under fixed geometric condi­
tions using a scintillation probe with a 
7.5-cm sodium iodide crystal (Fig. 1).
FIG. 1—Excretion of administered ra­
dionuclide, pyridoxylideneglutamate la­
belled with technetium-99m (Tc PYG), by 
means of biliary tree and its recovery from 
stomach. IV =  intravenous, gb =  gall­
bladder, duod =  duodenum, NG tube =  
nasogastric tube.
FIG. 2—Variations in activity of gastric 
aspirates from same individual during 
period of study (KF, FW and HG repre­
sent three subjects).
Under these conditions, 1 jj,Ci of 99mTc 
corresponds to approximately 2000 
counts/min.
Counts in each sample of aspirate are 
plotted against time to determine their 
maximum. This is necessary because 
the counts intermittently alternate be­
tween high and low (Fig. 2). The colour 
of the aspirate is noted and recorded as 
colourless, yellow or green. To minim­
ize error in the counts due to free ac­
tivity we selected 40 000 or more counts 
per minute as indicating abnormal 
reflux.
Patients
This method was used in the study 
of 3 healthy volunteers and 13 random­
ly selected patients with symptoms of 
gastrointestinal disease. Three patients 
had clinical symptoms and radiologic 
evidence of cholecystitis. Four patients 
had symptoms of esophagitis related to 
a diaphragmatic hiatus hernia. Six pa­
tients suffered epigastric pain following 
gastric operation; four of these had 
had transabdominal vagotomy and pylo­
roplasty and the other two had had gas­
tric resection supplemented by either a 
gastroduodenostomy or a gastrojejuno­
stomy.
Before the bile reflux study each pa­
tient had an esophagogastric endoscopic 
examination performed by the same 
gastroscopist (A.N.). The interpretation 
of the findings with respect to bile re­
flux was made without prior knowledge 
of the endoscopic findings.
Results
In the three patients with cholecys­
titis severe bile reflux was demonstrated 
that was not seen during endoscopy 
(Table I).
Two of the four patients with symp­
toms of esophageal hiatus hernia had 
severe bile reflux as shown by the radio­
nuclide method. In contrast, no bile re­
flux was observed by endoscopy in 
either of these two patients.
In four of the six patients who had 
had a previous gastric operation bile 
reflux was not demonstrated by the 
radionuclide method, but in the other 
two patients reflux was proved by both 
methods.
Discussion
Previous attempts to measure gastric 
reflux of bile have proved unsatisfac­
tory.4 In one study1 gastric regurgitation 
of barium infused by an indwelling 
duodenal tube was observed. This tech­
nique is unphysiologic. Alkaline indi­
cators such as polyethylene glycol and 
phenol red have been introduced 
directly into the stomach but these do 
not exclude alkaline substances other 
than bile. A radionuclide method using
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Table I— Results of Study in 13 Patients with Gastrointestinal Symptoms and 3 Healthy Volunteers
Group Sex
Age,
yr
Reflux demonstrated by
Radionuclide activity 
of aspirate, 
Endoscopy counts/min
Colour of 
aspirate
Cholecystitis F 58 49 260 Y-GF 76 — 50 550 G
F 38 — 57 000 Y-GHiatus hernia M 78 + 219 Y
M 78 530 YM 75 — 146 940 Y-GF 60 — 122 240 YPrevious gastric M 35 + 18 000 Y-Gsurgery M 52 9 280 Y
M 58 + 223 900 Y-GF 19 — 6 700 Y
M 43 — 6 300 Y
F 70 110 200 Y
Healthy volunteers IV! 49 Not done 10 000 Y
M 28 Not done 420 Y
M 36 Not done 210 Y
+  =  positive, — =  negative, ±  =  equivocal. 
Y =  yellow, G =  green.
bile salts labelled with carbon-14 has 
been described by Rhodes and col­
leagues.5 However, that method has an 
inherent inconsistency due to low 
activity of the isotope and the error 
caused by bile discolouration and con­
tamination by stomach contents.
As a result of the introduction of 
biliary scanning using gamma-emitting 
radionuclides, a method of measuring 
bile reflux is available that is accurate 
and is reproducible in any department 
of nuclear medicine. Originally, biliary 
scanning using iodine-131 rose bengal 
was proposed but was unsatisfactory due 
to its high radiation dose and relatively 
poor imaging characteristics. However, 
99mTc pharmaceuticals such as 99mTc 
PY G  or 99mTc Hida, as used in our 
study, have a rapid blood clearance, 
early concentration in the liver and 
rapid transit through the liver cell to 
reach a high concentration in bile. Fur­
thermore, chromatographic analysis 
with acetone indicates that the techne­
tium  is approximately 96% bound to 
the pharmaceutical. Minimal in-vivo 
unbinding (approximately 1% to 2%) 
is suggested by the absence of activity 
on scanning the thyroid and salivary 
glands and low activity in gastric as­
pirates from  normal subjects.
Reflux of bile into the stomach and 
esophagus is now considered a positive 
factor in the production of gastritis and 
esophagitis. Results of recent studies6 
suggest that bile contributes to gastric 
erosion by the destruction of the muco­
sal barrier of the gastric epithelium.
The lack of correlation in this pre­
liminary study between symptoms, en­
doscopic findings and the amount of 
gastric bile reflux indicates the need 
for an objective assessment in a patient 
suspected of having bile reflux gastritis 
or esophagitis.
It is of interest that each of the 
patients with cholecystitis demonstrated 
severe gastric reflux of bile. This was 
an unsuspected finding. However, Cap­
per and associates7 have described a 
condition of “gallstone dyspepsia” and 
suggest that it is caused by bile, not 
stones, and is not corrected by chole­
cystectomy.
The method we have described makes 
possible the study of the excretion and 
transit of bile under normal and pathol­
ogic conditions. It may also be useful 
in differentiating acid esophagitis and 
alkaline esophagitis in patients with a 
symptomatic hiatus hernia. Our find­
ings suggest that this radionuclide meth­
od is a useful adjunct, and is more 
physiologic than endoscopy, in the as­
sessment of gastric bile reflux.
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continued from page 419
merely be noted if they are recognized 
during the dissection. Perzik believes that 
a dissection to expose the glands might 
well result in some damage to their blood 
supply; in any event, the only certain 
identification is achieved by biopsy and 
histologic examination.
The author has very definite views on 
surgery for malignant disease of the 
thyroid. Total thyroidectomy is indicated 
in patients with infiltrating cancer and 
positive nodes in the neck, in those with 
medullary carcinoma and when there is 
a history of irradiation to the neck in 
childhood. He does not subscribe to the 
concept of multicentricity and therefore 
does not advise total thyroidectomy for 
the less malignant forms of thyroid car­
cinoma; his own experience as well as 
other evidence from the literature supports 
the view that if the opposite lobe appears 
normal a total lobectomy is adequate 
treatment.
Residents in surgery have had com­
paratively little exposure to thyroid sur­
gery during the last 15 years but for a 
number of reasons there are signs that 
this may be changing. First, the success 
of parathyroid surgery, requiring wide ex­
posure and mobilization of the thyroid 
gland, has increased the confidence of 
medical endocrinologists in the ability of 
their surgical colleagues. Second, the as­
sociation between carcinoma of the thyroid 
and irradiation of the neck in childhood 
has raised serious doubts about the safety 
of iodine-131 in the treatment of hyper­
thyroidism. Third, a negative report on a 
needle biopsy specimen from a thyroid 
mass usually reassures the medical endo­
crinologist, but many patients with a 
palpable mass in the neck are less trusting 
and seek a surgeon who will remove it 
for them.
This is an important book, both for 
surgeons with an interest in thyroid sur­
gery and for medical endocrinologists. Its 
publication may herald a new era in 
thyroid surgery.
H.T.G. Williams
Professor and chairman,
Department of surgery,
The University of Alberta,
Edmonton, Alta.
TEXTBOOK OF GYNECOLOGY. Edited 
by Russell Ramon de Alvarez. 546 pp. 
Illust. Lea & Febiger, Philadelphia; The 
Macmillan Company of Canada Lim­
ited, Toronto, 1977. $45. ISBN 0-8121- 
0515-X.
In the preface the editor states that this 
book is to be a reference source with 
emphasis on diagnosis and treatment for 
those who deal with the gynecologic pa­
tient. In spite of the brevity of this book, 
he has succeeded. De Alvarez has as­
sembled 29 writers; he has welded their 
contributions into a uniform text that is 
as up-to-date as possible.
The book is divided into six sections: 
structure and development, function, 
ectopic pregnancy and abortion, neo­
plasms, special entities and gynecologic 
surgery. The section on special entities 
continued on page 468
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Ionized Hypocalcemia in Critically III Patients with Sepsis
B. Taylor, md,* W.J. Sibbald, md, frcp[c],* M.W. Edmonds, md, frcp[c],+
R.L. Holliday, md, frcs[c]* and C. Williams, md, F R C P [c ]f
Although total serum calcium (CaT) 
concentrations are depressed in 
critically ill patients with sepsis, the 
ionized fraction (Ca2 + ), which represents 
the active moiety of CaT, has not been 
examined in depth in such patients.
In a prospective study, CaT and Ca2+ 
concentrations were measured in 75 
healthy volunteers and 62 patients 
with sepsis. Serum Ca2 + was measured 
with an ionized calcium selective 
electrode. The mean CaT value 
in patients with sepsis was 
significantly lower than in healthy 
control patients (1.90 ±  0.18 mmol/L 
vs 2.31 ±  0.09 mmol/L [7.62 ±  0.73 
mg/dL vs 9.27 ±  0.35 mg/dL];
P <  0.001). Although the serum Ca2 + 
value in the patients with sepsis was 
also significantly lower than in control 
subjects (0.91 ± 0.09 mmol/L vs 1.09 ±  
0.04 mmol/L [3.66 ±  0.38 mg/dL vs 
4.36 ±  0.15 mg/dL]; P <  0.001), 
the value of Ca2+ as a percentage of 
Car was not significantly different in 
the two groups (sepsis, 47.8 ± 5.3% 
vs control, 47.5 ±  3.0%; P =  0.65).
In patients with sepsis both serum 
albumin (P <  0.01) and total serum 
protein concentrations (P <  0.001) were 
also lower than in healthy volunteers. 
The serum magnesium value in patients 
with sepsis was 0.82 ± 0.16 mmol/L 
(1.64 ±  0.32 meq/L) and was 
0.92 ±  0.08 mmol/L (1.83 ±  0.16 meq/L) 
in controls (not significant). Although 
the patients with sepsis were 
significantly more alkalotic than those 
in the control group (pH, 7.45 ±  0.09 vs 
7.40 ±  0.05; P <  0.05), this does not
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explain entirely the low Ca2+ value 
found. Despite the low Ca2+ concen­
tration, the serum parathormone value 
in the patients with sepsis was 
0.27 ±  0.14 ng/mL (normal, less than 
0.5 ng/mL). Urinary cyclic AMP was 
similar in both groups (2.45 ±  1.33 
atnol/g creatinine vs 2.55 ± 1.25 
y,mol/g creatinine; P =  0.85).
Ionized hypocalcemia is present in 
patients with sepsis and may result 
from failure of appropriate parathormone 
secretion in response to low Ca2+ 
concentrations, as has previously been 
described in patients with acute 
pancreatitis.
Bien que les concentrations seriques 
de calcium total (CaT) soient abaissees 
chez les patients septiques dont I’etat 
est tres grave, la fraction ionisee 
(Ca2 + ), qui represente la partie active 
du Car, n'a pas ete etudiee en pro- 
fondeur chez ces patients. Dans une 
etude prospective, les concentrations 
en Ca' et en Ca2+ ont ete mesurees 
chez 75 volontaires sains et chez 
62 patients septiques. Le serum Ca2+ 
a ete mesure avec une electrode 
selective pour le calcium ionise.
La concentration moyenne de CaT chez 
les patients septiques etait significative- 
ment plus basse que chez les sujets 
temoins sains (1.90 ±  0.18 mmol/L 
compare a 2.31 ± 0.09 mmol/L [7.62 
0.73 mg/dL compare a 9.27 ± 0.35 
mg/dL]; P <  0.001). Bien que la teneur 
serique en Ca2+ chez les patients 
septiques eut aussi ete significativement 
plus faible que chez les sujets temoins 
(0.91 ±  0.09 mmol/L compare a 
1.09 ±  0.04 mmol/L [3.66 ±  0.38 
mg/dL compare a 4.36 ± 0.15 mg/dL]; 
P <  0.001), la valeur du Ca2+ exprimee 
en pourcentage du Ca1 n’etait pas 
significativement differente pour les 
deux groupes (groupe septique,
47.8 ±  5.3% et groupe temoin,
47.5 ± 3.0%; P =  0.65). Chez les patients 
septiques, les concentrations seriques 
en albumine et en proteine totale 
etaient aussi plus faibles (respec- 
tivement, P <  0.01 et P <0.001) que 
chez les volontaires sains. La valeur 
magnesium serique des patients 
septiques etait de 0.82 ±  0.16 mmol/L 
(1.64 ±  0.32 meq/L) et celui des 
temoins, de 0.92 ± 0.08 mmol/L
(1.83 ±  0.16 meq/L) (une difference 
non significative). Bien que les patients 
septiques eussent ete significativement 
plus alcalosiques que ceux du groupe 
temoin (pH, 7.45 ±  0.09 compare a 
7.40 ± 0.05; P <  0.05), ceci n’explique 
pas completement la faible concen­
tration de Ca2+ retrouvee. En depit 
de cette faible teneur en Ca2+, la 
concentration serique en parathormone 
dans les patients septiques etait 
de 0.27 ± 0.14 ng/mL (la normale est 
de moins de 0.5 ng/mL). La concen­
tration urinaire en AMP cyclique etait 
semblable pour les deux groupes 
(2.45 ±  1.33 ij.mol/g de creatinine, 
compare a 2.55 ±  1.25 u.mol/g de 
creatinine; P =  0.85).
L'hypocalcemie chez les patients 
septiques est peut-etre le resultat de 
I’echec des glandes parathyroi'des de 
repondre a les concentrations en Ca2 + 
faible, comme les patients qui souffrent 
de la pancreatite aigue.
In recent years the occurrence and 
significance of hypocalcemia during 
episodes of acute illness have been the 
subjects of a number of articles in the 
medical literature;1'3 as a result new 
concepts of calcium metabolism in both 
healthy and critically ill patients have 
emerged. Calcium plays an important 
role in both extra- and intracellular 
physiology. Fine regulation of calcium 
concentrations is necessary to modulate 
nerve conduction, muscle contraction, 
enzyme activity, membrane potentials, 
blood clotting, and hormone release 
and response, as well as bone meta­
bolism.4
Until recently the concentration of 
the biologically active ionized calcium 
fraction (Ca2+) was inferred by methods 
correcting for serum protein changes, 
such as use of the formula described 
by Parfitt.5 Moore6 developed a method 
for measuring ionized calcium directly. 
Using an electrode specific for ionized 
calcium, he demonstrated that 30% to 
55% of the total serum calcium 
(CaT =  2.1 to 2.6 mmol/L [8.5 to 
10.5 mg/dL]) is bound to plasma prote­
ins (81% to albumin, 19% to globu­
lins) (Fig. 1). From 5% to 15% of 
CaT is bound in complexes and chelates 
but is still diffusible. The remainder 
is free ionized calcium, the biologically
VOLUME 21, NO. 5, SEPTEMBER 1978 /  THE CANADIAN JOURNAL OF SURGERY 429
active fraction that directly inhibits 
parathormone (PTH) secretion. PTH 
in turn plays an important role in close­
ly regulating the ionized calcium con­
centrations. Ionized magnesium con­
centrations also influence PTH, but to 
a lesser extent, since it is the total 
divalent cation concentration to which 
PTH responds, and normally serum 
Ca2i is far greater than serum mag­
nesium.7
Previous observations by one of us 
(W.J.S.) using indirect measurements 
have supported the idea that ionized 
hypocalcemia occurs in sepsis.8 In the 
present study serum concentrations of 
Ca2+ were measured by the direct 
method in a broad group of patients 
with severe bacterial infections (sepsis). 
The function of the parathyroid glands 
was investigated at the same time by 
measurement of serum PTH and uri­
nary cyclic AMP. Ionized hypocalcemia 
would be expected to result in elevated 
serum PTH values, which in turn 
should augment urinary cyclic AMP 
excretion.
Methods
A group of 75 healthy volunteers 
served as controls. Venous blood was 
drawn anaerobically (after overnight 
fasting) into vacuum tubes for meas­
urement of CaT, Ca2+, magnesium, al­
bumin and total protein. The samples 
were allowed to clot and were then 
centrifuged. For measurement of Ca2+ 
the serum was withdrawn anaerobically 
into syringes and frozen until analysed 
in the Orion SS-20 flow-through elec­
trode (Orion Research Inc., Cam­
bridge, MA). Total calcium was meas­
ured on the SMA-12/60 Auto Analyzer 
(Technicon Instruments, Tarrytown, 
NY) by the method of Gitelman;9 al­
bumin was assayed by the method of 
Dpumas, Watson and Biggs10 and total 
protein by the method of Weichsel- 
baum.11 Serum magnesium values were 
measured by the method of Sunderman 
and Carroll.12
Sixteen “healthy” patients who had
Bound to Albumin
FIG. 1— Composition of total serum 
calcium. Serum calcium is composed of 
several different fractions defined by trans­
porting molecule.
undergone minor urologic or gyne­
cologic surgery served as a control 
group for measurement of renal ex­
cretion of cyclic AMP (patients with 
impaired renal function were excluded). 
These patients were ambulatory and 
taking a regular hospital diet. All had 
indwelling urinary catheters which per­
mitted accurately timed 4-hour meas­
urement of urine. Urinary cyclic AMP 
was analysed in this group by a modi­
fication of Gilman’s13 method. The 
same serum components that had been 
measured in the healthy volunteers 
were assessed to verify that these 16 
patients were, in fact, healthy.
The study group consisted of 62 
patients with sepsis who were being 
treated in the critical care/trauma unit 
of Victoria Hospital, London. Sepsis 
was defined as the presence of an in­
fectious process as evidenced by an 
identifiable site, a febrile response and 
a leukocytosis with or without a posi­
tive blood culture. A few patients were 
in septic shock. Nine patients with renal 
failure (serum creatinine concentration 
greater than 133 /zmol/L [1.5 mg/dL]) 
were also studied. The same serum 
constituents were measured in the con­
trol group as in the study group; the 
blood was drawn from indwelling cen­
tral venous catheters. Capillary blood 
gases were analysed in the patients 
with sepsis using the standard Astrup 
technique. In addition, venous blood 
for measurement of PTH concentra­
tions was collected from 17 patients 
from the study group in heparinized 
tubes, kept in ice, centrifuged and 
separated, and measured by Dr. C. 
Williams (Wellesley Hospital, Toronto) 
using a radioimmunoassay technique 
and the type 21132 antibody (Bur­
roughs Wellcome & Co., Willowdale, 
Ont.) to the amino-terminal region of 
bovine PTH.
Observations
Results from the analysis of blood 
and urine constituents are summarized 
in Tables I and II. The mean serum 
Ca2+ concentration in the healthy 
volunteers was 1.09 ±  0.04 mmol/L 
(4.36 ± 0 .1 5  mg/dL) and the CaT was 
2.31 ±  0.09 mmol/L (9.27 ±  0.35 
mg/dL). The value of Ca2+ was 47.5% 
of that for CaT, which agrees with the 
findings of others.14 These measure­
ments were not significantly different 
in the group of postoperative patients 
also examined.
In the group with sepsis, which was 
subdivided into patients with normal 
renal function and those with acute 
renal failure, both Ca2+ (0.91 ±  0.09 
mmol/L [3.66 ±  0.38 mg/dL]) and 
CaT (1.90 ±  0.18 mmol/L [7.62 ±  
0.73 mg/dL]) were significantly de­
creased; the difference was most marked
in the patients with renal failure (Ta­
ble I). The percentage of CaT repre­
sented by Ca2+ (47.8%) was not signi­
ficantly different from that in the con­
trol group.
The constant overall Ca2+:CaT ratio 
in the two groups suggests that one 
could calculate Ca2+ knowing CaT. 
However, this ratio did not apply to 
patients with sepsis as evidenced by 
the insignificant correlation coefficients 
between Ca2+ and CaT (Fig. 2, Table 
III).
Concentrations of both total protein 
and albumin were low in the patients 
with sepsis, as previously reported by 
Deysine, Lieblich and Aufses15 and 
Sibbald, Sardesai and Wilson.8 In both 
groups, albumin values correlated well 
with those for CaT (Fig. 3, Table III). 
The Ca2+ concentration did not corre­
late with that of albumin in either 
group.
The group of patients with sepsis 
had a borderline respiratory alkalosis 
(Table II), likely because most of these 
patients were maintained on ventilators. 
Since the regression correlation of Ca2+ 
on pH was not significant, it is unlike­
ly that the ionized hypocalcemia was 
related to this alkalosis.
Serum phosphate (P04) in the pa­
tients with sepsis was significantly 
lower than in the volunteers (Table II), 
thereby ruling out the possibility of in­
creased binding of ionized calcium, 
known to occur in hyperphosphate­
mia.7,16 In the 16 patients with renal 
failure the serum POt value was slight­
ly elevated.
Serum magnesium concentrations 
were slightly depressed in the patients 
with sepsis who had normal renal func­
tion (P =  0.03), although the value 
was not outside the normal laboratory 
range (0.55 to 1.15 mmol/L [1.1 to 
2.3 meq/L]).
Urinary cyclic AMP concentrations 
in the group with sepsis were not sig­
nificantly different from those of 
healthy volunteers, a surprising finding 
considering that these patients had 
ionized hypocalcemia and normally 
should have manifested elevated values 
secondary to increased PTH activity at 
the renal tubular level.17
Serum PTH concentrations measured 
in 17 patients with sepsis, 15 with nor­
mal renal function and 2 with acute 
renal failure, were well within normal 
laboratory limits. This finding, to­
gether with the “normal” cyclic AMP 
excretion, would suggest a relative 
deficiency of PTH in view of the low 
value for circulating ionized calcium. 
Although there seems to be an inverse 
relation between Ca2+ and PTH (Fig. 
4), this relation was not significant 
(P >  0.1). The poor correlation may 
be a consequence of the small number 
of subjects in the study, or there may
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Table 1-Serum Total Calcium (Car) and Ionized Calcium Fraction (Ca2+) and Proteins in Patients with Sepsis
Ca2+ as percentage Total protein, Albumin,
Group Car, mmol/L Ca2+, mmol/L of Car g/L g/L
Controls 2.31 ±  0.09 1.09 ±  0.04 47.5 ±  3.0 70 ±  3 42 ±  2
(n =  75)
All patients with 1.90 ±  0.18* 0.91 ±  0.09* 47.8 ±  5.3 (NS) 56 ±  9* 28 ±  8*
sepsis (n = 62) 
Patients with sepsis 1.92 ±  0.02* 0.93 ±  0.01* 48.4 ±  0.7 (NS) — 28 ±  1*
and normal renal 
f unction (n =  53)
46.1 ±  1.2 (NS) 30 ±  4fPatients with sepsis 1.82 ±  0.08* 0.83 ±  0.05* —
a nd acute renal 
failure (n =  9)
*P <  0.001. 
fP <  0.05.
NS = not significant.
Table II -Other Serum and Urine Constituents Measured in Patients with Sepsis
Group
Magnesium,
mmol/L
Phosphate,
mmol/L pH
Parathormone,
ng/ml
Urinary cyclic AMP, 
p.mol/g creatinine
Controls 
(n =  75)
All patients with 
sepsis (n =  62) 
Patients with sepsis 
and normal renal 
function (n =  53) 
Patients with sepsis 
and acute renal 
failure (n=  9)
0.92 ±  0.08 
0.82 ±  0.16 
0.81 ±  0.02f
0.88 ±  0.08 
(NS)
1.09 ±  0.05 
0.91 ±  0.07* 
0.76 ±  0.045*
1.53 ±  0.28 
(NS)
7.35 -  7.45 
(lab)
7.45 ±  0.09
7.46 ±  0.01
<0.5
(lab)
0.27 ±  0.14 
(n =  17)
0.26 ±  0.05 
(n =  15)
0.135 ±  0.05 
(n =  2)
2.55 ±  0.13
2.45 ±  0.13 
(NS)
3.01 ±  0.35 
(NS)
1.56 ±  0.48 
(NS)
(n =  7)
*P <  0.001.
tP <  0.05.
NS= not significant.
2.50 3.00 3.50 4.00 4.50
C « 2 +  B g /dL
FIG. 2— Serum ionized calcium fraction (Ca2+) vs total serum calcium (CaT) in patients with sepsis. N o significant corre­lation exists (r =  0.17, P =  NS).
9.00
Table III —Calcium Correlation Coefficients
Group Caf vs Ca2+ CaT vs albumin Ca2+ vs albumin pH vs Ca2+ Ca2+ vs PTH
Controls 
(n =  75)
0.47* 0.52 0.15 (NS) —
Patients with 
sepsis (n =  62)
0.17 (NS) 0.69* 0.11 (NS) 0.08 (NS) 0.37 (NS)
*P <  0.001.
NS =  correlation nof significant.
Ca 1
mg/dL 8.00
indeed be no correlation because of a 
relative deficiency of PTH.
2.00 3 .00  4.00
Albumin mg/dL
FIG. 3—Relation between serum albu­min and CaT concentrations in patients with sepsis. Values correlated well despite hypoalbuminemia (r =  0.69, P <  0.001).
Ca 2+ mg/dL
FIG. 4—Relation between serum para­thormone (PTH) and Ca2 + concentrations in patients with sepsis. Inverse relation ap­pears to be present but is not significant (r — 0.37, P =  NS).
D iscu ssion
Total and ionized hypocalcemia oc­
cur in critically ill patients with sep­
sis, and in no such individuals can the 
value for Ca2+ be predicted from that 
for CaT. Moore6 found that even in 
normal individuals Ca2+ cannot be predicted from CaT because albumin 
concentrations vary from person to 
person. In our control group the corre­lation coefficient of 0.47 supports a 
weak relation between values for CaT 
and Ca2+.Trunkey, Carpenter and Holcroft4 
demonstrated pronounced decreases in Ca2+ as compared with CaT during 
endotoxic shock in baboons and postu­lated that ionized hypocalcemia may 
have contributed to the hypotension ob­
served by impairing vascular tone. Drop
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and Laver1 showed that Ca2+ decreased 
markedly in comparison with CaT in 
humans during cardiogenic and septic 
shock and noted that large amounts of 
calcium chloride were needed to re­
store Ca2+ to its normal concentration.
Although the low concentrations of 
CaT in our patients with sepsis may be 
explained by hypoalbuminemia, it is 
evident that ionized hypocalcemia is 
due to other causes since ionized cal­
cium concentrations are independent of 
the concentrations of albumin (Table 
III). Elevated or depressed magnesium 
concentrations are known to cause low 
Ca2+ values,7 but the borderline depres­
sion of magnesium that we observed 
does not appear to have been enough 
to affect them.
Moore6 calculated that a 0.1-unit 
increase in pH would cause a 0.04- 
mmol/L (0.16 mg/dL) decrease in 
Ca2+. In this study the slight alkalosis 
present in the patients with sepsis 
would not significantly affect the Ca2+ 
value, nor was there any significant 
correlation between Ca2+ and pH in 
this group of patients. Urinary calcium 
losses accounting for the low serum 
Ca2+ concentration may occur, but we 
were unable to establish this in a pre­
vious study.8
Ionized calcium may also have been 
bound to anion complexes present in 
the serum of these patients. Moore18 
has demonstrated increased calcium 
binding in patients with cirrhosis; how­
ever, the ligand is unknown. Globulins, 
lactate and pyruvate are all possible 
binding substances. Denlinger and 
Nahrwold2 have shown that massive 
transfusions of whole blood cause low 
Ca2+ concentrations by the complexing 
of calcium ions with citrate; they re­
ported a case of acute congestive heart 
failure from low Ca2+ concentrations 
during transfusion. Deysine, Lieblich 
and Aufses15 and Trunkey, Carpenter 
and Holcroft4 noted that hyperphospha­
temia occurred in their subjects during 
septic shock; here the phosphate could 
have formed a complex with calcium 
ions, thus causing a low Ca2+ con­
centration. Hyperphosphatemia was not 
observed in patients in this study (Ta­
ble II).
In the patients with sepsis, the Ca2+ 
value was significantly depressed. The 
parathyroid glands normally respond to 
ionized hypocalcemia, so serum PTH 
concentrations should have increased 
in order to mobilize calcium from bone 
and to increase reabsorption from the 
renal tubules to correct the deficit. In 
the patients with sepsis the PTH con­
centrations were not increased in the 
presence of ionized hypocalcemia. The 
only patient in the group with an 
elevated PTH value was a young man 
with pancreatitis and lobar pneumonia 
(PTH =  0.62 ng/mL, Ca2+ =  0.93
432
mmol/L). This patient had an elevated 
PTH value appropriate for his degree 
of hypocalcemia. Serum PTH con­
centrations are known to increase in 
chronic renal failure,19 probably be­
cause of hypocalcemia. In two patients 
with sepsis and acute renal failure the 
Ca2+ value was indeed low, but the 
PTH value was within the expected 
normal range (Table II). Normal values 
for urinary cyclic AMP in the patients 
with sepsis also supported the finding 
of “normal” serum PTH concentra­
tions. These data suggest hypofunction 
of the parathyroid glands in sepsis, with 
or without renal failure.
Robertson and colleagues20 demon­
strated inappropriately low concentra­
tions of PTH in nine patients with 
acute pancreatitis and a low Ca2+ value 
and concluded that inadequate para­
thyroid response was the cause of the 
hypocalcemia. Condon and associates21 
demonstrated that 75% of patients with 
hypocalcemia secondary to pancreatitis 
had undetectable concentrations of 
PTH. In contrast, Weir and associates22 
found that PTH was elevated in five of 
eight patients with pancreatitis and a 
low Ca2+ value and in one patient with 
a low-normal Ca2+ value. The con­
flicting results may be due to the im- 
munoheterogenicity of antibodies to 
PTH used in different laboratories.
The failure of elevation of PTH 
secretion might have several causes. 
Fischer, Blum and Binswanger23 have 
shown that stimulation of (i receptors 
with exogenous catecholamines results 
in increased concentrations of serum 
PTH. In sepsis, plasma norepinephrine 
and epinephrine are increased24 which, 
according to Fischer and associates, 
would increase serum PTH and hence 
Ca2+. The lack of elevation of the se­
rum PTH concentration in response to 
known elevation of endogenous cate­
cholamines may be an indicator of a 
generalized “sick cell syndrome” in 
sepsis wherein cellular receptors are 
incapable of a normal response to cir­
culating cathecholamines.
The glands may also have been “re­
set” to respond with PTH secretion to 
lower concentrations of Ca2+.
A third possible cause of the pro­
longed ionized hypocalcemia is end- 
organ failure, but if this were the case 
serum PTH concentrations would be 
elevated. Our patients were not given 
PTH extract to assess the response, but 
Robertson and colleagues20 showed an 
increase in Ca2+ concentrations in pa­
tients with hypocalcemia secondary to 
pancreatitis who were given the extract.
Finally, Robertson and associates20 
stated that a possible cause of the low 
PTH concentrations in pancreatitis 
could be catabolism of the hormone in 
the serum by trypsin. A similar mechan­
ism may operate in patients with sepsis 
as they are extremely catabolic.
In summary, patients with sepsis 
have hypocalcemia resulting not only 
from decreased amounts of calcium 
bound to protein, but also from low 
concentrations of ionized calcium. The 
reason or reasons for the low Ca2+ 
value are not clearly defined at present 
but relative hypoparathyroidism may 
be involved.
Conclusions
Ionized and total hypocalcemia exist 
in critically ill patients with sepsis and 
the low value for CaT is secondary to 
hypoalbuminemia. Low Ca2+ concen­
trations may result from relative hypo­
parathyroidism, due either to “reset­
ting” of the glands to lower concentra­
tions of Ca2+ or to inability of the 
glands to secrete appropriate amounts 
of PTH in the presence of sepsis.
The fact that ionized calcium con­
centrations cannot be predicted ac­
curately from the value for CaT in the 
individual patient with sepsis empha­
sizes the need for direct measurement 
of Ca2+ on the flow-through electrode.
The therapy of hypocalcemia in 
critically ill patients depends upon the 
clinical situation. Patients with ful­
minant septicemia or those receiving 
large amounts of citrated blood will 
have a marked decrease in the Ca2+ 
value2 and should immediately be given 
free calcium supplements intravenously. 
Patients with sepsis who are critically ill 
but whose condition is more stable re­
quire a number of therapeutic proce­
dures: removal of the septic focus, 
introduction of hyperalimentation to 
reverse the protein catabolism and 
administration of free calcium supple­
ments to raise the Ca2+ concentration. 
We are currently assessing the hemo­
dynamic response of these patients to 
calcium infusion to determine the im­
portance of ionized hypocalcemia.
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Effect of Wheat Bran on Serum Lipoproteins and
Biliary Lipids
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In this study nine patients with 
gallstones and nine healthy volunteers 
were given a high bran diet for 4 weeks. 
At the outset and at 4 weeks bile 
specimens were obtained for deter­
mination of biliary lipid values, size 
of the bile-acid pool and bile-acid ratios, 
and blood specimens were drawn to 
determine the serum concentration of
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triglycerides and of lipoprotein-bound 
cholesterol. Three patients with 
gallstones remained on the high bran 
diet for 6 months or more and 
samples were analysed again. The 
high bran diet produced a substantial 
decrease in biliary cholesterol values 
in patients with gallstones after 4 
weeks, and a significant increase in 
the concentration of high density 
lipoprotein-cholesterol in the serum of 
patients whose course was followed 
for 6 months or longer.
Dans cette etude, neuf patients 
souffrant de calculs biliaires et neuf 
volontaires sains ont recu pendant 
4 semaines un regime alimentaire a 
forte teneur en son. Des echantillons 
de bile ont ete preleves au commen­
cement et apres 4 semaines, pour la 
determination des teneurs en lipides 
biliaires, le volume du pool d’acide 
biliaire et les rapports d’acide biliaire, 
et des echantillons de sang ont ete 
pris pour determiner la concentration 
des triglycerides et celle du cholesterol
lie aux lipoproteines. Trois patients 
souffrant de calculs biliaires ont ete 
maintenus sur le regime riche en son 
pendant 6 mois et plus, et ont eu des 
determinations sanguines additionnelles. 
Le regime alimentaire a forte teneur 
en son a produit, apres 4 semaines, 
une importante diminution des 
concentrations de cholesterol biliaire 
chez les patients ayant des calculs 
biliaires, et une augmentation signi­
ficative de la concentration du complexe 
cholesterol-lipoproteine de haute 
densite dans le serum des patients 
dont 1'evolution a ete suivie pendant 
6 mois ou plus.
Cholesterol cholelithiasis and athero­
sclerosis have been linked, by their 
world-wide geographic incidence, to the 
low fibre diet characteristic of Western 
countries.1'2 The metabolic relation be­
tween these entities and dietary fibre 
is unclear but cholesterol is the main 
constituent of both gallstones and 
atheromas. Moreover, the synthesis of 
bile acids from cholesterol, in the
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liver, constitutes the metabolic pathway 
whereby cholesterol may be lost from 
the body.3 The metabolic link between 
cholesterol, bile acids and dietary fibre 
is the bile-acid-binding property of fibre 
and its effect on intestinal transit time.4 
In order to investigate the relation be­
tween dietary fibre, biliary lipids and 
serum lipids, we ascertained lipid meas­
urements in nine patients with radio- 
lucent gallstones and in nine healthy 
volunteers, before and after the subjects 
were placed on a high bran (fibre) diet.
Patients and Method
Nine patients with radiolucent stones 
in radiologically functioning gallblad­
ders and nine healthy control subjects 
with no history of biliary tract disease 
were admitted to the study after we 
had obtained the informed consent of 
each subject. At the beginning of the 
study a bile sample was obtained from 
each subject, through a duodenal tube 
positioned radiologically, to determine 
the size of the total bile-acid pool, 
the proportion contributed by individ­
ual bile acids (cholic acid [CA], 
chenodeoxycholic acid [CDCA], deoxy- 
cholic acid [DCA] and lithocholic acid 
[LCA]) and the amounts of biliary 
lipids (cholesterol, phospholipid and 
total bile acids). At the same time a 
blood sample was obtained by vene­
puncture to determine the concentration 
of serum lipids (cholesterol and trigly­
cerides). The subjects were instructed 
to eat 50 g of a wheat bran cereal 
daily in addition to their normal diet. 
This amount of bran altered the bowel 
habit of every subject, usually from 
one stool daily to two or three bulky 
stools each day. At the end of 4 weeks 
bile and blood samples were again anal­
ysed. Three of the subjects in the group 
of patients with gallstones remained on 
the high bran diet for 6 months (one 
patient) to 1 year (two patients) and 
their serum lipid concentrations were 
measured again at the end of these time 
periods.
The amounts of biliary cholesterol, 
lecithin and total bile acids in the col­
lected bile specimens were determined 
by methods described previously.5 Bile 
acids were measured by the method of 
Engert and Turner6 using a 3-a-de- 
hydroxysteroid dehydrogenase extracted 
from Pseudomonas testosteroni, phos­
pholipid by the method of Bragden7 
and cholesterol by the method described 
by Abell and associates8 using the Lie- 
bermann Burchard reaction. From the 
data obtained we determined the litho- 
genic or saturation index (SI) of 
Metzger, Heymsfield and Grundy9 for 
each bile sample, taking the cholesterol 
solubility line of Admirand and Small10 
as a reference point. Individual bile 
acids in bile were measured by gas-
liquid chromatography as described pre­
viously,11 and the size of the total bile- 
acid pool was determined by isotope 
dilution using 4 /xCi of cholic acid 
labelled with carbon-14, administered 
intravenously 14.5 hours before col­
lection of bile samples.12
High density lipoprotein (HDL) was 
separated from low density lipoprotein 
(LDL) and very low density lipoprotein 
(VLDL) by precipitation of LDL and 
VLDL with heparin and manganese 
chloride, according to the method of 
Burstein, Scholnick and Morfin,13 and 
the LDL plus VLDL precipitate was 
solubilized with sodium citrate.14 Choles­
terol concentrations were measured di­
rectly in both fractions and in the native 
serum by the cholesterol-esterase/ 
cholesterol oxidase reaction,15 using a 
commercial kit (Boehringer Mannheim 
Biochemicals, Indianapolis, IN). Native 
serum triglyceride values were estimated 
enzymatically by the lipase-esterase-gly- 
cerokinase reaction.16 The Abbott bi- 
chromatic analyzer (Abbott Diagnostics, 
South Pasadena, CA) was used for both 
types of assay.
Results
Determinations of biliary cholesterol, 
phospholipid and total bile acids, with 
subsequent calculation of SI showed 
that the bile of the nine patients with 
gallstones was initially saturated, or 
supersaturated, with cholesterol (SI =  
1.43 ± 0.16, mean ± SEM). Biliary 
cholesterol fell to unsaturated concen­
trations in all patients but one after 4 
weeks of a high bran diet (SI =  0.76 — 
0.07, P <  0.01 by Student’s paired t- 
test); in the patient who was the ex­
ception the SI fell from 2.1 to 1.2 
(Fig. 1). In nine control subjects bile 
was unsaturated with cholesterol initial­
ly (SI =  0.70 ±  0.1) and remained un­
saturated during the period they were 
on a high bran diet (SI =  0.50 ± 0.06).
FIG. 1— Biliary saturation index in nine 
patients with gallstones before institution 
of high bran (fibre) diet and after 4 weeks 
(P <  0.01).
The total bile-acid pool in nine con­
trol subjects initially was 2.37 ±  0.36 g 
(mean ±  SEM) and remained essential­
ly unchanged at 2.32 ±  0.16 g after 4 
weeks of a high bran diet. The pool 
was slightly smaller initially in the nine 
patients with gallstones (1.75 ±  0.6 g) 
and did not increase significantly during 
the period of the diet (2.03 ± 0.21 g).
Analysis of the individual bile acids 
showed the proportion of DCA to be 
greater in the bile of patients with gall­
stones than in that of control subjects. 
DCA formed 31.3% of the total bile- 
acid pool in patients with gallstones 
and only 19.0% in control subjects 
(P <  0.02, Fig. 2). The proportion of 
DCA in the bile-acid pool of patients 
with gallstones decreased to a mean 
value of 23.3% after 4 weeks of 
high bran diet (P <  0.05, Fig. 3) but 
did not change significantly in control 
subjects. The proportion of CDCA in 
the bile-acid pool in control subjects was 
40.4% and in patients with gallstones 
28.8% (P <  0.01) before bran was 
included in the diet but did not change 
significantly in either group after 4 
weeks of the diet. The proportions of 
CA and LCA were not significantly dif­
ferent in the two groups either before 
or after the high bran diet.
The serum cholesterol concentration 
in nine control subjects prior to in­
gestion of the diet was 161 ± 9.4 
mg/dL (4.16 ± 0.24 mmol/L) (mean 
± SEM); after 4 weeks it was essen­
tially unchanged at 168 ± 12.0 mgd/L 
(4.34 ± 0.31 mmol/L). By comparison, 
the serum cholesterol concentration was 
significantly elevated in the nine pa­
tients with gallstones before the high 
bran diet was instituted (219 ± 15.1 
mgdL [5.7 ± 0.39 mmol/L], P <  
0.01), and was unchanged after 4
6 0 - ,
5 0 -
4 0
3 0
%DCA
20
1 0 -
Controls Gallstones
Mean 19% Mean 313%
FIG. 2— Proportion of deoxycholic acid 
(DCA) in bile-acid pool of nine control 
subjects and nine patients with gallstones 
(P <  0.02).
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FIG. 3—Proportion of DCA in bile-acid 
pool of 9 patients with gallstones before 
and after high bran diet (P <  0.05).
weeks (211 ± 17.4 mg/dL [5.46 ±
0.45 mmol/L]) and in three patients 
after 6 to 12 months (211 ±  24.7 mg/ 
dL [5.46 ±  0.64 mmol/L]).
Serum triglyceride concentrations in 
control subjects initially were 113 ±  
14.7 mg/dL (1.28 ±  0.17 mmol/L) and 
did not change after bran was included 
in the diet (112 ±  16.5 mg/dL [1.26 ±  
0.19 mmol/L]). In patients with gall­
stones they were significantly higher in­
itially (195 ±  23.9 mg/dL [2.20 ±  
0.27 mmol/L], P <  0.01) and did not 
change when bran was added to the 
diet (219 ±  34.2 mg/dL [2.47 ±  0.39 
mmol/L]).
The lipoprotein-cholesterol ratio 
(VLDL +  LDL/HDL) in control sub­
jects was unchanged after they had 
been on a high bran diet for 1 month 
(2.5 ±  0.31 and 2.4 ±  0.28). The ratio 
was significantly elevated initially in 
patients with gallstones when compared 
with controls (3.9 ±  0.39, P <  0.01) 
and did not change after 1 month of 
administration of a high bran diet
(3.8 ±  0.41), but did decrease signif­
icantly in the three patients who stayed 
on the diet for 6 to 12 months (2.5 ±  
0.07, P <  0.05). The serum lipid data 
are set forth in Table I.
Discussion
Bile from the nine patients with 
radiolucent gallstones was supersat­
urated with cholesterol initially. The 
biliary cholesterol concentration fell 
significantly in all after 4 weeks’ intake 
of increased dietary fibre in the form 
of wheat bran. Dietary bran acts as 
a weak bile-acid binding agent4 and 
decreases intestinal transit time, prob­
ably causing increased excretion of bile 
acids in the feces and thus effecting a 
partial interruption of the enterohepatic 
circulation of bile acids. In this situa­
tion, hepatic synthesis of primary bile 
acids (CA and CDCA) is increased, and 
newly synthesized cholesterol in the 
liver is converted into primary bile 
acids instead of being secreted un­
changed into bile. Additional support 
for this hypothesis is to be found in the 
change in the proportion of the second­
ary bile-acid DCA in patients with gall­
stones that was brought about by in­
gestion of a high bran diet. Initially the 
proportion of DCA in the bile-acid pool 
of patients with gallstones was high, and 
fell after 4 weeks of a high fibre diet. 
This change may indicate binding and 
excretion of DCA by bran, and replace­
ment of DCA in the bile-acid pool by 
the primary bile acids CA and CDCA.
A change in the serum lipoproteins 
transporting cholesterol in the blood of 
patients with gallstones was not ap­
parent after 1 month on a high bran 
diet but appeared in three patients 
whose course was followed for 6 to 12 
months. The VLDL +  LDL/HDL 
ratio fell in these three patients, in­
dicating an increase in the concentra­
tion of HDL cholesterol (i.e., the cho­
lesterol being transported from the 
tissues to the liver).17 It is possible that 
the long-term drain of hepatic choles­
Table I— Serum Lipid Data (Mean ±  SEM) in Control Subjects and Patients with Gallstones
Control subjects Patients with gallstones
(n = 9 )  (n =  9)
Late (6 to 12 mo)
Serum factor* Before bran A fter bran Before bran A fter bran (n = 3)
Cholesterol,
mg/dL
Triglycerides,
mg/dL
VLDL ±  LDL,
161 ±  9.4 168 ±  12.0 219 ±  15.1 211 ±  17.4 211 =b 24.7
113 ±  14.7 112 ±  16.5 195±  23.9 219 ±  34.2 —
121 ±  10.4 121 ±  12.9 179 ±  13.9 185 ±  13.9 150 ± 18.2
mg/dL 
HDL, mg/dL 52 ±  4.4 53 ±  3.9 49 ±  4.2 52 ±  5.4 61 6.6
VLDL +  LDL/HDL 2.5 ±  0.31 2.4 ±  0.28 3.9 ±  0.39 3.8 ±  0.41 2.5 0.07
ratio
*VLDL =  very low density lipoprotein, LDL =  low density lipoprotein, HDL =  high density  
lipoprotein.
terol by its conversion into primary bile 
acids, caused by ingestion of bran, 
stimulates the observed increase in HDL 
cholesterol, which indicates that more 
cholesterol is being transported to the 
liver for metabolism. This chain of 
events may also indicate a possible me­
tabolic link between atherosclerosis, 
cholesterol cholelithiasis and fibre de­
ficiency.
References
1. Burkitt DP: Some diseases character­
istic of modern western civilization. 
Br Med J 1: 274, 1973
2. Trowell H: Ischemic heart disease 
and dietary fiber. Am J Clin Nutr 25: 
926, 1972
3. Brandt LJ, Bernstein LH: Bile salts: 
their role in cholesterol synthesis, 
secretion and lithogenesis. Am J Gas­
troenterol 65: 17, 1976
4. Pomare EW, H eaton KW: Alteration 
of bile salt metabolism by dietary 
fibre (bran). Br Med J 4: 262, 1973
5. McDougall RM, Walker K, 
Thurston OG: Prolonged secretion 
of lithogenic bile after cholecystec­
tomy. Ann Surg 182: 150, 1975
6. Engert R, T urner MD: Problems in 
the measurement of bile acids with 
3a-hydroxysteroid dehydrogenase. Anal 
Biochem 51: 399, 1973
7. Bragden JH: Extraction of lipids from 
serum, in Lipids and the Steroid Hor­
mones in Clinical Medicine, Sunder- 
man FW, Sunderman FW jr  (eds), 
Lippincott, Philadelphia, 1960
8. Abell LL, Levy BB, Brodie BB, et 
al: Cholesterol in serum, in Standard 
Methods of Clinical Chemistry, vol 2, 
Furman NH (ed), Acad Pr, New 
York, 1958, p 26
9. Metzger AL, H eymsfield S, G rundy 
SM: The lithogenic index: a numerical 
expression for the relative lithogenicity 
of bile (C). Gastroenterology 62: 499, 
1972
10. Admirand WH, Small DM: The phy­
sicochemical basis of cholesterol gall­
stone formation in man. J Clin Invest 
47: 1043, 1968
11. McDougall RM, Walker K, T hur­
ston OG: Bile acid alterations in pa­
tients with cholesterol gallstones. J 
Surg Res 21: 233, 1976
12. Idem: Effect of increased dietary fiber 
on biliary cholesterol in patients with 
gallstones. Surg Forum 28: 416, 1977
13. Burstein M, Scholnick HR, Morfin 
R: Rapid method for the isolation of 
lipoproteins from human serum by 
precipitation with polyanions. J Lipid 
Res 11: 583, 1970
14. Kostner GM: Enzymatic determina­
tion of cholesterol in high-density lipo­
protein fractions prepared by polya­
nion precipitation. Clin Chem 22: 695, 
1976
15. Klose S, Greif H, H agen H : Com­
parison of two new developed enzy­
matic cholesterol colortests on auto­
analyzer systems with other cholesterol 
tests (abstr). Clin Chem 21: 942,
1975
16. Eggstein M, Kreutz FH: Eine neue 
Bestimmung der Neutralfette im Blut- 
serum und Gewebe. I. Mitteilung: 
Prinzip, Diirchfuhrung und Bespre- 
chung der Methode. Klin Wochenschr 
44: 262, 1966
17. Small DM: Cellular mechanisms for 
lipid deposition in atherosclerosis. 
(First of two parts.) N Engl J Med 
297: 873, 1977
VOLUME 21, NO. 5, SEPTEMBER 1978 / THE CANADIAN JOURNAL OF SURGERY 4 3 5
436
an urgent problem 
postoperative anaerobic
in gynecological in abdominal
infections infections
'■ • ■ clindamycin is an important antibiotic in the 
therapy of such [gynecological] infections.’ ’
Swenson, R.M., et al. (1974). Obstet. & Gynecol., 44:699.
This study suggests " . .. clindamycin is an excellent 
and relatively safe antibiotic for treatment of 
[abdominal] infection caused by anaerobes when 
combined with surgery (when indicated) or other 
antibiotics active against aerobic gram-negative 
bacilli, if present.”
Levison, M.E.,etal.(Mar., 1974).
Antimicrob. Agents & Chemother., p. 276-280.
an accepted solution 
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infections
in pulmonary 
.anaerobic infections
.. clindamycin has been reported to be the most 
active antimicrobial agent tested in vitro against 
,anaerobic bacteria; [in the pulmonary tract]
concentrations of 3.1 /rg/ml or less inhibited 96% 
bf strains tested...”
Fass, R.J., et al. (1973). Annals Intern. Med., 78:853.
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ORIGINAL CONTRIBUTIONS
Mediastinoscopy for Diagnosing Diseases of the Lung 
Other than Primary Carcinoma
R.A. F orse, m d , J.W. D u tto n , md and D.D. M unro , m d , m  sc , facs
Mediastinoscopy is an efficient method 
of assessing lymphatic spread in 
carcinoma of the lung. It is also 
valuable in providing a definitive 
diagnosis of other lung diseases. At 
the Montreal Chest Hospital Centre 
diagnostic mediastinoscopy was 
performed in 60 patients with diseases 
of the lung other than primary 
carcinoma. All had preoperative 
radiologic evidence of hilar adenopathy.
A definitive diagnosis was obtained 
in 91.7% of cases. Nonspecific adenitis 
was diagnosed in four patients and in 
none was there evidence of serious 
intrathoracic disease subsequently. 
Morbidity was minimal and there were 
no deaths.
Mediastinoscopy is a safe, accurate 
and efficient aid in the evaluation of 
primary or secondary disease of the 
anterior intrathoracic lymphatic system.
La mediastinoscopie est une methode 
efficace d'evaluer I'envahissement 
lymphatique du cancer du poumon.
Elle est aussi utile pour arriver a un 
diagnostic definitif dans d'autres 
maladies du poumon. Au Centre Hos- 
pitalier Thoracique de Montreal, la 
mediastinoscopie diagnostique a ete 
effectuee chez 60 patients souffrant
From the department of surgery, 
Montreal Chest Hospital Centre, 
Montreal, PQ
Presented at the annual meeting of the 
Canadian Thoracic Society, Moncton, NB, 
June 13-15, 1977
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de maladies pulmonaires autres qu'un 
carcinome primaire. Tous presentaient 
des signes radiologiques preoperatoires 
d’adenopathie hilaire.
Un diagnostic definitif a ete obtenu 
dans 91.7% des cas. Une adenite 
nonspecifique a ete diagnostiquee chez 
quatre patients et aucun n’a subse- 
quemment montre de signes d'une 
maladie thoracique serieuse. La mor­
bidity est demeuree minimale et il 
n’y a eu aucun deces.
La mediastinoscopie est un moyen 
sur, precis et efficace servant a 
revaluation des maladies primaires ou 
secondaires du systeme lymphatique 
thoracique anterieur.
Since its introduction by Carlens1 in 
1959 mediastinoscopy has become well 
established as a diagnostic procedure. 
It enables the surgeon to obtain lym­
phatic tissue from the anterior medi­
astinum for direct microscopic and 
bacterial evaluation. It is the most 
accurate method of assessing the lym­
phatic spread of primary carcinoma of 
the lung.2 It is also valuable in diag­
nosing other primary or secondary dis­
eases affecting the paratracheal and 
parabronchial lymph nodes. The pur­
pose of this report is to outline our 
experience with mediastinoscopy in the 
diagnosis of diseases of the lung other 
than primary carcinoma.
Clinical Material
Sixty patients underwent mediastino­
scopy at the Montreal Chest Hospital 
Centre during the period Jan. 1, 1966 
to Dec. 31, 1975 for the diagnosis of
diseases of the lung other than carci­
noma. Thirty-five were men and 25 
were women and their ages ranged 
from 16 to 66 years (mean, 37.5 years). 
Mediastinoscopy was performed when 
tissue specimens obtained by broncho­
scopy, gastric lavage, needle biopsy, or 
peripheral node biopsy did not permit 
a definitive diagnosis. Involvement of 
the anterior mediastinal lymph nodes 
in the underlying disease process was 
suggested by chest roentgenography or 
mediastinal tomography in all patients. 
When clinical examination did not re­
veal evidence of peripheral adenopathy, 
particularly in the supraclavicular area, 
mediastinoscopy was performed in 
preference to biopsy of a clinically un­
involved scalene node.
Results
The pathological diagnosis in the 60 
patients following mediastinoscopy is 
shown in Table I. Tissue was obtained 
for histologic and bacteriologic evalua­
tion in all cases. A definitive diagnosis 
was established in 55 (91.7%) cases.
Sarcoidosis was the most common 
diagnosis; it was present in 45 patients. 
Hodgkin’s lymphoma involving para­
tracheal or parabronchial nodes was 
found in four patients. Secondary ade­
nocarcinoma, arising from the breast 
in each case, was discovered in four 
patients. One patient had tuberculous 
adenitis, confirmed by the presence of 
caseation necrosis and positive culture 
of lymphoid tissue. Normal thymic tis­
sue was determined to be the cause 
of apparent hilar adenopathy in an­
other patient.
There were four cases of nonspecific
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Table I— Pathological Diagnosis following Mediastinoscopy
Diagnosis No. of cases
Sarcoidosis*
Lymphoma (Hodgkin’s disease)
Metastatic carcinoma (breast)
Normal thymic tissue causing apparent hilar adenopathy
Tuberculosis
Nonspecific adenitis
Granulomatous adenitis
‘ Consistent with Boeck’s sarcoid.
45
4
4
1
1
4
1
%
75.0
6.7
6.7 
1.6 
1.6
6.7 
1.6
Table II— Clinically Suspected Cases vs. Pathological Findings
Disease
Sarcoidosis
Lymphoma
Metastatic carcinoma
41
3
4
Clinically
suspected
Pathologically
confirmed
38
3
4
Not clinically suspected 
but pathologically suggestive
adenitis and one of granulomatous 
adenitis. Samples of tissue from these 
five patients showed no evidence of 
tuberculosis by direct culture and 
guinea pig inoculation.
A comparison of the clinical pre­
operative diagnosis and the result of 
mediastinoscopy is presented in Table 
II. The clinical preoperative diagnosis 
was remarkably accurate, particularly 
in patients with sarcoidosis. In three of 
the four cases of Hodgkin’s lymphoma 
the disease was suspected preopera- 
tively. In all four patients with meta­
static breast cancer, the diagnosis was 
suspected clinically; however, a tissue 
diagnosis was indicated before further 
therapy could be recommended.
There were two complications— a 
postoperative air leak from the right
bronchus, which healed spontaneously, 
and nonfatal pulmonary embolism 
which occurred 7 days postoperatively.
We describe three typical cases.
Case Reports
Case 1.—A 20-year-old man had a 
2-week history of left-sided precordial 
chest pain. There were no associated 
respiratory symptoms. The patient denied 
experiencing fever, chills or night sweats 
and had no known contact with tuber­
culous persons.
The physical findings were normal. 
There was no adenopathy and the chest 
was clear. Results of laboratory investiga­
tions including biochemistry, hematology 
and sputum tests were inconclusive. The 
chest roentgenogram (Fig. 1) revealed 
enlargement of paratracheal and broncho­
pulmonary lymph nodes bilaterally and
a widened superior mediastinum. Medi­
astinoscopy was performed and specimens 
of lymphatic tissue were obtained. The 
pathological diagnosis was consistent with 
sarcoidosis.
Case 2.—A 48-year-old man had a 
2-month history of persistent cough, 
wheezing and occasional night sweats. He 
had lost 10 kg in weight during that 
time. He was a nonsmoker.
The physical findings were within nor­
mal limits. Results of hematologic and 
biochemical investigations and sputum 
tests were not diagnostic. The chest ro­
entgenogram (Fig. 2) demonstrated a left 
hilar mass with normal lung parenchyma. 
Bronchoscopy findings were normal. The 
patient underwent mediastinoscopy. The 
pathological diagnosis was Hodgkin’s 
lymphoma, nodular sclerosing type.
Case 3.—A 46-year-old woman had 
had progressive shortness of breath over 
a 7-month period. Seven years earlier she 
had undergone a radical mastectomy on 
the right side for infiltrating duct carci­
noma. Routine follow-up chest roentgeno­
grams had been normal. On her admission 
the chest roentgenograms (Fig. 3) revealed 
an ill-defined density in the hilar region 
on the right, which compressed the right 
main-stem bronchus, and distal atelectasis. 
The diaphragm on the right was elevated 
and immobile.
Physical examination demonstrated a 
well-healed mastectomy scar and de­
creased breath sounds over the right side 
of the chest. There was no lymphadeno- 
pathy. Other investigations, including 
lung and bone scanning, gave normal 
results. Mediastinoscopy was performed 
and resulted in a diagnosis of infiltrating 
duct carcinoma.
Discussion
Mediastinoscopy is most commonly 
used for the clinical staging of primary 
carcinoma of the lung.3 Its value in 
managing bronchogenic carcinoma has 
been reviewed in a num ber of papers.2,4 
Ashbaugh,5 Tucker,6 Provost, Oliver 
and Schwaber7 and Foster, M unro and 
Dobell8 have presented excellent re­
views of the anatomic considerations, 
complications and results of mediastino­
scopy.
In  this series of 60 patients lymphoid 
tissue was obtained for bacteriologic 
and pathological assessment in all cases. 
Lymph nodes were considered to  be 
involved in the disease process in all 
cases as demonstrated by enlargement 
on preoperative roentgenograms.
Sarcoidosis: was the postoperative 
diagnosis in 75% of these cases. M it­
chell and Scadding,9 in a recent review, 
pointed out the difficulty in securing 
a firm  diagnosis of sarcoidosis. A t the 
International Conference on Sarcoidosis 
in Washington, DC,10 it was stated that 
sarcoidosis could not be defined on 
the basis of histopathology alone be­
cause the characteristic histologic ap­
pearance of sarcoidosis is not patho-FIG. 1—Case 1. Hilar lymph nodes are enlarged bilaterally and superior media­stinum is widened.
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gnomonic. Similar noncaseating granu­
lomas may be seen in a wide variety 
of diseases including leprosy, syphilis, 
fungal infections, foreign body reac­
tions and Crohn’s disease. Mitchell and 
Scadding9 believed that in a patient 
with clear clinical features of sarcoido­
sis and without discordant symptoms 
or signs, a positive Kveim test or his­
tologic confirmation was sufficient 
to establish the diagnosis. Kent and 
associates,11 however, have warned of 
the high frequency of other diseases, 
particularly tuberculosis, in patients 
with a clinical picture of sarcoidosis. 
As we have shown, with mediastino­
scopy the surgeon can obtain tissue for 
direct culture and guinea pig inocula­
tion to eliminate tuberculosis as a 
cause of symptoms.
In the past, relatively high diagnostic 
accuracy has been Obtained for sar­
coidosis by “blind” biopsy of the 
clinically uninvolved scalene fat pad. 
Elliott and colleagues,12 however, have 
shown that mediastinoscopy is more 
likely to produce a definitive diagnosis 
of sarcoidosis or other intrathoracic 
disease. In view of their findings it has 
been our practice to use mediastino­
scopy primarily when there is no 
clinical supraclavicular adenopathy.
A malignant condition involving the 
anterior mediastinal nodes was docu­
mented in eight (13.3%) cases in this 
series; four were cases of Hodgkin’s
lymphoma. The treatment regimen used 
for Hodgkin’s disease today13 is based 
on the anatomic extent of the disease. 
Using mediastinoscopy we were able 
to provide definite pathological evi­
dence of supradiaphragmatic involve­
ment in these cases and morbidity was 
minimal.
Four postmastectomy patients were 
found to have metastatic spread of dis­
ease to mediastinal nodes from 9 
months to 7 years after the initial op­
eration. Radiotherapy, or chemo­
therapy, or both, could be instituted 
immediately following diagnostic medi­
astinoscopy without retarding wound 
healing or prolonging postoperative 
convalescence.
In none of the six patients who had 
a diagnosis of nonspecific adenitis did 
tuberculosis or a malignant condition 
develop during the follow-up period. 
Thus, while a specific diagnosis was 
not made in this group, serious under­
lying disease does not appear to have 
been overlooked.
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FIG. 2— Case 2. Left hilar mass is present. Lung parenchyma is normal.
FIG. 3— Case 3. There is right hilar mass, right upper lobe atelectasis and elevated 
diaphragm on right side.
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Peripheral Arterial Insufficiency Due to Giant Cell Arteritis
P.K. O’Brien, mb, frcp[c], facp* and A.J.D. Pudden, md, frcs[c], FACsf
Progressive peripheral arterial insuf­
ficiency developed in a 53-year-old man 
who was referred for investigation of 
fever of unknown origin. Angiograms 
showed a smooth beaded appearance to 
both deep femoral arteries and biopsy 
of an occluded popliteal artery disclosed 
the lesions of giant cell arteritis. An 
excellent clinical response was obtained 
with steroid therapy.
Une insuffisance arterielle peripherique 
progressive est apparue chez un 
homme de 53 ans recu en consultation 
pour I'investigation d'une fievre 
d’origine inconnue. Les angiogrammes 
ont montre un aspect en chapelet lisse 
pour les deux arteres femorales 
profondes et la biopsie d’une artere 
poplitee obliteree a revele les lesions 
d'une arterite a cellules geantes. Une 
excellente reponse clinique a ete 
obtenue avec un traitement steroi'dien.
It has long been known that the mor­
phologic lesions of giant cell arteritis 
are not confined to the arteries of the 
carotid system.1’2 The occurrence of 
symptoms due to peripheral arterial in­
volvement, however, has only recently 
been emphasized.3 We report a case in 
which intermittent claudication with 
progression to pregangrenous change 
developed in a patient with clinical, 
radiologic, and pathological evidence 
of involvement of the femoropopliteal 
system by giant cell arteritis.
Case Report
A 53-year-old man was first seen on 
Dec. 6, 1974. He gave a history of fever 
and sweating, mainly in the mornings and 
evenings, of 2 to 3 weeks’ duration accom­
panied by a 2.3-kg weight loss. Physical 
examination prior to referral had revealed 
no clinical abnormality but abnormal find-
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ings of laboratory tests included an 
erythrocyte sedimentation rate of 108 
mm/h and a leukocyte count of 11 X 
109/L. The patient had smoked up until 
2 months before his initial attendance. He 
had a history of left retinal detachment in 
1941 and of allergy to sulphonamides.
The patient was 168 cm in height and 
weighed 81 kg. The blood pressure was 
120/70 mm Hg. No murmur was noted 
over the precordial area. The carotid pul­
ses were normal and all peripheral pulses 
were palpable. There was slight hepato- 
splenomegaly. Findings on urinalysis were 
normal and culture of urine and blood 
produced no growth of organisms.
On Dec. 18 the patient complained of 
pain in both calves; the pain began after 
he had walked about 100 m and ceased 
when he rested. The pain was present to 
an equal degree bilaterally. The anterior 
tibial pulses were now not palpable and 
the dorsalis pedis pulses were difficult to 
feel. Carotid and femoral pulses were 
normal. The popliteal pulse was palpable 
bilaterally but less so than on the previous 
examination. There was good tissue capil­
lary refill and venous return. The blood 
pressure was 120/80 mm Hg. A tentative 
diagnosis of collagen vascular disease or 
vasculitis was made. No treatment was 
instituted.
The patient was admitted to hospital on 
Dec. 30. Femoral pulses were present and 
normal and no bruits were heard over the 
femoral arteries. Popliteal pulses were 
diminished and the pedal pulse was absent 
on both sides. Abnormal findings of labo­
ratory studies were as follows: leukocyte 
count, 13 X 109/L  (polymorphonuclear 
cells 68%, lymphocytes 26%, monocytes 
6%); erythrocyte sedimentation rate, 104 
mm/h; serum <*2 globulin value, 11 g/L 
(normal, 4 to 8 g/L); serum albumin 
value, 3 g/L (normal, 38 to 50 g/L); 2-hr 
pc blood glucose value, 150 mg/dL (8.3 
mmol/L). The following measurements 
or tests gave normal or negative results: 
hemoglobin concentration, platelet count, 
test for rheumatoid factor, VDRL, routine 
urinalysis, cultures of blood, urine and 
stool, antinuclear factor, concentrations of 
serum electrolytes, blood urea nitrogen, 
serum creatinine, BjA/ILC complement, 
uric acid, serum acid phosphatase, serum 
alkaline phosphatase, serum glutamic oxa­
loacetic transaminase, serum bilirubin (total 
and conjugated), serum cholesterol and 
serum triglycerides, lipoprotein electro­
phoresis and chest roentgenogram. While 
the patient was in hospital the erythrocyte 
sedimentation rate settled down to 9 mm/h 
and on discharge the patient was taking no 
medications but was on a modified diet.
In April 1975 he began to complain of
increasingly severe intermittent claudica­
tion, particularly in the right leg, accom­
panied by severe pain in the right fifth 
toe. Incipient gangrene of the right foot 
was evident. Hepatosplenomegaly was 
present. There was bilateral loss of the 
popliteal pulse and a decrease in the 
femoral pulse on both sides. A translum- 
bar aortogram on Apr. 17 showed com­
plete obstruction of the right superficial 
femoral artery and both deep femoral 
arteries had a smooth beaded appearance. 
Little evidence of collateral flow was 
noted (Fig. 1).
A right translumbar sympathectomy was 
performed on Apr. 22 and resulted in some 
clinical improvement. On May 2 the right 
femoropopliteal artery was explored. The 
artery was bound down to the vein. It was 
dissected free and a longitudinal arterio- 
tomy was performed. Virtually total occlu­
sion of the lumen was evident and no flow 
was observed. It was impossible to intro­
duce a Fogarty catheter into the vessel 
lumen. A 1-cm portion of the popliteal 
artery was excised.
Histologic examination of the excised 
portion of vessel showed the lumen to be 
almost totally occluded by proliferating 
fibrous tissue undergoing collagenization. 
Revascularization was evident. Examina­
tion under high power showed extensive 
disruption of the internal elastic lamina 
associated with foreign-body giant cells 
and spotty calcification. There was a 
round cell panarteritis with adventitial 
fibrosis. Occasional granulomatous foci 
were noted in the tunica media.
Treatment with prednisone, 60 mg/d, 
was started without delay. The diabetes 
was controlled with diet and chlorpropa­
mide. Subjective improvement was noted 
soon after the patient started taking 
steroids. There was a notable improvement 
in his clinical status. The pregangrenous 
changes noted in the right foot gradually 
disappeared and he was discharged on
FIG. 1—Translumbar aortogram show­
ing complete obstruction of right super­
ficial femoral artery and smooth beaded 
appearance of both deep femoral arteries.
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May 20 on a regimen of prednisone, 5 mg 
qid. At follow-up on Sept. 23, 1975 both 
lower limbs were warm and the femoral 
pulses were normal; faint bruits were 
audible over the femoral arteries. However, 
the pulses below the knees were impal­
pable although both feet were warm and 
slightly flushed.
Repeat translumbar aortography on 
Sept. 24, 1975 showed complete obstruc­
tion of both superficial femoral arteries 
from the point of origin. The deep femoral 
arteries still showed the smooth beaded 
appearance previously noted (Fig. 2). 
Numerous collateral branches were present 
throughout both legs. The superficial 
femoral artery on the left side was patent 
below the level of the adductor hiatus.
Discussion
The combination of fever, malaise, 
weight loss, high erythrocyte sedimen­
tation rate and an elevated serum a l  
globulin concentration in this patient is 
consistent with the presence of giant 
cell arteritis, which was confirmed by 
the almost pathognomonic histologic 
changes in the right popliteal artery. At 
no time in the course of the illness did 
the patient have symptoms referable to 
the temporal arteries and no signs of 
disease affecting these vessels were 
elicited on clinical examination at any 
time. However, careful questioning 
revealed that jaw pain on chewing had 
been present in the months preceding 
initial examination and had led to 
dental treatment. This symptom was 
probably due to claudication of the 
masseter muscles. The patient had 
never experienced polymyalgic symp­
toms.
Large-artery lesions in giant cell ar­
teritis are accompanied by appreciable 
mortality and morbidity. The emphasis 
that has been given to the cranial 
aspects of the disease has tended to 
overshadow the fact that serious symp­
toms due to involvement of large ar­
teries are often found if looked for in 
patients with the more classical forms 
of presentation.3 Claudication of an arm 
or leg can be the presenting symptom.4
FIG. 2—Repeat translumbar aortogram 
showing complete obstruction of both su­
perficial femoral arteries. Previously noted 
beaded appearance of deep femoral ar­
teries is still prominent. Numerous col­
laterals are now present.
Lesions of giant cell arteritis have been 
found in the arteries of limbs that have 
been amputated for gangrene,5 and the 
disease has caused the aortic arch syn­
drome,3 subclavian artery occlusion,6 
aortic rupture3 and dissecting aneurysm 
of the aorta.7 Giant cell arteritis affect­
ing principally the femoropopliteal sys­
tem has been diagnosed in the past as 
Buerger’s disease in the elderly.8
The angiographic appearance of 
beading noted in this case may be an 
important clue to the underlying pathol­
ogy. A similar appearance has been 
noted previously in cases of intracra­
nial9 and peripheral4 giant cell arteritis, 
and represents alternate smooth arterial 
stenoses and aneurysmal dilatations. 
Other arteriographic findings that sug­
gest the possibility of giant cell arteritis 
include smooth tapered vessel segments, 
or smooth-walled stenotic segments.4 In 
the legs concomitant atherosclerosis can 
complicate the roentgenographic ap­
pearance.
Intermittent claudication is most 
commonly due to arteriosclerotic vas­
cular disease. When dealing with cases 
that have an atypical presentation or 
angiographic appearance it is important 
to bear in mind the possibility of giant 
cell arteritis; early temporal artery biop­
sy should be performed even when there 
is no clinical evidence of involvement 
of these vessels.4
We thank P. Evtushenko, Toronto Insti­
tute of Medical Technology, for providing 
the illustrations and G. Burton for typing 
the manuscript.
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Massive Lower Gastrointestinal Bleeding: An Unusual 
Complication of Crohn’s Disease
J.C. H arvey, md,* L. Rotstein, md,* M. Steinhardt, md, FRCP[c],f M.M. Reingold, md, frcs[c],*
E. Rubin, md, ms|  and R.M. Stone, md, frcs[c]*
Massive rectal bleeding may complicate 
Crohn’s disease at any stage and tends 
to be persistent. Limited experience 
gained with this complication supports 
the use of selective angiography followed 
by conservative resection as the 
management of choice. Results of 
experimental studies suggest that 
selective infusion of vasopressors may 
be safely attempted when hemorrhage 
complicates Crohn’s disease in its early 
stages but is probably too hazardous 
in cases in which the disease is more 
advanced.
Une hemorragie rectale massive peut 
venir compliquer une maladie de Crohn, 
a n'importe quel stade clinique, et elle 
tend a persister. Une experience limitee 
obtenue avec cette complication, 
soutiens I’emploi d'une angiographie 
selective suivie d'une resection 
conservatrice comme le traitement de 
choix. Les resultats d'etude experi- 
mentales indiquent que I’infusion 
selective d'agents vasopresseurs peut 
etre tentee avec securite quand une 
hemorragie vient compliquer une maladie 
de Crohn dans ses stades initiaux mais 
cette pratique est probablement trop 
dangereuse dans les cas oil la maladie 
est plus avancee.
Massive lower gastrointestinal bleeding 
is an unusual complication of Crohn’s 
disease. In the most recent review of 
this subject, Homan, Tang and Thorb- 
jarnarson1 reported seven cases collected 
over a 43-year period at New York 
Hospital—Cornell Medical Center and 
reviewed 19 other well-documented 
cases in the literature. There was suf­
ficient data to justify comment upon
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the frequency of repeated episodes of 
bleeding in 24 patients; 12 had recur­
rent massive bleeding while 5 others had 
at least one episode of less serious re­
bleeding. Four patients received no sur­
gical treatment;2,3 two died and a third 
suffered another massive hemorrhage.4 
Thus, present knowledge of the course 
of Crohn’s disease indicates that once 
massive bleeding occurs it is highly 
likely either to persist or to recur.1'5,6 
The purpose of this report is to place 
on record two additional cases and to 
provide recommendations for manage­
ment.
Case Reports
Case 1.—A 55-year-old woman was ad­
mitted to Mount Sinai Hospital, Toronto, 
on Mar. 25, 1975 with a diagnosis of deep 
vein thrombophlebitis. Results of routine 
laboratory investigations were normal ex­
cept for anemia (hemoglobin value, 8.1 
g/dL) and prolongation of prothrombin 
time (13 seconds, control 11 seconds). Al­
though she denied symptoms of gastro­
intestinal disease, a full investigation was 
planned because of her anemia. Sigmoido- 
scopic examination was normal to 22 cm. 
Gastrointestinal barium studies revealed 
that changes consistent with Crohn’s di­
sease were present in a 15-cm length of 
the distal ileum (Fig. 1). The stomach and 
duodenum appeared normal. The patient 
was treated orally with anticoagulants for 
her deep vein thrombophlebitis and re­
ceived supplemental iron, vitamin B,, and 
folate. Her recovery was uneventful and 
the anticoagulants were discontinued 3 
months later.
She was well until Mar. 20, 1976 when 
she was admitted with bloody diarrhea. On 
admission her blood pressure was 120/90 
mm Hg, pulse rate 120 beats/min and 
hemoglobin value 11.4 g/dL, but over the 
next 3 days transfusion of 5000 mL of 
blood was required to maintain vital 
signs. Superior mesenteric arteriography 
disclosed a bleeding point in the distal 
ileum within an area of inflammatory 
bowel disease (Fig. 2). At laparotomy the 
right colon and distal 20 cm of ileum were 
resected. Gross and microscopic examin­
ation of the specimen confirmed the diag­
nosis of Crohn’s disease. The postoperative 
course was complicated by an enterocu- 
taneous fistula which closed after a 5-week 
course of total parenteral nutrition. Since 
that time the patient has been well and 
there has been no further bleeding.
Case 2.—A 23-year-old woman was ad­
mitted to Mount Sinai Hospital on Jan. 29, 
1977 after passing a large amount of bright 
red blood per rectum. Two years earlier 
she had complained to her family doctor 
of crampy abdominal pain, but no diag­
nosis had been made. Except for occasional 
diarrhea and recent blood-streaked stools 
she had been well. There was no family 
history of inflammatory bowel disease.
She was a pale, tremulous young woman. 
Her blood pressure was 90/60 mm Hg and 
pulse rate was 138 beats/min. Abdominal 
examination revealed no tenderness or 
masses. Prothrombin time was 12.5 sec­
onds (control, 11.5 seconds) and her hemo­
globin value was 10.2 g/dL. She continued 
to pass bright red blood mixed with clots 
per rectum and 3500 mL of whole blood
FIG. 1—Case 1, March 1975. Crohn's 
disease of distal 15 cm of ileum with 
marked narrowing of bowel lumen and 
separation of loops due to thickened me­
sentery.
FIG. 2—Case 1, March 1976. Superior 
mesenteric arteriogram demonstrates con­
trast extravasation in area of Crohn’s di­
sease in distal ileum. Vasculature is tor­
tuous with loss of normal tapering and 
terminal coiling of rectal arteries. Bowel 
wall is thickened.
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was required to maintain vital signs. To 
rule out upper gastrointestinal bleeding a 
nasogastric tube was inserted; there was 
no evidence of blood in the aspirate. Sig- 
moidoscopic examination to 15 cm was 
obscured by blood and clots. Emergency 
angiography revealed a bleeding point in 
the terminal ileum. The pattern of the 
vessels in the region was consistent with 
Crohn’s disease (Fig. 3). At laparotomy 
an inflammatory mass was found involving 
the ileocecal region. There was “creeping 
fat” over the surface of the serosa with a 
thickened mesentery and palpable mesen­
teric lymph nodes. Approximately 18 cm 
of ileum and 8 cm of ascending colon 
were resected. Gross and microscopic 
examination confirmed the diagnosis of 
Crohn’s disease.
The patient’s postoperative course was 
complicated by a superficial wound in­
fection which was treated by drainage. She 
was discharged on the 10th postoperative 
day. On follow-up examination 2 months 
later she was asymptomatic except for 
mild wound discomfort.
Discussion
Massive lower gastrointestinal bleed­
ing is an indication for arteriography 
whenever the patient’s condition per­
mits. In cases of diverticulosis selective 
infusions of vasopressors may be used 
to control the hemorrhage; surgery is 
reserved for use when arterial infusion 
has failed. When the source of bleeding 
is a lesion for which conservation man­
agement is not considered to be ap­
propriate, arteriography will allow the 
surgeon to operate with the knowledge 
of the source of bleeding, thus avoiding 
the problems and frustration of a 
“blind” search for the source of hemor­
rhage.
Early in the course of Crohn’s di­
sease the arteriographic pattern in the 
small bowel is that of hyperemia with 
dilatation of submucosal vessels.7‘° In 
later stages the angiographic9 ' 10 and 
pathologic8,10 pattern consists of thick­
ening of vessel walls and narrowing of 
luminal diameter. This is true for the
PIG. 3—Case 2. Subtraction film in ar­
terial phase readily demonstrates bleeding 
point in distal ileum in area of abnormal 
vascularity. Rectal arteries are wide, tor­
tuous and have lost their normal tapering 
indicating that inflammatory bowel disease 
is present.
colon as well as the small bowel. In a 
study of patients in the hyperemic stage 
of Crohn’s disease, Erikson and col­
leagues11 demonstrated a response to 
vasopressors, but to our knowledge no 
report has described the successful man­
agement of bleeding Crohn s disease by 
selective infusion of vasopressors. Bleed­
ing in advanced stages of the disease, 
although it may be less common because 
of cicatrization and decreased blood 
flow , 0 does occur. Massive bleeding has 
been the initial presentation5' 1 2 1 5  as well 
as a later complication of Crohn’s di- 
sease. 3 -5' 6' 10 Because of the decreased 
number of collateral vessels in advanced 
stages of Crohn’s disease, such infusion 
therapy may be hazardous and probably 
should not be used.
Massive lower gastrointestinal bleed­
ing due to Crohn’s disease is life-threat­
ening. Angiographic localization of the 
site of bleeding followed by conserva­
tive resection of the involved bowel is 
the recommended management. A brief 
trial of selective vasopressor infusion 
may be employed when bleeding occurs 
in the early hyperemic stages of the 
disease but should not be attempted in 
cases of advanced disease where total 
flow is known to be decreased and col­
lateral flow is probably inadequate.
We agree with Homan, Tang and 
Thorbjarnarson1 that all involved bowel 
should be resected, if practicable, when 
the surgeon has to operate without pre­
operative angiographic localization of 
the bleeding site. This recommendation 
is based on the fact that a few patients 
have had recurrence of massive 
bleeding following conservative resec- 
tion, 1' 4 ,5 ’1 7 1 9  but it is emphasized that 
preoperative angiography was not done 
in any of these cases.
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Orthopedic Outpatient Surgery
John W. Hazlett, md, b sc(m ed), frcs[c]
Changes in provision of health care 
by the province of Ontario have included 
forced reduction in the number of 
hospital beds. In this situation the needs 
of patients with orthopedic disabilities 
have been met by a dramatic increase 
in outpatient surgery.
At the Hotel Dieu Hospital, Kingston, 
the total number of surgical procedures 
increased from 5516 in 1970 to 7260 in 
1975. During this period the number of 
outpatient surgical procedures performed 
under general anesthesia rose from 
820 in 1970 to 2927 in 1975, an increase 
of 264%.
Of 1197 orthopedic procedures 
performed in 1975, 632 (52%) were 
performed on an outpatient basis.
In the author’s personal experience 
of outpatient surgery, which in 1975 
included 38 meniscectomies, 10 major 
shoulder repairs, 28 foot reconstructions, 
11 nerve releases, 14 tendon releases 
and 4 elbow arthroplasties, patient 
acceptance has been good. Adequate 
clinic facilities, trained nurses, appro­
priate anesthesia and patient education 
are essential if management in this 
locale is to be successful.
Des modifications dans la distribution 
des soins de sante en Ontario ont inclus 
la diminution forcee du nombre de lits 
d hopitaux. Devant cette situation, les 
besoins des patients ayant une incapacity 
d ordre orthopedique ont ete rencontres 
par une importante augmentation de la 
chirurgie en externe.
A I'Hotel-Dieu Hospital de Kingston, 
le nombre total des interventions 
chirurgicales est passe de 5516 
en 1970 a 7260 en 1975. Durant cette 
periode, le nombre des interventions 
chirurgicales pratiquees en externe 
sous anesthesie generate a augmente 
de 820 en 1970 a 2927 en 1975, soit une 
augmentation de 264%.
Sur 1197 operations d’orthopedie
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realisees en 1975, 632 (52%) ont ete 
effectuees en externe.
Selon ('experience de I’auteur en 
chirurgie en externe, laquelle, en 1975, 
comprend 38 meniscectomies, 10 re­
parations majeures de I’epaule, 28 
reconstructions du pied, 11 liberations 
d'un nerf, 14 liberations d’un tendon et 
4 arthroplasties du coude, I’acceptation 
des patients est bonne. Des installa­
tions cliniques adequates, des infirmieres 
entrainees, une anesthesie appropriee 
et I’education du patient sont essentielles 
si le traitement dans ce champ doit 
avoir du succes.
When the Government of Canada Med­
ical Care Act became operative in the 
province of Ontario on Oct. 1, 1969 
residents of the province were provided 
with complete ward-type inpatient and 
outpatient services in hospitals with 
coverage of about 95% of health care 
costs.
Following the implementation of the 
act a number of events resulted in 
greatly increased costs of health care 
coverage in the province: nurses and 
hospital employees received large salary 
increases, physicians and patients made 
greater use of hospital services, the 
provincial government extended its 
health care coverage and persons over 
65 years of age were exempted from 
paying premiums.
In 1973, because of concern about 
mounting health care costs, the Ontario 
government attempted to avoid duplica­
tion of health services in neighbouring 
hospitals, by amalgamating obstetric and 
pediatric units. By such means a num­
ber of hospital beds were eliminated. 
The pressure of increased use of pre­
paid hospital services was instrumental 
in bringing about a number of changes 
in medical practice, particularly with 
regard to admission of patients to hos­
pital.
The orthopedic service of the Hotel 
Dieu Hospital, Kingston, which served 
as a teaching unit for Queen’s Univer­
sity medical school, was a self-contained 
unit of 16 beds situated in one of the 
oldest parts of the hospital. It was 
closed by the hospital authority in 1973, 
and orthopedic patients were obliged 
to share the accommodation on a larger 
general surgical service. To avoid long
waiting lists and to offer prompt service 
to patients with orthopedic disabilities, 
more and more operative procedures 
were undertaken on an outpatient basis. 
This was possible because the hospital 
had a separate surgical outpatient clinic 
with adequate facilities and personnel 
able to handle 15 to 20 patients a day 
for “in and out” surgery.
The total number of operations per­
formed at the Hotel Dieu Hospital, 
Kingston, in 1970 was 5516; by 1975 
this number had increased by 31% to 
7260, in spite of the loss of 15 to 20 
beds to the surgical service in 1973. 
The volume of outpatient surgery in­
creased by 264% from 820 operations 
in 1970 to 2927 in 1975. During this 
time the percentage of outpatient opera­
tions increased from 15% to 40% of 
the total number of operations per­
formed. This increased volume of out­
patient surgery affected all the divisions 
of surgery. With respect to orthopedic 
surgery, there was a notable shift of 
operative procedures from an inpatient 
to an outpatient basis; between 1974 
and 1975, there was an increase in the 
number of operative procedures per­
formed by two orthopedic surgeons of 
157 (from 1040 to 1197), but the num­
ber of outpatient procedures performed 
by these surgeons increased by 276 
(from 356 to 632). By 1975, 53% of 
the orthopedic operative procedures 
were performed under general anesthe­
sia on an outpatient basis.*
Personal Experience
In 1970, out of a total of 576 oper­
ations performed, 73 (13%) were done 
in the outpatient department. In 1975 
the percentage performed on an out­
patient basis increased to 46% (292 
of 627 operations).
An analysis of the number of closed 
procedures performed (Table I) in­
dicates that they formed about 40% of 
the total outpatient operations in 1975. 
There was a particular increase in the 
number of neck manipulations.
’"This figure is higher than the correspond­
ing one for general surgery and reflects 
the greater difficulty of orthopedic sur­
geons in obtaining hospital admission for 
their patients and the better adaptation of 
orthopedic patients to the reduction of 
inpatient facilities.
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Open procedures were undertaken 
much more commonly on an outpatient 
basis in 1975 (Table II). In particular, 
there were increases in the number of 
median and ulnar nerve releases, knee 
meniscectomies, shoulder repairs and 
foot procedures.
Meniscectomy of the knee is a com­
mon orthopedic procedure. In 1970 
this operation was performed 27 times 
and in all instances the patient was 
admitted to hospital. In 1975 this oper­
ation was done on an outpatient or “in 
and out” basis in 38 patients—more 
than half the total of 63 patients who 
underwent this procedure. It is notable 
that the inpatient meniscectomies were 
performed on those persons who were 
elderly, who lived a long distance from 
the hospital, who had bilateral disease, 
or who had other disorders. Of the 38 
subjects who underwent meniscectomy 
as outpatients, 32 were men and 6 were 
women; their average age was 38 years.
Other outpatient procedures included 
10 shoulder repairs for recurrent dis­
location or rotator cuff tears, on nine 
men and one woman (average age, 47 
years), and 28 foot and ankle proce­
dures such as metatarsal osteotomy, 
Keller arthroplasty, excision of acces­
sory tarsal navicular bone and arthro- 
tomy of the ankle. Of the 76 patients 
in whom meniscectomy, shoulder re­
pair, or a foot or ankle procedure was 
planned for an “in and out” attendance 
at hospital, 8 eventually had to be ad­
mitted because of excessive pain or 
disability. With added experience in
patient selection and more complete 
preoperative instruction, the number of 
failures to carry through the original 
plans has decreased.
Patients who required admission after 
knee surgery included a 37-year-old 
man who had had both medial and 
lateral menisci removed, a 28-year-old 
man who had had a medial capsular 
repair, a 45-year-old man with asso­
ciated arthritis and probable gout of 
his knee and a 31-year-old man with 
associated ligament derangement.
Two patients were admitted after a 
shoulder repair: a 38-year-old man who 
was operated upon 8 months after he 
had sustained a grossly displaced frac­
ture of the greater tuberosity of the 
humerus and a 28-year-old man who 
was poorly prepared psychologically to 
accept outpatient surgery.
Of the two patients admitted after 
foot surgery one was a woman who 
had undergone bunionette and sesam­
oid removal, and the other was an 
elderly man who had had bilateral 
Keller procedures.
Needs for Outpatient Surgery
Table 1—Outpatient 
Closed
Orthopedic S urgery- 
Procedures
Manipulation 1970 1975
Neck 51 84
Back — 11
Shoulder 4 14
Knee 3 6
Fracture* 3 1
Total 61 116
*Local anesthesia was used for most frac­
tures.
Table II—Outpatient Orthopedic S urgery- 
Open Procedures
Procedure 1970 1975
Removal of pin, screw, etc. 3 11
Ganglion or cyst 4 4
Incision and drainage 2 2
Nerve release i 11
Amputation 2 6
Meniscectomy ---- 38
Shoulder repair — 10
Foot procedures — 28
Miscellaneous 64
Total 12 174
A patient who wishes to have surgery 
such as knee meniscectomy performed 
on an outpatient basis must have a firm 
desire to avoid hospitalization and must 
be able to secure the assistance of an­
other person. A large number of stairs 
at home or the need to obtain meals 
outside the home pose difficult prob­
lems for a patient on crutches after 
surgery.
The patient is confidently advised 
about the procedure to be followed at 
the hospital, the need for fasting, for 
hemoglobin estimation and urinalysis, 
and the use of analgesics. Allergies, 
other health problems and medications 
taken by the patient are carefully docu­
mented.
The hospital must supply a suitable 
outpatient and waiting area and have 
nurses who are familiar with the con­
cepts of outpatient surgery. Halothane 
anesthesia and a cooperative anesthetic 
staff are helpful to the patient in avoid­
ing postoperative nausea and other 
complaints. Recovery room staff must 
avoid the use of hypodermic injections 
and should offer reassurance.
For lower limb surgery, the likelihood 
of wound discomfort, the type of ban­
dage or cast and its adjustment or care, 
the need for limb elevation and the type 
of exercise program are all explained 
to the patient.
Generally, a friend or relative takes 
the patient to his home or apartment 
and follow-up care is available from the 
doctor by phone or through the hospital 
emergency department. Initially, in this 
program, we provided home care 
through a visiting nurse and a physio­
therapist but this seemed to create more 
difficulties than it solved because of the 
varied personnel involved, the excessive 
sympathy extended to the patient and 
the frequent use of hypodermic injec­
tions of narcotic agents. Since these 
factors could not be ^controlled, home 
care was discontinued early in the pro­
gram, which has been more successful 
in consequence.
Conclusions
Increased use of orthopedic outpa­
tient surgery has been prompted by re­
duced hospital inpatient facilities in 
Ontario and long waiting lists for hos­
pital admission.
Inpatient care has been reserved for 
complicated problems and for the care 
of patients with back and hip disabil­
ities.
Patient acceptance of outpatient sur­
gery and the interest and help of re­
latives and friends have allowed de­
velopment of a successful program. 
Procedures have included knee menis­
cectomy, major shoulder repair and 
various foot reconstructions.
An understanding and cooperative 
nursing staff in the outpatient depart­
ment, operating room and recovery 
room has greatly aided the safe, prompt 
and acceptable discharge of patients 
who have undergone major orthopedic 
procedures.
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Compression Treatment of Hypertrophic Scars
in Burned Children
M. G arcia-V ela sc o , m d , R. L ey , m d , D. M u t c h , m d , N . Su r k es , m aot  and H.B. W il l ia m s , m d , fr c s[c ]
The formation of hypertrophic scars is 
common following healing of the burn 
wound, particularly in children. The 
control of scar formation is an important 
part of overall treatment in these cases 
and this paper describes a newer 
method that applies compression to the 
burn scar in an attempt to improve the 
ultimate appearance. The 35 patients 
treated by this method included some 
with partial-thickness and others with 
full-thickness burns. The results of 
treatment with compression garments 
were assessed at 6 months and at 12 
months, using a grading system based 
on colour, consistency and thickness 
of the scar. The design of facial moulages 
and their use in compression of facial 
scars are dealt with. Overall there was 
a 75% to 80% improvement in the 
state of burn scars. The reasons for 
this improvement are discussed.
Suite a la guerison d’une brulure, la 
formation d'une cicatrice hypertrophique 
est frequente, particulierement chez 
les enfants. Dans ces cas, le controle 
du processus de cicatrisation constitue 
une partie importante du traitement 
d ensemble, et cette communication 
decrit une methode plus nouvelle qui 
consiste a exercer une compression 
sur la cicatrice du tissu brule dans une 
tentative pour en ameliorer I’apparence 
finale. Les 35 patients traites de cette 
facon incluent certains patients ayant 
une brulure de profondeur partielle 
et d autres de pleine epaisseur. Les 
resultats du traitement avec des 
vetements compression ont ete evalues 
apres 6 et 12 mois, a I’aide d’un 
systeme de classification reposant sur 
la couleur, la consistance et I'epaisseur 
de la cicatrice. On discute du modele 
des moulages faciaux et de leur 
emploi pour la compression des 
cicatrices faciales. Pour I’ensemble,
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on a observe une amelioration de 75% 
a 80% de I’etat des cicatrices de 
brulures. Les raisons de cette 
amelioration sont discutees.
The formation of hypertrophic scars 
and contractures in children who have 
suffered partial- and full-thickness 
burns is a well-known problem to any­
one who attends these patients. The 
functional disabilities from scar con­
tractures and their grotesque appear­
ance have been viewed as the normal 
outcome of healing of burn wounds. 
The scarring may be reduced by proper 
use of split-thickness skin grafts but 
extensive scar contractures may develop 
even at the margin of these grafts. In 
recent years compression applied in a 
variety of ways has been used in an 
attempt to control and reduce such ex­
tensive scarring. Cronin1 described the 
use of splints to prevent anterior neck 
contractures after skin grafting. Fuji­
mori, Hiramoto and Ofuji2 reported a 
method of treating burn scars using 
self-adhesive sponges and pressure on 
the burn area. Larson and associates3-6 
introduced a program for the preven­
tion and treatment of hypertrophic 
scars and contractures that combined 
splints and pressure with custom-made 
elastic garments (Jobst Elastic Gar­
ments, Toledo, OH). These garments 
are worn day and night to provide con­
stant, even pressure to the burn scars. 
This compression method with some 
modifications has been used at the 
Montreal Children’s Hospital in 35 
burned children. In this paper we de­
scribe the technique and the results we 
obtained.
Patients
Thirty-five patients with hypertrophic 
scars that developed after partial- or 
full-thickness burns were studied in the 
18-month period from Jan. 1, 1975 
through June 30, 1976. There were 20 
boys and 15 girls whose ages ranged 
from 1 to 16 years.
Fifty scars were studied, of which 
35 were randomly treated by compres­
sion methods and 15 were left un­
treated and considered as the control
group. The estimated depth of the burn 
wound at the time of admission was of 
partial thickness in 20 of the scarred 
areas and of full thickness in the re­
maining 30 areas. All burns had been 
caused by either flame or scalds.
Grading
All patients were followed up by 
clinical examination and with serial 
photographs at a special clinic for burn 
scars which was held once monthly. 
Personnel from a number of health care 
fields, including plastic surgeons, occu­
pational therapists, physiotherapists, 
clinic nurses and social workers, were 
involved in the assessment process. A 
consensus was reached in grading the 
scars on a scale of 1 to 3 according to 
colour, consistency and thickness (Ta­
ble I).
The compression garments were ad­
justed or changed as necessary during 
the course of treatment.
Results
The overall improvement seen in 
the compression group was of a much 
greater degree than in the control group 
(Table II).
Improvement in the colour of the 
scar was evident in all the patients by 
the end of 12 months but was seen 
earlier in the treated patients than in 
the controls. Also, the scar in the 
treated patients was much softer after 
6 months, particularly when treatment 
had been continued for a year. With 
respect to the thickness of the scar, 
the percentage of the treated group in 
grades 1 and 2 rose from 77% to 92% 
after 6 to 12 months of treatment; 
only 50% of the control group were 
in the latter category after 12 months.
Improvement was noted after a few 
weeks of treatment in most patients 
and the improvement in the appearance 
and consistency of the scar continued 
even up to 1 year after treatment was 
started. Some areas of the body, such 
as the presternal region and axillary 
webs, respond better to compression 
treatment, and the use of additional 
measures, such as rubber foam fitted 
under the garment, is helpful in in-
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Discussion
FIG. 1— Facial moulage (left) with silicone facial mask (centre) which is moulded 
im negative impression (right).
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FIG. 3— Mask is usually worn under 
standard elastic compression garment.
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creasing localized pressure in specific 
areas. Splinting o f webs and other sites 
o f contractures is an integral part o f 
the treatment. Light moulded splints 
are used for patients in whom joint 
areas are involved in the burn.
In the application of pressure to 
scars in the facial region custom-made 
silicone facial masks fitted from plaster 
impressions have been very useful 
(Figs. 1 and 2). A  facial moulage is
Table 1— Grading of Scars by Colour, Consistency and Thickness
Grade Colour Consistency
Thickness
1
2
3
White or mildly 
pigmented 
Pink or purple 
Red
Soft
Moderately hard 
Hard
Flat
Slightly raised 
Prominent
Hypertrophic scars have several 
characteristics evident on m icroscopic 
examination: the collagen is arranged 
in a whorl-like pattern, is more vascu­
lar and contains a greater number o f 
fibroblasts than does usual scar tissue. 
The ground substance consists mainly 
o f chondroitin sulfate A  which is 
present in greater amounts than in ma­
ture scar tissue.7,8 Compression causes 
the collagen pattern to break down 
bringing about the linear appearance 
characteristic o f mature scar and a 
decrease in the amount o f chondroitin 
sulfate A  (Fig. 6). Electron micro­
scopic study o f sections showed the 
presence of intracellular fibrils in some 
o f the fibroblasts in the hypertrophic 
group. These specialized cells, known 
as myofibroblasts, may well play a role 
in the formation o f contractures as
made and a negative silicone mask is 
fashioned with built-up areas corre­
sponding to the scarred region (Larsofl 
D: personal communication, 1976).
This method is used in the case o f 
irregular scars in the nasolabial folds 
and on the lips, side o f the nose and 
the chin. Usually the mask is worn 
under a standard elastic garment (Fig. 
3). Our results with this method have 
been very encouraging (Figs. 4 and 5).
FIG. 2— Mask placed on face.
Table I I - Evaluation of Scar Colour, Consistency and Thickness at 6 and 12 Months*
6 months 12 months
Characteristic
Compression 
(n =  35)
Control 
(n =  15)
Compression 
(n =  30)
Control 
(n =  10)
Colour
20
70
1
68 25Grade 1 
2 
3
55 32 75010 45 0
Consistency
23
62
15
80 0Grade 1
2
3
20
80
20
0
75
25
Thickness
23
54
23
50
Grade 1 
2 
3
13
87
42
8
50
50
‘ Figures are percentages.
FIG. 5—Improvement in scars after 2 
months of treatment, using facial mask 
and compression.
H y p e r t r o p h i c  S ca r C o m p r e s s i o n  
+ 2 0 m m  Hg
described by Gabbiani, Ryan and 
Majno9 (Fig. 7).
There is no adequate explanation of 
the changes in scars brought about by 
pressure. They might be attributed to 
the direct effect on collagen of pres­
sure alone or acting through ischemia, 
since in order to be effective the elastic 
devices must exert a pressure above 
20 mm Hg which is higher than the 
intercapillary pressure.
Control of scars is better achieved 
if treatment is started in the early 
phases of the scarring process. Hence 
the measurements for the custom-made 
garments should be taken as early as 
possible, even before the wounds are 
healed. Open and granulating areas 
still present may be covered with small 
dressings. The parents are informed of 
the importance of the treatment method 
and the necessity of wearing the gar­
ments both day and night. In some 
cases superficial skin breakdown re­
quires local dressings and it is often 
necessary to change the elastic garments 
every 2 to 3 months owing to reduction 
in their elasticity. Some children com­
plain of pruritus and discomfort dur­
ing hot weather; nevertheless the treat­
ment should continue for at least 6 
months and preferably up to 1 year 
following the burn.
Summary
Thirty-five children with burn scars 
and scar contractures were treated by 
compression with an elastic garment. 
After 6 months of therapy 75% to 
80% showed a definite improvement 
when compared with patients in a 
control group who were not so treated. 
The improvement continued for up to
12 months after treatment was insti­
tuted. Adequate splinting of associated 
contractures is an important part of 
the overall management. Compression 
garments and splints used together are 
highly valuable for controlling scarring 
due to burn wounds.
We thank Dr. T.A. Seemayer, pathol­
ogist, Montreal Children’s Hospital, for 
the electron microscopy.
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FIG. 6—Schematic representation of 
change seen in collagen under compression. 
Whorl-like pattern is gradually changed to 
linear pattern with clearer orientation. c V ; .  Pnotomicrograph of myofibroblast found in hvnertscar, Note intracellular myofibrils (arrow) (reduced by 29% from X2500).
FIG. 4—Severe facial burn scars.
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Critique of Items 465-468 
(SESAP II)
Hirsrhsnrunfz’s disease (aeanelionic megacolon) is characterized by a congenital absence of the myen- “ rk S t o n  cells of th fd lta l  segment of the intestine; symptoms of obstruction are noted shortly 
liter birth. Depending on the length of colon involved and the delay in diagnosis, varying degrees of 
anemia, malnutrition, and other complications may occur.
Psvchoeenic or functional constipation is the most common cause of megacolon in children. It 
frequently begins in early childhood, and fecal soiling is common. Children with functional constipa- tion arc Seldom undernourished and do not have symptoms of intestinal obstruction. Digital examma- 
tion of such patients demonstrates the rectal vault to be grossly dilated by fecal impaction. This symp­
tom complexes extremely difficult to treat and constitutes a major portion of the severe constipation
problems of children.
465 0  466 [B] 467 (c) 468 [H
Reference
465-468/1. Santulli TV: Constipation, in Mustard WT, Ravitch MM, Snyder WH Jr, et al: Pediatric 
Surgery, ed. 2. Chicago, Year Book Medical Publishers Inc, 1969, vol 2, p 1014
*
The Royal College of Physicians and Surgeons of Canada
THORACIC SURGERY — EXAMINATIONS
The first examinations leading to the Certificate of Special Competence in the specialty of Thoracic Surgery will be held in 
September, 1979. Prospective candidates should note the following:
1. Only candidates who are Royal College Certificants in General Surgery are eligible to take the examinations in Thoracic Surgery. 
2 Candidates who wish to take the examinations in 1979 should send a documented account of their training in Thoracic Surgery to the 
address below as soon as possible, and, in any case, not later than December 1,1978. Only candidates whose assessment of crede 
tiais is complete will be eligible to take the examinations. There is no charge for this assessment.
3. Further information may be obtained from:
Division of Training and Evaluation,
Royal College of Physicians and Surgeons of Canada,
74 Stanley Avenue,
Ottawa, Ontario, Canada, K1M 1P4.
Le College Royal des Medecins et Chirurgiens du Canada
EXAMENS -  CHIRURGIE THORACIQUE
Le premier examen en vue du certificat de competence particulibre en chirurgie thoracique aura lieu a I’automne de 1979. Tous les 
candidats qui sont int6ress6s a se presenter a cet examen devront prendre connaissance de ce qui suit.
1. Les candidats qui dbsirent se presenter aux examens en chirurgie thoracique doivent etre detenteurs du certificat de spbcialiste en 
chirurgie generate du College royal.
2 Les candidats qui dbsirent se presenter aux examens en 1979 doivent envoyer les details de leur formation en chirurgie thoracique, 
avec p re u vT fl^p p S  a I’adresse ci-dessous, le plus tot possible et au plus tard le 1er decembre 1978. Les candidats ne peuvent etre 
admisd I’examen avant que l’appr<§ciation de la formation soit terminee. II n y a pas de frais a payer pour cette appreciation.
3. On peut obtenir de plus ampies renseignements a I ’adresse suivante:
Division de la Formation et de I’Evaluation,
College royal des M6decins et Chirurgiens du Canada,
74, avenue Stanley,
Ottawa, Ontario, K1M 1P4.
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To lower 
blood pressure 
during 
anesthesia
reduces excessive 
blood loss
Precautions
(sodium nitroprusside)
for controlled hypotension during anesthesia 
Rx Summary
‘Nipride’ is only to be used as an infusion with sterile 5% dextrose 
in water without preservatives. Not tor direct injection.
Indications
'Nipride’ is indicated for producing controlled hypotension during 
anesthesia to reduce bleeding in surgical procedures where deemed 
appropriate. Benefit-risk ratio should be carefully considered on an 
individual basis.
Contraindications
Adequate facilities, equipment and personnel should be available 
for frequent and vigilant monitoring of blood pressure. When the infu­
sion is slowed or stopped, blood pressure usually begins to rise imme­
diately and returns to pretreatment levels within one to ten minutes.
It should be used with caution and initially in low doses in elderly 
patients, since they may be more sensitive to the hypotensive effects 
of the drug.
If, in the clinical situation, stress induced by pain or manipulation 
is reduced or eliminated during 'Nipride' infusion, the patient could 
experience a greater than expected reduction in blood pressure 
unless the rate of infusion is adjusted downward as required.
‘Nipride’ tends to deteriorate in the presence of light. Therefore, the 
infusion bottle should be wrapped with aluminum foil or other opaque 
material. Solutions of 'Nipride' should not be kept or used longer 
than four hours. 'Nipride' in aqueous solution yields the nitroprusside 
ion, which reacts with even minute quantities of a wide variety of 
organic and inorganic substances to form usually highly coloured 
reaction products (blue, green or dark red). If this occurs, the infusion 
should be replaced as quickly as possible.
In the treatment of compensatory hypertension, e.g. arteriovenous 
shunt or coarctation of the aorta. It is also contraindicated in physically 
poor-risk patients (A.S.A. Risk 5), in patients with uncorrected anemia 
or hypovolemia or in those with known inadequate cerebral circulation. 
In patients with liver disease, severe renal disease, Leber’s optic 
atrophy and disease states associated with vitamin B12 deficiency.
Warnings
'Nipride' is only to be used as an infusion with sterile 5% dextrose 
in water without preservatives. Not for direct injection. Infusion rates 
greater than 8 mg/kg/minute are virtually never required. If at this 
rate an adequate reduction in blood pressure is not obtained within 
10 minutes, administration of ‘Nipride’ should be stopped.
Fatalities due to cyanide poisoning have occurred following sodium 
nitroprusside administration. One factor is common to all known 
cases, namely that large amounts of nitroprusside were infused at 
high rates. Since detoxification relies upon enzymatic action, the 
rare possibility of deficient or atypical enzymes occurring in humans 
should always be considered. Patients most apt to run into difficul­
ties are those who are resistant to the hypotensive effect or those 
in whom maintenance at the selected blood pressure level is difficult 
or impossible. , .
Constant attention to the patient’s dose-response characteristics 
is mandatory. If infusion rates are in excess of 8 mg/kg/minute deter­
mine the nature of the response (effective constant response at 
higher dose; tachyphylactic; resistant -  none or less than expected). 
As soon as either tachyphylaxis or resistance is determined the infu­
sion of ‘Nipride’ should be discontinued immediately. In abnormal 
responders it has been noted that metabolic acidosis may occur 
at higher doses.
Caution should be exercised in using ‘Nipride’ in patients with hypo­
thyroidism or severe renal impairment.
Blood levels of thiocyanate should be determined if treatment is to 
be extended especially in patients with severe renal dysfunction.
As long as blood thiocyanate levels do not exceed 10 m g/100 ml, it is 
probably safe to continue with the infusion. Peritoneal dialysis can 
be helpful if too high levels of thiocyanate are found.
Hypertensive patients are more sensitive to the intravenous effect 
of sodium nitroprusside than are normotensive subjects. Patients 
receiving concomitant antihypertensive medications (especially 
hydralazine or hexamethonium) are more sensitive to the hypotensive 
effect of sodium nitroprusside and the dosage of 'Nipride' should 
be adjusted downward accordingly.
The following Warnings apply to the use of ‘Nipride’ for controlled 
hypotension during anesthesia:
1. Extreme caution should be exercised in patients who are especially 
poor surgical risks (A.S.A. class 4 and 4E).
2. Tolerance to blood loss, anemia and hypovolemia may be dimin­
ished. If possible, preexisting anemia and hypovolemia should be 
corrected prior to employing controlled hypotension.
3 Hypotensive anesthetic techniques may alter pulmonary ventilation 
perfusion ratio. Patients intolerant of additional dead air space
at ordinary oxygen partial pressure may benefit from higher oxygen 
partial pressure.
4 Resistance and tachyphylaxis occur more frequently in normoten­
sive patients infused with sodium nitroprusside. Induction of delib­
erate hypotension in healthy young individuals may prove to be 
more difficult than in other segments of the population.
5 Upon discontinuance of the sodium nitroprusside infusion for the 
purpose of controlled hypotension during anesthesia a rebound 
hypertension has been observed on rare occasions.
Usage in pregnancy
The safety of 'Nipride' in women who are or who may become preg­
nant has not been established; hence, it should be given only when 
the potential benefits have been weighed against possible hazard 
to mother and fetus.
Usage in children
The safety of Nipride’ in children has not been established. Clinical 
experience is limited.
Adverse reactions
Nausea, retching, emesis, diaphoresis, apprehension, headache, 
restlessness, agitation, muscle twitching, retrosternal discomfort and 
chest pain, palpitations, dizziness, faintness, weakness, rash, abdo­
minal pain, confusion and somnolence have been noted with too 
rapid reduction in blood pressure. These symptoms rapidly disap­
peared with slowing of the rate of infusion or temporary discontinua­
tion of infusion and did not reappear with continued slower rate 
of administration.
Irritation of the injection site may occur. Methemoglobinemia and 
one case of hypothyroidism following prolonged therapy have been 
reported.
Dosage and administration (for controlled hypotension)
Use of ‘Nipride’ in anesthetized normotensive patients undergoing 
deliberate hypotensive surgery must be restricted to carefully 
selected cases. There is a possibility of an abnormal response 
occurring in normotensive patients. In this event, the infusion of 
'Nipride' should be discontinued immediately. (See Warnings).
The contents of a 50 mg 'Nipride' vial should be dissolved in 3 ml 
of sterile dextrose in water without preservatives. No other diluent 
should be used. Depending on the desired concentration, all of the 
prepared stock solution should be diluted in 500 or 1000 ml of 5 per­
cent sterile dextrose in water and promptly wrapped in aluminum 
foil or other opaque material. Both stock solution and infusion solu­
tion should be freshly prepared and any unused portion discarded. 
The freshly prepared solution for infusion has a very faint brownish 
tint. If it is highly coloured, it should be discarded. (See Precautions). 
The solution should not be kept or used longer than four hours from 
initial reconstitution. The infusion fluid used for the administration 
of 'Nipride' should not be employed as a vehicle for simultaneous 
administration of any other drug.
‘Nipride’ dosage varies considerably from patient to patient, hence 
the need for individual titration. The infusion should be started at 
the lower dosage range, 0.5 mg/kg/minute and increased by 
0.2 mg/kg/minute every 5 minutes until the desired reduction in 
blood pressure is obtained. The blood pressure usually starts to drop 
immediately or at least within a few minutes. Continuous monitoring 
of the blood pressure is necessary. Blood pressure should not be 
allowed to drop at too rapid a rate and systolic pressure should not 
be lowered below 60 mm Hg.
Infusion rates greater than 8 mg/kg/minute should rarely be used.
The maximum recommended dose is 800 mg /minute.
‘Nipride’ should be administered by an infusion pump, micro-drip 
regulator or any similar device that will allow precise measurement 
of the flow rate. Avoid extravasation. The rate should be adjusted 
to maintain the desired hypotensive effect, as determined by frequent 
blood pressure determinations.
For the use of 'Nipride’ in the treatment of hypertensive crises please 
refer to the Product Monograph.
Supply
‘Nipride’ is supplied in 5 ml amber-coloured vials containing the 
equivalent of 50 mg sodium nitroprusside for dilution with 5 percent 
sterile dextrose in water (available in packages of 10).
Product Monograph available on request.
*  Reg. Trade Mark for sodium nitroprusside 'Roche'
®Reg. Trade Mark
Hoffmann-La Roche Limited 
Vaudreuil, Quebec 
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Major Amputation following Vascular Reconstructive 
Procedures (Including Sympathectomy)
Gordon Hunter, mb , frcs, frcs[c] and Pam Holliday, b sc( pt ), mcpa*
To study the effects of vascular 
reconstruction or sympathectomy, or 
both, on the level of amputation, the 
number of revision procedures 
performed and the mortality following 
amputation, the authors reviewed the 
records of 504 patients from three 
Toronto teaching hospitals who had one 
or both limbs removed at or above 
the below-knee level. It appears that 
(a) previous vascular surgery or 
sympathectomy, or both, actually 
increases the number of patients in 
whom a below-knee amputation is 
successful, (b) the number of revision 
procedures necessary is increased after 
failed vascular surgery or sympathec­
tomy, or both, and (c) revision 
procedures following amputation do 
not affect the mortality from lower limb 
amputation.
Dans le but d’etudier les effets de 
la reconstruction vasculaire ou de ia 
sympathectomie, ou des deux, sur le 
niveau de I'amputation, le nombre 
d'interventions de revision effectuees 
et la mortalite consecutive a I'ampu- 
tation, les auteurs ont passe en revue 
les dossiers de trois hopitaux 
universitaires de Toronto ou 504 patients 
ont eu un membre ou les deux membres 
amputes sous le niveau du genou ou 
au-dessus. II semble que (a) une 
chirurgie vasculaire ou une sympa­
thectomie precedent, ou les deux, 
augmentent le nombre de patients pour 
qui une amputation sous le niveau 
du genou est reussie, (b) le nombre 
de revisions necessaires est augmente 
apres echec de la chirurgie vasculaire, 
de la sympathectomie, ou des deux, 
et fc) les interventions de revision 
apres une amputation n’affectent en 
rien la mortalite reliee a I’amputation 
des membres inferieurs.
From the Amputee Research Centre, 
Toronto, Ont.
'"‘Amputee unit, University of Toronto, 
West Park Hospital, Toronto
Reprint requests to: Dr. G.A. Hunter, 
Amputee Research Centre, West Park 
Hospital, 82 Buttonwood Ave., Toronto 
Ont. M6M 2J5
Because arteriosclerosis, with or with­
out diabetes, accounts for 70% to 86% 
of all lower limb amputations,1-4 vascu­
lar reconstructive procedures (endarter­
ectomy, bypass by vein or synthetic 
implant, and aortoiliac surgery) and 
sympathectomy have been used to im­
prove circulation to the lower ex­
tremity. The aims of such procedures 
are:
1. To treat intermittent claudication 
and rest pain.
2. To avoid the necessity for am­
putation when there is impending 
necrosis.
3. To allow a distal amputation with 
preservation of as much as possible of 
the patient’s own tissue.
Hunter5 suggested that the results of 
amputation of one or more toes were 
enhanced if vascular reconstruction had 
been performed during the preceding 
month. However, this was not the case 
for patients who underwent transmeta­
tarsal amputation or Syme’s amputation.
Kihn, Warren and Beebe8 showed 
that previous arterial reconstruction 
did not influence the eventual healing 
of below-knee amputations but it did 
affect healing of above-knee amputa­
tions. In the latter group the wound 
from a recent reconstructive procedure 
lowered the rate of primary wound 
healing.
Burgess and Marsden7 reported that 
the level of initial lower extremity am­
putations does not differ greatly in pa­
tients who have previously undergone 
vascular surgery and in the amputees 
who have not had vascular reconstruc­
tion. They also noted that delayed heal­
ing and local wound complications 
were more frequent in the former 
group, especially when the amputation 
had been performed within 4 weeks of 
the last attempted vascular procedure. 
There is still uncertainty about the 
value of sympathectomy; of the 142 
patients on whom these workers had 
based their conclusions, 36 had had 
lumbar sympathectomy alone. We be­
lieve that the effect of vascular surgery 
on wound healing should be assessed 
less than 6 months after the perform­
ance of the last vascular procedure. 
Pedersen stated that if reamputation
was necessary, it did not significantly 
affect the mortality.8
Our clinical impression had not con­
firmed these earlier reports and there­
fore we conducted our own study of 
the effect of vascular reconstruction 
on subsequent major amputations of 
the lower limb. Our purpose was to 
analyse the effect of previous vascular 
procedures or sympathectomy, or both, 
on the level of amputation, the number 
of revision procedures required and the 
mortality following amputation.
We reviewed the results of major am­
putations of the lower limb from three 
University of Toronto teaching hospi­
tals over a 5-year period from 1970 to 
1975.
Clinical Material
There were 504 patients for whom 
adequate records were available. In 
this group all amputations were carried 
out for severe peripheral vascular dis­
ease. In 407 patients the amputation 
was unilateral and in 97 it was bila­
teral. There were 366 women and 138 
men. Diabetes was a complicating fea­
ture in 166 (33%) of the 504 patients. 
Primary wound healing was defined 
as healing within 3 months of the in­
itial amputation.
Results and Discussion
Level of Amputation in Relation to 
Previous Vascular Surgery
When there was no history of pre­
vious vascular reconstruction 140 
(46%) of 304 limbs demonstrated 
primary wound healing at the below- 
knee level. Vascular reconstruction, 
often combined with lumbar sympathec­
tomy and performed at any time prior 
to amputation, resulted in primary 
wound healing in 114 (52%) of 220 
limbs. The corresponding figure for 
patients who had undergone sympa­
thectomy alone any time before am­
putation was 37 (48%) of 77 limbs.
These results were not significantly 
different when submitted to yf analy­
sis. However, when they were further 
analysed in relation to the timing of 
vascular surgery and the exact proce-
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dure performed (Table I), prior vascu­
lar reconstruction or sympathectomy, 
or both, appeared to increase signifi­
cantly the number of patients in whom 
a below-knee amputation was success­
ful, provided the amputation was car­
ried out between 1 and 6 months after 
the last vascular procedure.
Bickel and Ghormley9 first suggested 
use of a long posterior skin flap in 
below-knee amputations done for peri­
pheral vascular disease, and Burgess 
and colleagues10 popularized the tech­
nique. Ultimate healing after this pro­
cedure has been reported in 75% to 
80% of patients.7-11'12
In spite of the obvious success of 
below-knee amputations, Waterhouse 
(personal communication, 1975) re­
ported that in Ontario in 1972, only 
50% of amputations for peripheral 
vascular disease were at the below- 
knee level. We were surprised and dis­
appointed to find that such amputa­
tions were successful in under 50% 
of patients in three major teaching cen­
tres where there is an aggressive atti­
tude towards preservation of the knee 
joint. These results confirm the views 
expressed by Kihn, Warren and Beebe6 
and Burgess and Marsden.7
Information concerning the value of 
sympathectomy before amputation var­
ies from the views of Pedersen, who 
believed that sympathectomy was of no 
value,8 to the opinions of Perlow13 and 
Paloschi and Lynn,14 who claimed that 
lumbar sympathectomy was an impor­
tant adjunct to healing and would per­
mit a more distal amputation. The 
results from our series suggest that
sympathectomy may help to preserve 
the knee joint in the dysvascular am­
putee.
Revision Procedures following Vas­
cular Reconstruction or Sympathec­
tomy, or Both
In our series we found that when no 
vascular reconstruction had been per­
formed, revision of the amputation to 
a more proximal level was necessary in 
62 (20%) of 304 limbs. When vascular 
reconstruction, with or without sym­
pathectomy, had been performed prior 
to amputation, such revision was neces­
sary in 90 (41%) of 220 limbs. Fol­
lowing sympathectomy alone at any 
time before amputation, revisions were 
necessary in 23 (30%) of 77 limbs.
When these figures were analysed to 
take into account the timing of vascu­
lar surgery prior to amputation and the 
exact procedure performed (Table II), 
the rate of revision at or above the 
below-knee level appeared to be in­
creased after failure of vascular surgery 
or sympathectomy, or both, especially 
when amputation was necessary within 
4 weeks of the vascular surgery. These 
results confirm the views of Burgess 
and Marsden.7 The risks accompanying 
below-knee amputation after vascular 
reconstruction must be compared with 
the greater chances of preserving the 
knee joint (Table I) and should not 
deter the surgeon from attempting be­
low-knee amputation whenever possible.
Effect of Increased Number of
Revision Procedures on Mortality
Of the 504 patients, 60 (12%) died
within 6 months after final amputation.
Of these 60 patients, 17 (28%) required 
revision to one or both limbs. In the 
patients who survived for 6 months the 
rate of revision was similar— 127 
(29%) of 444 patients required revi­
sion procedures.
The mortality following amputation 
in the dysvascular amputee is high. An 
editorial from The Lancet15 stated that 
one quarter of patients will probably 
be dead within 1 year, half within 3 
years and two thirds within 5 years, 
and a patient surviving for 5 years has 
an almost 50% chance of losing his 
other leg.
Our results support the views of 
Pedersen8 and of Kihn, Warren and 
Beebe.6 Although dysvascular amputees 
do not live long after their amputation, 
an aggressive attempt at preserving the 
knee joint and acceptance of a higher 
revision rate is justified even after un­
successful vascular surgery or sympa­
thectomy, or both.
We would stress16 that the only con­
traindications to below-knee amputa­
tion in patients with vascular disease, 
whether or not they have had recent 
vascular reconstructive procedures, are:
1. Necrosis up to or above the level 
of the knee joint, usually associated 
with an acute thrombotic or embolic 
occlusion of the femoral artery.
2. Fixed flexion contracture of more 
than 30° at the knee joint and more 
than 20° at the hip joint.
3. Absence of skin bleeding at trial 
amputation (hence the importance of 
avoiding a tourniquet at the time of 
surgery). Lack of bleeding from the 
muscle at the time of amputation is 
worrying but should not deter the sur­
geon from proceeding at the below- 
knee level provided that the skin itself 
bleeds.
Conclusions
This survey justifies the following 
statements with respect to the decision 
on the level for major amputations in 
patients following vascular reconstruc­
tion or sympathectomy, or both:
1. Too many above-knee amputations 
are being performed in Ontario.
2. Prior vascular reconstruction or 
sympathectomy, or both, appears to 
increase the number of patients in 
whom a below-knee amputation is suc­
cessful, provided the amputation is car­
ried out between 1 and 6 months after 
the last vascular procedure.
3. The rate of revision procedures at 
all levels is increased after failure of 
vascular surgery or sympathectomy, 
especially when amputation is neces­
sary within 4 weeks of the vascular 
surgery.
4. Revision procedures do not appear
Table 1— Healing of Below-Knee Amputations in Relation to Tim e Period and Procedure
Time between last
Vascular reconstruction, 
with or w ithout 
sympathectomy, no. of Sympathectomy alone,
vascular procedure patients/total no. no. of patients /to tal no. (and % )and amputation, mo (and % )
<  1 40/97 (41) 13/29 (45)
1 - 3 23/38 (60) 10/15 (67)
3 - 6 20/24 (83)* 8/10 (80 )f
>  6 31/61 (51) 6/23 (26)
*P =  0.01. 
|P  =  0.05.
Table I I— Incidence of Revision at Any Level in Relation to Tim e Period and Procedure
Tim e between last 
vascular procedure 
and amputation, mo
Vascular reconstruction 
with or w ithout 
sympathectomy, no. of 
patients/total no. 
(and % )
Sympathectomy alone, 
no. of patients /to tal no. 
(and % )
< 1
1 -  3 
3 -  6 
> 6
42/97 (43)* 
10/38 (26) 
5/24 (21) 
33/61 (54)
10/29 (34) 
3/15 (20 ) 
1/10 (10) 
9/23 (39)
*P =  0.001.
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to affect the mortality following lower 
limb amputation.
5. A below-knee amputation should 
be attempted, whenever possible, 
whether or not the patient has had 
recent unsuccessful vascular recon­
structive procedures.
We thank the surgeons of Toronto Gen­
eral Hospital, Toronto Western Hospital 
and St. Michael’s Hospital, Toronto, who 
allowed us access to their records, and 
we are extremely grateful to the Ontario 
March of Dimes who financed this in­
vestigation. Mrs. Csima from the Uni­
versity of Toronto carried out the statis­
tical analysis and Miss Marie Dennis typed 
the manuscript.
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Bilateral Carcinoma of the Breast: 
Frequency and Mortality
C. Barber M ueller, md, frcs[c] and Frances A mes
Of 3558 women with cancer of the breast, 
129 were found to have bilateral primary 
cancers, in approximately one quarter 
(33) of these women the two cancers 
developed synchronously; in the re­
mainder (96) the second cancer de­
veloped metachronously, more than 
6 months after the appearance of the 
first primary tumour. In two thirds (64) 
of the women in the latter group the 
second cancer made its appearance 
within 4 years after the first was 
detected.
The 15-year survival curve for the 
129 patients shows a 50% mortality at 
approximately 10 years, slightly better 
than that for the total group of 3558.
At the time of our study (April 1975)
70 were alive and 59 were dead;
53 died as a result of their breast 
cancer and 6 from other causes. Only 
3 of the 48 women in whom the first 
cancer developed before the age of 
70 years died of causes other than 
breast cancer, giving a mortality due 
to breast cancer of 90%.
The clinical stage, the recorded 
histopathology, the type of operation 
and the duration of time at risk after 
the first diagnosis did not differ signif­
icantly between those who lived and 
those who died. The authors conclude 
that age, stage or type of growth, 
operative therapy or time at risk do not 
determine the time of death or alter the 
90% certainty that death will be due 
to carcinoma of the breast.
Sur 3558 femmes atteintes de cancer 
du sein, 129 ont presente un cancer 
primaire bilateral. Chez environ un quart 
(33) d’entre elles les deux cancers se 
sont developpes de maniere synchro- 
nisee; chez les autres (96), le deuxieme 
cancer a evolue en asynchrone, plus 
de 6 mois apres I'apparition de la 
premiere tumeur primaire. Chez deux 
tiers (64) des femmes de ce dernier 
groupe, le deuxieme cancer a fait son
From the department of surgery, McMas- 
ter University, Hamilton, Ont.
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apparition moins de 4 ans apres 
que le premier eut ete detecte.
La courbe de survie a 15 ans pour 
les 129 patientes montre une mortalite 
de 50% apres approximativement 10 ans, 
ce qui est un peu mieux que pour 
I’ensemble des 3558 patientes. Au 
moment de notre etude (avril 1975),
70 patients vivaient et 59 etaient 
decedees; 53 sont mortes de leurs 
cancers du sein et 6 d'autres causes. 
Seulement 3 des 48 femmes dont le 
premier cancer s’est developpe avant 
I’age de 70 ans sont mortes de causes 
autres que le cancer du sein, ce qui 
donne un taux de mortalite due au 
cancer du sein de 90%.
Le stade clinique, I'histopathologie 
observee, le type d’operation et la duree 
du temps d’exposition apres le premier 
diagnostic n'etaient pas significativement 
differents entre celles qui ont survecu 
et celles qui sont mortes. Les auteurs 
concluent que I'age, le stade ou le type 
de tumeur, le traitement operatoire ou 
le temps d'exposition ne determinent 
pas le temps du deces ou n'alterent 
la probability a 90% que le deces sera 
du au carcinome du sein.
Bilateral breast cancer is of continuing 
interest to surgeons, partly because it 
raises the question of whether prophy­
lactic contralateral mastectomy is in­
dicated1-3 and partly because it is a 
biologic curiosity, due to its apparent 
rarity in a breast supposedly subject 
to the same influences that induced 
cancer in the first breast.4'5 A precise 
method of defining the incidence of 
bilateral breast cancer is difficult to 
find;6 groups under observation are not 
always similar, the time between diag­
nosis of the first carcinoma and the 
detection of the second is variable, the 
depletion of the original group at risk 
is difficult to ascertain, follow-up is 
frequently incomplete and results may 
be inexactly reported.2 The average 
time to the diagnosis of a second 
primary tumour has been reported as 
7.4 years by Robbins and Berg,7 6.3 
years by Kilgore, Bell and Ahlquist,8 
6.1 years by Watanatittan and Ram,9 6 
years by Lewison and Neto'° and 5 
years by Farrow.5 All state an “average”
time to a second primary cancer in 
survivors of the original cancer without 
disclosing the decreasing numbers at 
risk as death depletes the initial group. 
Slack and associates11 described pro­
bability of a second cancer as a func­
tion of patient-years at risk. Using data 
collected during the National Cancer 
Institute breast II study they showed 
a gradually decreasing incidence of a 
second primary tumour per patient- 
year at risk, from 5/1000 to 1/1000 
during the 6 years of the study. 
McCredie, Inch and Alderson12 sug­
gested that the rate of development of 
a second carcinoma is 1% per year, 
remaining constant for 20 years.
The study reported herein derives 
from a larger study of 3558 unselected 
women who have been followed up 
after the development of carcinoma 
of the breast. Of this group, 129 
women developed bilateral breast can­
cer, either synchronously (simultaneous­
ly) or metachronously (nonsimultane- 
ously). (We have excluded two cases 
of bilateral inflammatory carcinoma of 
the breast.) We examined the data to 
compare the two sides with respect to 
the type and stage of growth and the 
operation performed. We relate the oc­
currence of the second tumour to the 
number of patients at risk and the 
survival curve of the bilateral cases to 
that for the total group. We report the 
cause of death in those women who 
died after bilateral breast cancer de­
veloped.
Data Utilized
Data for this study were collected by 
the Upstate Medical Center Cancer 
Registry, Syracuse, NY, which has 
been in operation since 1956. Every 
cancer patient in the Syracuse catch­
ment area is registered. The accession 
information includes name, address and 
age, the site, stage and type (histopa­
thology) of tumour, the method of 
treatment and the name of the re­
sponsible physician. Each patient in the 
register or her physician is contacted 
annually. The source of contact is 
recorded and the annual status is shown 
as one of the following:
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Detailed information available on request.
•  Alive, without breast cancer.
•  Alive, with breast cancer.
•  Alive, status unknown.
•  Dead, due to breast cancer.
•  Dead, due to other causes.
•  Dead, cause unknown.
•  Lost to follow-up.
Note is made of all admissions to 
Syracuse area hospitals and charts are 
reviewed upon discharge. When a pa­
tient dies, physicians are contacted, 
hospital records or autopsy reports, or 
both, are reviewed and the cause of 
death is recorded. Our study of the 
records of women with bilateral breast 
cancer began in April 1975. Every 
registrant had been contacted annually 
to the time of death or to Dec. 31, 
1974 and no patient was lost to follow- 
u p .
Since this report is based on a review 
of cancer registry records, not on data 
for individual patients, we do not apply 
the rigorous criteria of Robbins and 
Berg7 for an unequivocal diagnosis of 
bilateral mammary carcinoma. The 
Syracuse registry maintains a registra­
tion card for each separate carcinoma, 
so that two cards are kept for the 
single patient in whom bilateral breast 
carcinoma develops.
Methods
Information from the registry cards 
was transferred to sorting cards accord­
ing to a code that listed year of ac­
cession, age at diagnosis, stage of 
tumour, histopathology, primary treat­
ment and type of operation upon each 
breast. The interval between the first 
appearances of the two tumours, the 
age at death, cause of death and autop­
sy findings were also coded. Hospital 
charts were not reviewed or tumour 
specimens re-examined since this study 
was concerned more with frequency of 
occurrence, cause of death and death 
rates than with type of tumour or 
specific management. In accordance 
with the practice in prior publica­
tions1310 we used three age categories 
(21 to 50 years, 51 to 70 and 71 to 100 
years). The cause of death specified as 
breast cancer on the registry card was
considered reliable: (a) if an autopsy 
had been performed; (b) if the individu­
al had died in a Syracuse area hospital 
and the chart had been reviewed; (c) 
if, prior to the time of death, a letter 
from the responsible physician had 
indicated that the patient was alive 
with the disease; or (d) if the registry 
card showed that therapeutic proce­
dures for breast cancer such as chemo­
therapy, irradiation and hormone 
ablative therapy had been carried out 
during previous hospital admissions. 
For seven cases that did not satisfy 
these criteria, the registry personnel 
reinstituted a search to determine the 
cause of death by once again contact­
ing the physician, family or other in­
dividuals acquainted with the patient 
at or near the time of death. Table I 
sets forth, according to the three age 
groups, the status (alive or dead) of 
the 129 patients and also indicates the 
cause of death.
Accession Data
Age at Diagnosis
Fig. 1 shows the age of the 129 pa­
tients at the time of first diagnosis. 
There was no significant difference be­
tween those who lived (“alive group”) 
and those who died (“dead group”) in 
regard to age at diagnosis or whether 
the two breast cancers appeared syn­
chronously or metachronously. This 
group of 129 patients was substantially 
younger than the group of 3558 from 
whom this subset is drawn.12'15
Timing of Bilaterality
Fig. 2 shows the time distribution of 
occurrence of the second cancer. Two 
cancers developed in 33 of these 129 
patients within an interval of less than 
6 months (an incidence of slightly less 
than 1% [0.93%] in the entire series 
of 3558 patients) and these were con­
sidered synchronous. In 96 women the 
second cancer developed after a longer 
interval—metachronously. In 48 pa­
tients with metachronous tumours the 
second carcinoma developed within 3 
years, in 16 the second cancer occurred 
in 3 to 4 years and in 32 the second
T a b le  1— N u m b er o f  C ases  o f B i la te ra l  M a m m a ry  C arc inom a in  Each o f T h r e e  A g e  G roups
A g e C a u s e  o f d e a th N o . on w hom  
au to p s y  w as  
p e rfo rm e d
g ro u p ,
y r
N o . o f 
p a tie n ts S ta tu s S yn ch ro n o u s M eta ch ro n o u s
B re a s t
c a n c e r O th e r
21 -  50 61 A liv e  28 4 24
51 -  70
D ead  33 6 27 32 1 1446 A liv e  31 8 23
71 -  100
D ead  15 7 8 13 2 2
22 A liv e  11 3 8
T o ta ls
D ead  11 5 6 8 3 i129 A liv e  70 15 55
D ead  59 18 41 53 6 17
cancer was first noticed between 5 and 
20 years after the development of the 
first. There appears to be a consistent 
annual percentage of occurrence of a 
second tumour when account is taken 
of the decreasing numbers at risk with 
the passage of time.12 The depletion 
curve for the 3558 patients was affected 
by death as well as by reduction in 
numbers at risk due to recent entrance 
into and insufficient time in the registry 
files, that is, the group considered 
withdrawn alive ' in the calculation of 
life tables.16
Stage of the Disease
The stage of the cancer at the time 
of diagnosis was determined by clinical 
examination, supplemented by the pa­
thologist’s report whenever axillary 
nodes were examined. The staging was 
as follows: stage I—tumour limited to 
the breast; stage II—tumour known to 
be present in the axillary lymph nodes; 
stage III—disseminated carcinoma; and 
stage IV—unspecified. The initial car­
cinoma and the second carcinoma were 
staged as shown in Table II. There was 
no significant difference in the stage 
observed between the first and the sec­
ond appearance of the disease or be­
tween the alive and the dead groups.
H istopathology
Brief notes made on the registry cards 
permitted identification of the histopa­
thologic type in accordance with diag­
noses made by pathologists of the
3
Z
UJ>
Zi<
Q
2O
FIG. 1— Age distribution of 129 women 
m whom bilateral breast carcinoma de­
veloped. Age is shown as age at time of 
diagnosis of first carcinoma. Distribution 
suggests slightly higher incidence of syn­
chronous breast cancers in older women.
FIG. 2— Annual occurrence of second 
cancers in 129 patients shown in relation 
to number at risk derived from total group
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Table I I— The Three Age Groups Showing Stage a t Tim e of Diagnosis of 
First and Second Cancers According to Age Group
Stage
I
Breast only Axilla
I I I
Disseminated
IV
Unspecified
Age group,
yr
No. of 
patients Status
1st
tumour
2nd
tumour
1st
tumour
2nd
tum our
1st
tumour
2nd
tumour
1st
tumour
2nd
tumour
21 -  50 61 Alive
Dead
18
35
17
21
37
16
7
14
7
4
18
14
0
2
2
1
3
2
3
10
7
2
3
1
51 -  70 46 Alive
Dead
18
23
5
17
21
4
13
21
8
10
20
10
0
0
0
1
1
0
0
2
2
3
4
1
71 -  100 22 A live
Dead
8
13
5
8
13
5
1
2
1
1
3
2
0
2
2
0
2
2
2
5
3
2
4
2
Totals 129 Alive 44 46 21 15 0 2 5 7
71
Dead 27
71 37
25 16
41 17 11
26 12
Table I I I— Histopathologic Type of First and Second Cancers in Three Age Groups
Duct cell 
carcinoma
Scirrhous
carcinoma
Anaplastic
carcinoma
Adeno­
carcinoma Other Unspecified
Age group,
yr Status
1st
tumour
2nd 1st 
tumour tumour
2nd
tumour
1st
tumour
2nd
tumour
1st
tumour t
21 -  50 Alive 28 14 19 - 5 2 4 i
Dead 33 15 19 - 3 - 8 6
51 -  70 Alive 31 15 14 4 9 - 8 4
Dead 15 8 9 - 4 - 2 1
71 -  100 Alive 11 5 3 1 7 1 1 1
Dead 11 6 4 - 4 - 1 2
Totals Alive 70 34 36 5 21 3 13 6
Dead 59 29 32 ~ 11
'
11 9
Table IV— Frequencies w ith Which Both Breasts Had
Similar or Dissimilar Histopathologic Findings
Age group, Both sides No.
yr Status sim ilar sim ilarity
21 -  50 Alive 28 14 14
Dead 33 16 17
51 -  70 Alive 31 13 18
Deac 15 8 7
71 -  100 Alive 11 4 7
Dead 11 6 6
Totals Alive 70 31 39
Deac 59 30 29
2nd 1st 2nd 1st 2nd
10
5
8
5
3
2
21
12
age groups, it was apparent that radical 
mastectomy was the treatment of choice 
for the younger women and slightly 
less so for the group over 70 years of 
age (Table V). It is also apparent that 
radical mastectomy, although accept­
able treatment for the first manifesta­
tion of cancer, was employed far less 
frequently for the second tumour, a 
difference that is highly significant 
(P <  0.001). There was no difference 
in the mode of primary treatment be­
tween patients in the alive group and 
those in the dead group.
Syracuse area. In reviewing the entire 
registry effort, we noted15 wide varia­
tions in the classification of breast car­
cinoma among the various pathologists, 
but by the late 1960s the influence of 
the United States Armed Forces Insti­
tute of Pathology fascicle was apparent 
and histopathologic typing became 
more uniform. Disparities among the 
several pathologists were not examined 
and this study reports only the recorded 
diagnoses. Table III lists the types of 
tumour diagnosed in the initial and sec­
ond cancer. There was no appreciable 
difference in type of tumour observed 
between the first and the second ap­
pearances of the disease or between the 
alive and the dead groups. Table IV 
notes the presence or absence of histo­
logic similarities between the tumours 
on each side.
Primary Treatment
The primary treatment for 124 of 
the 129 women was ablation of the 
breast. The five women who did not 
undergo a breast resection were con­
sidered to have stage III disease when 
first seen and underwent radiation 
therapy, oophorectomy and chemo­
therapy, variously combined. When the 
women were divided into the three
Outcome
Rate of Death
The survival curve for the 129 pa­
tients, plotted by life-table analysis 
(Fig. 3),16 shows a half-death (T/2) 
time (i.e., 50% of patients are dead) 
of approximately 10 years, compared 
with 7.5 years for the women in the 
unselected group of 3558. When per­
centage survival is plotted semi-logarith- 
mically (Fig. 4) a slow death rate is 
demonstrated in the first 5 years, then 
there is a decay curve that appears 
reasonably close to a single exponential 
from the 7th to the 15th years.17 This
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1Table V—Operative Treatment Employed for First and Second Cancers
A g e  g roup , 
y r
R a d ic a l 
m a s te c to m y  
no. (a n d  % )
M o d ifie d
ra d ic a l
m a s te c to m y
S im p le
m a s te c to m y U n s p e c ifie d
S ta tu s
1st
tu m o u r
2nd
tu m o u r
1st
tu m o u r
2nd
tu m o u r
1s t 2nd  
tu m o u r  tu m o u r
1st
tu m o u r
2nd
tu m o u r
21 -  50 
51 -  70 
71 -  100 
T o ta ls
A liv e
D ead
A liv e
D e a d
A liv e
D ead
A liv e
D ead
28
33
31
15
11
11
70
59
24 (8 5 )  
28 (8 5 )  
27 (8 7 )  
12 (8 0 )
5 (4 5 )
6 (5 5 )  
56 (8 0 )  
46 (7 8 )
19 (6 8 )  
19 (5 8 )  
14 (4 5 )  
9 (6 0 )
3 (2 8 )
4 (3 6 )  
36 (5 2 )  
31 (5 2 )
2
1
3
1
2
1
7
3
4
8
8
2
1
1
13
11
1
2
1
2
4
2
6
6
5
3 
9
4 
7 
4
21
11
1
2
2
1
4
3
2
5
line, when its points are calculated by 
the method of least squares, shows a 
T /2  of approximately 7 years, a fig­
ure also slightly in excess of that seen 
in an unselected population of women 
with breast cancer.13"18 The figures for 
our curves were terminated at 15 years 
because only six women were at risk 
for the 16-year computation.
FIG. 3—Survival curve constructed by 
life-table method16 showing that half of 
women survived for 10 years. This group 
of patients with bilateral breast carcinoma 
cannot be identified at time of diagnosis 
of first cancer.
TIG. 4—Survival curve constructed by 
life-table method and presented as logarith­
mic plot, suggesting that rate of dying is 
constant between Sth and 15th year.15'17
Cause of Death
Fifty-nine patients from our group 
were dead and 70 were still alive at the 
time this review was compiled. Fifty- 
three deaths were from breast can­
cer and six were from other causes. 
Table I shows that only 3 of 48 women 
in whom the cancer developed before 
the age of 70 years died of other 
causes, representing a 94% mortality 
due to cancer of the breast in the two 
younger age groups.
Discussion
The reported frequency of bilateral 
carcinoma varies from 1% to 12% of 
all women in whom breast cancer de­
velops. 1"“'18,19 -phis frequency is ob­
viously difficult to determine, because 
in order for the second primary breast 
cancer to develop, the women must 
survive the first and have sufficient 
time at risk for the second to develop 
while others in the same group at risk 
are dropping out because of the mor­
tality induced by the first carcinoma. 
In the total group of 3558 women with 
breast cancer, bilateral carcinoma had 
developed synchronously in 33, but 6 
months to 4 years elapsed before the 
appearance of the second carcinoma in 
64 of the remaining 96. During this 
time the basic population at risk (3558 
women) was being depleted owing to 
death before sufficient time at risk had 
elapsed for a contralateral tumour to 
develop. The ultimate rate of occur­
rence for bilateral disease is therefore 
difficult, if not impossible, to determine 
with any finality. It is probably in the 
range of 2.5% to 5% of all women in 
whom unilateral breast cancer develops.
A better means of expressing bila­
terality seems to be a statement of its 
annual incidence among those at risk. 
From Fig. 2 bilaterality appears to 
have an occurrence rate of 0.8% to 
1.0% per year in the population at risk 
(3558 patients), continuing for at least 
15 years.12 This figure is probably use­
less except to remind the clinician that 
second cancers do occur. Sufficient
survival time from the diagnosis of the 
first cancer is required for a second 
primary to appear. This occurs by the 
end of the fifth year in 75% of such 
cases. The basic group (3558 patients) 
from which this review is drawn con­
sisted of all women with cancer of the 
breast and included a number in whom 
the diagnosis was made at or just be­
fore death, as well as others destined 
to die early (i.e., those classified as 
stage III). Since this total group of 
women is used as the reference base, 
the percentage with bilateral carcinomas 
should be, and is, somewhat lower than 
that reported in studies conducted only 
upon women subjected to curative ef­
forts on one side.12
In the absence of a specific review 
of the histopathology by examining the 
actual microscopy specimens, the pre­
cise definition of pathologic type was 
not possible in this study. In 50% of 
cases the tumour type of the second 
lesion was the same as in the first and 
this similarity did not seem to affect 
the outcome. This leads to speculation 
that the histopathologic features may 
be of minimal importance in determin­
ing the ultimate outcome—the time and 
cause of death.
The stage of the disease at the time 
of diagnosis was similar in both the 
initial and the second breast tumours, 
a fact that must reflect both on the 
vigilance of the physicians who treated 
these women and on the eagerness with 
which the women appeared for follow­
up examination. It is somewhat sur­
prising that in these women, who had 
already had one primary breast tumour, 
the second tumour was not detected at 
an earlier stage and tumours classified 
as stage I were not found with increas­
ing frequency in the second breast. 
With regard to the ultimate outcome, 
the therapeutic effort employed seemed 
to have little effect upon the cause of 
death (i.e., these women died of their 
cancer), although a delay of death is a 
possibility not measured in this study. 
Mastectomy should probably be used 
only to rid the patient of a mass on
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the chest wall and should not be con­
sidered an effort to avert the death that 
is caused by distant metastases. We 
found nothing in this study to permit 
the claim that one operative procedure 
more than another can delay death or 
produce a cure.
There is reason to suppose that, as 
more time elapses, in those women who 
are still alive death will probably result 
from the same causes as were operative 
in those who have died, since the initial 
data are similar. Analysis showed that 
the duration of time at risk was the 
same for both the alive and dead 
groups, so that the force of mortality 
is not expressed simply in terms of time 
at risk. Each year some of the women 
at risk die of their disease. This frac­
tion is fairly constant through the years 
and seems to remain so for at least 15 
years.15 The alive/dead ratio of total 
registrants reflects the continuous entry 
into and departure (by death) from 
the register of women who have breast 
carcinoma.
Carcinoma of the breast is a lethal 
disease. There is little evidence in this 
study that the initial stage, histopa­
thologic features, age at diagnosis, or 
treatment alters the outcome when 
measured as cause of death. One is left 
with the unsatisfying explanation that 
some vague element designated as 
“host-tumour relationship” is probably 
the significant variant. If it is assumed 
that both breasts are subjected equally 
to the forces of carcinogenesis, one 
may wonder why so few women have 
bilateral breast cancer, rather than why 
so many women do. The time to T /2 
is longer for the group with bilateral 
cancer than for the group with uni­
lateral disease, probably partly because 
the time required for expression of the 
disease in the second breast is suffi­
ciently long that mortality due to the 
primary disease must be delayed. Also 
it is partly a function of the patient’s 
age at the time of diagnosis. The bila­
teral group contains a greater propor­
tion of younger women, in whom the 
decay curve15 is slower than in the 
older women.
There was nothing in the information 
from the register (i.e., stage, histologic 
type, operation, or time at risk) that 
distinguished the alive group from the 
dead group, and the inevitable conclu­
sion is that the forces defining the time 
of death are not measurable in the 
clinical setting at the time of initial 
diagnosis. Pearlman20 has recognized 
this and has approached the problem 
by attempting to measure cancer ag­
gressiveness, which relates to the time 
of first appearance of metastases. The 
nonspecific term “host-tumour relation­
ship” is an immunologic term today 
and may be an important determinant 
of the outcome. Even though treatment
may delay the apparently inevitable 
death due to breast cancer (in 90% 
of patients with the disease) and may 
influence the quality of life either 
adversely or favourably, it appears that 
cancer of the breast must be viewed as 
a systemic disease in which surgical re­
moval of the initial manifestation is 
unrelated to the ultimate expression of 
the disease, namely, death. Bilateral 
disease is another illustration of the 
lethal enigma of breast cancer.
Conclusions
Carcinoma of the second breast oc­
curs at a steady rate of slightly less 
than 1% per year among women at 
risk.
Ninety percent of the women in 
whom bilateral carcinoma of the breast 
develops die of this disease.
Development of the second carcino­
ma does not significantly enhance the 
lethality of the first breast cancer and 
survival curves do not show an increased 
rate of dying due to the second cancer.
Half of the women who have bila­
teral! carcinoma are dead within 10 
years after diagnosis of the first carci­
noma.
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Esophagoatrial Fistula
Kevin Cunnane, mb, ch b, frcp[c]
The author describes a case of eso­
phagoatrial fistula— an extremely rare 
condition. A 79-year-old man had had 
epigastric pain for 4 weeks. Physical 
and roentgenographic examinations 
disclosed atrial fibrillation with a systolic 
murmur and an ulcer of the lower 
esophagus which, on histologic examin­
ation, was benign. No specific treatment 
was recommended. The patient died 
suddenly 3 months later from massive 
gastrointestinal hemorrhage which, at 
autopsy, was found to be due to an 
esophagoatrial fistula. A review of the 
literature showed that this case differed 
from others previously reported in that 
the duration of symptoms up to the 
time of death was only 4 months and 
the patient had no embolism.
L auteur decrit un cas de fistule 
oesophagoauriculaire, une affection 
extremement rare. Un homme de 79 
ans s etait plaint de douleur epigastrique 
d'une duree de 4 semaines. Les 
examens physiques et radiologiques 
ont revele une fibrillation auriculaire 
avec murmure systolique et un ulcere 
de I’oesophage inferieur qui, a I’examen 
histologique s’est revele benin. Aucun 
traitement specifique n'a ete recom- 
mande. Le patient est decede 
soudainement, 3 mois plus tard, d’une 
hemorragie gastrointestinale massive 
qui, a I’autopsie, s’est avere etre due 
a une fistule oesophagoauriculaire.
Une revue de la litterature a montre 
que ce cas differait des autres signales 
precedemment, par la duree des 
symptomes jusqu’a la mort, qui n’a 
ete que de 4 mois, et par le fait que 
le patient n’a pas eu d’embolie.
A fistulous communication between the 
esophagus and left atrium is extremely 
rare. Six cases have previously been re­
ported.1'6 An additional case is de­
scribed.
Case Report
A 79-year-old man was admitted to
From the department of pathology, 
Chedoke Hospitals, Hamilton, Ont.
Reprint requests to: Dr. K. Cunnane, 
Pathology department, County Hospital 
Mullingar, Co. Westmeath, Ireland
hospital for investigation of epigastric pain 
of 1 month’s duration. The pain was de­
scribed as a constant dull ache located 
high in the epigastrium. It was not influ­
enced by taking food but was partly re­
lieved by antacids. There were no other 
symptoms (e.g., nausea, vomiting, dyspha­
gia). The patient was a nonsmoker and a 
teetotaller.
On physical examination he was found 
to have atrial fibrillation and a loud sys­
tolic murmur maximal at the apex and 
transmitted to the left axilla. The other 
findings were normal. An electrocardio­
gram confirmed the presence of atrial 
fibrillation and showed no evidence of 
infarction.
Results of laboratory investigations 
were essentially within normal limits. 
Chest roentgenograms showed normal 
lung fields. Roentgenography of the upper 
gastrointestinal tract showed an ulcer in 
the lower part of the esophagus; the 
stomach and esophagogastric junction were 
normal. Endoscopy revealed a flat ulcer
FIG. 1—Oval ulcer on anterior wall of 
lower third of esophagus.
covered by a grey slough on the anterior 
wall of the lower esophagus. The lumen 
of the esophagus did not appear constricted 
and the stomach appeared normal. His­
tologic examination of a biopsy specimen 
from the ulcer identified only necrotic 
debris and granulation tissue. Smears 
showed mixed gram-positive cocci and 
bacilli but no fungi. The patient was given 
no specific treatment and was discharged 
following some alleviation of symptoms.
He continued to experience intermittent 
attacks of epigastric pain for which he 
took a variety of antacids. Three months 
after discharge he collapsed suddenly at 
home. On admission to the emergency de­
partment of the nearest hospital the patient 
was unconscious and his blood pressure 
could not be recorded. He vomited fresh 
blood and died while resuscitative proce­
dures were being instituted.
Autopsy Findings
The stomach and proximal small 
bowel contained about 2000 mL of 
partly clotted blood. An oval ulcer 
measuring 3 X 2  cm was present on the 
anterior wall of the esophagus at the 
junction of the middle and lower thirds 
(Fig. 1). The esophagus at this point 
was densely adherent to the pericar­
dium. A small opening (diameter, 0.1 
cm) was discovered in the centre of the 
esophageal ulcer leading to a tract that 
penetrated the esophageal wall and the 
posterior wall of the left atrium. The 
remainder of the esophagus appeared 
normal apart from glycogenic acantho­
sis.7 The pericardial cavity was obliter­
ated by fibrous adhesions. When the 
heart was opened, a small ulcer (dia­
meter, 0.1 cm) was found on the pos­
terior wall of the left atrium about 1 
cm above the mitral valve. There was 
calcific aortic stenosis with left ventri­
cular hypertrophy.
Histologic sections and smears of the 
esophageal ulcer had an appearance 
similar to that observed in the initial 
investigation (Fig. 2). Sections from the 
centre of the ulcer showed a fistulous 
tract penetrating the esophageal wall 
(Fig. 3). Necrotic atrial myocardium 
was present on the cardiac aspect of 
the fistula. None of the sections showed 
evidence of neoplasia or of granulomas. 
Numerous sections taken from the 
esophagus distal to the ulcer showed 
normal squamous epithelium with no 
evidence of glandular metaplasia. Hy-
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perplastic changes were present in sec­
tions of mediastinal lymph nodes.
Discussion
Nontraumatic fistulas have been de­
scribed between the esophagus and 
pericardium,8 esophagus and left ven­
tricle,1 and esophagus and left atrium.1'6 
Sixteen cases of esophagopericardial fis­
tula were found by McDaniel and 
Knepper8 in a review of the literature 
and they described an additional case. 
Prolla, Taebel and Kirsner1 discovered 
in the literature accounts of seven cases 
of perforation of the left ventricle by a 
benign gastric ulcer. Six cases of eso- 
phagoatrial fistula have been de­
scribed.1'6 Like the case described here 
these opened into the left atrium and 
were diagnosed at autopsy. Five of the 
patients had long-standing peptic eso­
phagitis ranging in duration from 2 
years2 to 20 years.3 One patient had 
achalasia and esophageal carcinoma.4 
Hematemesis was a prominent feature 
of the terminal episode in three of these 
cases;1'3,5 particles of vegetable matter 
and debris were observed in the cere­
bral vessels in two of them.3,5
The case reported here differed from 
those previously described in that the 
duration of symptoms before the ter­
minal episode was only 4 months. The 
cause of the esophageal ulcer was un­
known. There was neither endoscopic 
nor roentgenographic evidence of pep­
tic esophagitis. Distal to the ulcer the 
esophagus was lined by squamous epi­
thelium, not the columnar type usually 
seen distal to midesophageal peptic ul-
FIG. 2—Esophageal surface of ulcer 
showing granulation tissue covered by 
necrotic debris (hematoxylin and eosin, 
reduced by 37% from X200).
cers.9 This squamous epithelium did not 
show the basal hyperplasia and elong­
ated submucosal papillas described in 
reflux esophagitis by Behar and 
Sheahan.19 There was no evidence of 
carcinoma or of granulomas. No fungi 
were seen on sections stained with Gro- 
cott’s stain. McManus and Webb11 de­
scribed an esophageal ulcer in a 67- 
year-old woman caused by Lactobacillus 
acidophilus following therapy with oral­
ly administered tetracycline. Although 
some gram-positive bacilli were seen in 
the necrotic debris covering the ulcer 
in the present case, there was no sem­
blance of a mycelial arrangement as 
described by McManus and Webb.11 
Furthermore, the bacilli were mingled 
with gram-positive cocci suggestive of 
colonization of the ulcerated surface 
by mixed bacteria.
Esophageal ulceration has been as­
sociated with various drugs12'14 but this 
patient was not taking any medication 
prior to the onset of symptoms. Ulcera­
tion of the esophagus has also been de­
scribed in Behcet’s syndrome,15 but no 
other features of the syndrome were 
present.
The presumed terminal event in this 
patient was erosion of the fistula into 
the lumen of the left atrium resulting in 
massive hemorrhage, syncope and 
death. Unlike patients from some pre­
viously described cases,3,5,6 this patient 
had no findings indicative of embolism.
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includes discussions on pediatric and 
adolescent gynecology, diseases of the 
vulva, infections, endometriosis, inconti­
nence of urine and shock.
In the first section there is an interest­
ing and clinically oriented chapter on 
anatomy that was a pleasure to read. 
Other chapters are devoted to cytology, 
genetics and developmental anomalies; 
these are clinically oriented and helpful.
The section on function contains the 
usual chapter on ovulation, menstruation 
and ovarian function. There is a detailed 
discussion on dysfunctional uterine bleed­
ing and another on the polycystic ovary; 
the latter includes material on androgen 
production in the female and an evalua­
tion of hirsutism. This section also in­
cludes long, well-referenced chapters on in­
fertility and family planning and two short­
er chapters on the menopause and psy- 
chosexual and psychosomatic gynecology.
Under the heading of neoplasms there 
is an entire chapter devoted to radiation 
therapy; this includes not only an ex­
planation of the nature and effects of 
ionizing radiation but also details of 
radiation treatment for each form of 
gynecologic cancer. Radiation therapy is 
also described in the chapters on carcino­
ma of the cervix and carcinoma of the 
endometrium and, as is inevitable in a 
multiauthored book, there is some du­
plication and disagreement. It was sur­
prising to read in the chapter devoted to 
radiation that in-situ carcinoma can be 
treated with one radium insertion and in 
the same paragraph, “for microinvasive 
carcinoma of the cervix, two radium in­
sertions of 48 hours for a total of 8000 
mg-hrs of radium are adequate”. Therapy 
for carcinoma in situ is becoming more 
conservative and this conservatism is re­
flected in the chapter on carcinoma of the 
cervix. It therefore does not seem reason­
able that radium should ever be con­
sidered. Treatment is surgical; the deci­
sions should only have to do with how 
much surgery is necessary. Treatment for 
microinvasive carcinoma may be a little 
more controversial, but surely milligram- 
hours as a measurement of radiation is 
obsolete.
In the management of endometrial car­
cinoma, surgery with preoperative radia­
tion, surgery with postoperative radiation 
or vaginal irradiation and even irradiation 
alone for the poor-risk patient are all 
compared. Unfortunately, the authors have 
not described which patients should be 
treated with surgery alone. Many patients 
whose disease is diagnosed very early and 
who have a well-differentiated tumour may 
well be spared the discomfort and mor­
bidity of radiotherapy.
Again, because of the multiple authors 
involved in the preparation of this text, 
there is some duplication and omission. 
The physiology of menstruation is dis­
cussed at least three times; on the other 
hand, no outline is provided for the in­
vestigation of the adolescent with delayed 
menarche or secondary amenorrhea.
Included in the book is a good discus­
sion on predisposing factors and the role 
of estrogen in the development of endo­
metrial carcinoma, but the factors that 
may play a role in the etiology of cervical 
cancer are not included.
Most of the book is well written and 
easy to read. The print is clear and 
“boxed” headings stand out well on the 
page. Nearly all the chapters have biblio­
graphies and some of these are lengthy. 
The index is adequate. I think that this 
book is small enough to be convenient 
and detailed enough to be useful.
One closing point: after all the criticism 
the feminists have heaped on the gyne­
cologists for their patronizing attitude to 
women, it is a little disconcerting to read 
in the chapter on pediatric gynecology, “It 
is often valuable to comment favorably 
on her appearance and dress because, like 
many women, the young girl will usually 
respond.” More fuel for the fire^
E m i l y  J .  G e a r
Department of obstetrics and gynecology, 
Ottawa Civic Hospital,
Ottawa, Ont.
THE YEAR BOOK OF PLASTIC AND  
RECONSTRUCTIVE SURGERY. 1977. 
Edited by Frederick J. McCoy, Reed 
O. Dingnian, Dwight C. Hanna and 
others. 405 pp. Illust. Year Book Medi­
cal Publishers, Inc., Chicago, 1977. 
Price not stated. ISBN 0-8151-5818-1.
The format of the 1977 year book of 
plastic and reconstructive surgery fol­
lows previous patterns and represents ma­
terial published up to luly 1976.
The book is divided into sections deal­
ing with congenital anomalies, neoplastic, 
inflammatory and degenerative diseases, 
trauma, aesthetic surgery, grafts and trans­
plantation, and general topics. The editors 
have included articles of special interest 
to the plastic surgeon from the allied spe­
cialties and the related basic sciences. At 
the beginning of the text is a series of 
55 questions related to the material 
furnished in the review. It is the reader’s 
task to seek the correct answers in the 
various sections of the book.
The editorial panel has selected pro­
vocative and fairly relevant articles. A 
conscientious reader of Plastic and Re­
constructive Surgery, the British Journal 
of Plastic Surgery and the Scandinavian 
Journal of Plastic and Reconstructive Sur­
gery will recognize that the bulk of the 
material in the year book comes from 
these sources.
There are numerous reviews of the 
European literature; the editors offer a 
quick recapitulation of articles and refer­
ences to the important papers. Most ab­
stracts of the material have already ap­
peared in Plastic and Reconstructive Sur­
gery, however, the material is presented 
here in greater depth, with carefully re­
produced illustrations.
As in previous issues, the editorial con­
sultant has included personal comments 
on the impact and interpretation of some 
of the articles. These will be of special 
value to the younger surgeon.
P a u l  R .  B e n o i t
Ste. 104,
340 McLeod St.,
Ottawa, Ont.
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